Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Patent applications/Patents.
- Presentations.
- Advised theses.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Zatloukal Kurt |

Presentations at scientific and public conferences

Zatloukal, K Quantum resistant cryptographic technology-based data repository for high and maximum containment laboratories.
1st International Conference on Hungarian National Biosafety; MAR 13-14, 2025; Pécs, HUNGARY. 2025. [Oral Communication]

Föderl-Höbenreich,E; Mach,L; Vergara,J; Zatloukal, K An in planta expressed ACE2-Fc decoy shows broad neutralization activity against SARS-CoV-2 variants and demonstrates in-vivo efficacy in a therapeutic hamster model
ÖGMBT Annual Meeting; SEP 17-19; Graz, AUSTRIA. 2024. [Poster]

Hardt, M; Kicker, E; Panzitt, K; Zatloukal, K Establishment of human Precision Cut Organ Slices as an ex vivo model for human respiratory viruses
24th European Congress on Alternatives to Animal Testing; SEP 18-20, 2024; Linz. 2024. [Poster]

Hardt, M; Kicker, E; Panzitt, K; Zatloukal, K Precision Cut Organ Slices
; OCT 25, 2024; 2024. [Onlinepräsentation]

Hardt, M; Kicker, E; Panzitt, K; Zatloukal, K Establishment of human Precision Cut Lung Slices as an ex vivo model for human respiratory viruses
ÖGMBT; SEP, 16-19, 2024; Graz, AUSTRIA. 2024. [Poster]
FullText

Hardt, M; Kicker, E; Panzitt, K; Zatloukal, K Establishment of human Precision Cut Lung Slices as an ex vivo model for human respiratory viruses
33rd Annual Meeting of the Society for Virology; MAR 25-28. 2024; Vienna . 2024. [Poster]

Hardt, M; Kicker. E; Panzitt, K; Zatloukal, K Generation of human Precision Cut Organ Slices as ex vivo models
24rd European Congress on Alternatives to Animal Testing (EUSAAT); SEP 18-20, 2024; Linz, Austria. 2024. [Poster]
FullText

Kicker, E; Zatloukal, K; Abuja, P.M; Harant, H Differential sensitivity of SARS-CoV-2 virus variants to the antiviral peptide TAT-I24
33rd Annual Meeting of the Society for Virology ; MAR 25-28, 2024; Vienna, Austria . 2024. [Poster]
FullText

Zatloukal, K Biobanking for Global Pandemic Responses: Working with Bangladesh.
Roundtable on "Biobanking with Bangladesh"; JAN 29, 2024; 2024. [Oral Communication]

Zatloukal, K The importance of fixation for proper analysis in anatomic and molecular pathology.
7th Pannonia Congress of Pathology; MAR 7-9, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

Zatloukal, K Innovationszyklen in der Pathologie.
Helmut Denk Symposium: Innovationszyklen in der Pathologie: Einfluss auf Forschung und Lehre; MAR 15, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

Zatloukal, K Panel discussion: UN Report: Governing AI for Humanity: Implications for Health Research.
Science Summit 2024 ; SEP 17-27, 2024; New York, USA. 2024. [Oral Communication]

Zatloukal, K BBMRI-ERIC (and BBMRI.at)...how it began.
Europe Biobank Week; MAY 14-17, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

Zatloukal, K 1x1 der künstlichen Intelligenz in der Medizin.
Jahrestagung der Österreichische Gesellschaft für Dermatologie und Venerologie; NOV 28-30, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

Zatloukal, K Trusted Data Environment for Digital Transformation of Health Systems: Role of Biobanks.
Biobanking and Digital Pathology in the Context of the UN Sustainable Development Goals; MAY 27-31, 2024; Geneva, AUSTRIA. 2024. [Onlinepräsentation]
FullText

Zatloukal, K Changes in research paradigms and the impact on medicine.
21st International medical doctoral conference; NOV 20-22, 2024; Hradec Králové, CZECH REPUBLIC. 2024. [Oral Communication]

Zatloukal, K Africa and the EU Global Health Strategy (Panel discussion).
4th AERAP Africa-Europe Science Collaboration Forum; APR 22-25, 2024; Brussels, BELGIUM. 2024. [Oral Communication]

Zatloukal, K Chair of session "Partnerships towards real world data - Opportunities, needs and hurdles”.
Europe Biobank Week; MAY 14-17, 2024; Vienna, AUSTRIA. 2024.

Zatloukal, K Using AI in Digital Pathology – Opportunities and Regulatory Challenges.
107. Jahrestagung der Deutschen Gesellschaft für Pathologie 2024 ; MAY 23-25, 2024; Munich, GERMANY. 2024. [Oral Communication]

Zatloukal, K ISO/AWI 24051-2: Medical laboratories — Part 2: Digital pathology and artificial (AI)-based image analysis.
ISO/TC 212 Working Group 4 - Microbiology and molecular diagnostics; JUN 12-14, 2024; Berlin, GERMANY. 2024. [Oral Communication]

Zatloukal, K Panel discussion: Summit of the Future.
Science Summit 2024 - One Health Science Summit Plenary; SEP 17-27, 2024; New York, USA. 2024. [Oral Communication]

Zatloukal, K Capacity Building for Pandemic Preparedness.
African Science Leadership for The Summit of the Future: Off Site event of the UN Civil Society Conference in support of the UN Summit of the Future; MAY 9, 2024; Nairobi, KENYA. 2024. [Onlinepräsentation]

Zatloukal, K Future perspectives of autopsies and autopsy research: High level biosafety, virtopsy and the application of artificial intelligence.
XXXV Congress of International Academy of Pathology (IAP 2024); OCT 27-31, 2024; Cancun, MEXICO. 2024. [Oral Communication]

Zatloukal, K Chair of session "Machine Learning & AI Clinical Application I".
20th European Congress on Digital Pathology; JUN 5-8, 2024; Vilnius, LITHUANIA. 2024.

Zatloukal, K Introduction to Integrated and Standardised NGS Workflows for Personalised Therapy .
NGS for Precision Medicine and Pharmacogenomics in Cancer ; APR 9, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

Zatloukal, K Standardization of pre-analytics and sample quality.
Platomics IVDReady Webinar 5 - GSPRs are challenging, standards are beautiful with Professor Kurt Zatloukal; JAN 30, 2024; Vienna, AUSTRIA. 2024. [Onlinepräsentation]
FullText

Zatloukal, K Cybersecurity meets biosecurity.
QCI Days; JAN 26, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

Föderl-Höbenreich, E; Groiss, S; Hardt, M; Pabst, D; Beller, M; Korfhage, C; Zatloukal, K Quantitative spatial mapping of complex host response dynamics to SARS-CoV-2 infection.
ISCOMS; JUN 5-8 2023; Groningen . 2023. [Poster]

Hardt, M; Zatloukal, K; Popper, H 3D model to study migration and invasion of lung cancer.
Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3614.. 2023; 83(7_Supp):-Proceedings of the American Association for Cancer Research Annual Meeting; APR 14-19, 2023; Orlando, FLORIDA. [Poster]
FullText

Hardt, Melina; Groiss, Silvia; Zatloukal, Kurt; Popper, Helmut; Gruber, Karl Establishing of 3D cell culture models to study infectious diseases and cancer
x. 2023; -ISCOMS; JUN 5-8, 2023; Groningen, NETHERLANDS. [Poster]

Kicker, E; Zatloukal, K; Abuja, P; Harant, H Molecular interference with SARS-CoV-2 replication by the antiviral peptide TAT I24
ISCOMS ; JUN 5-8, 2023; Groningen; Niederlande. 2023. [Poster]

Poelzl, S; Rieger, J; Zatloukal, K; Stummer, M; Hinterer, A; Kittinger, C Comparison of bacteriophage ɸ6 and SARS-CoV-2 in antimicrobial surface tests
26. DOSCH-Symposium der ÖGHMP; MAY 8-10, 2023; Velden, AUSTRIA. 2023. [Poster]

Poelzl, S; Rieger, J; Zatloukal, K; Stummer, M; Hinterer, A; Kittinger, C Comparison of bacteriophage ɸ6 and SARS-CoV-2 in antimicrobial surface tests
Federation of European Microbiological Societies; JULY 9-13, 2023; Hamburg, GERMANY. 2023. [Poster]

Zatloukal, K Was wird benötigt, um auf zukünftige Pandemien rascher reagieren zu können?
Covid-19 Mini-Symposium; DEC 7, 2023; Graz, AUSTRIA. 2023. [Oral Communication]

Zatloukal, K Digital Pathology and AI: from research to medical application.
UCD module PATH40050 AI & Digital Pathology; JUL 31, 2023; Dublin, IRELAND. 2023. [Keynote lecture]

Zatloukal, K Panel discussion: IVDR: Challenges & solutions for manufacturers, diagnostic laboratories and for self-testing.
Diagnostics-4-Future Conference; OCT 16-17, 2023; Konstanz, GERMANY. 2023.

Zatloukal, K Special Topics in Biobanking: Standardization of Pre-analytics and Sample Quality - Increasing Role of Data.
MSc Biobanks & Complex Data Management program, Côte d'Azur University; OCT 13, 2023; Nice, FRANCE. 2023. [Onlinepräsentation]

Zatloukal, K The Science and Innovation Agenda for the UN Summit of the Future 2024.
Science Summit at the United Nations General Assembly (UNGA78); SEP 12-15, 2023; New York, US. 2023. [Oral Communication]

Zatloukal, K INSTAND-NGS4P - Integrated and Standardized NGS Workflows for Personalised Therapy.
OECI Oncology Days; JUN 14-16, 2023; Paris, FRANCE. 2023. [Oral Communication]

Zatloukal, K Round Table: Cancer Science and Policy.
OECI Oncology Days; JUN 15-16, 2023; Paris, FRANCE. 2023. [Oral Communication]

Zatloukal, K Standardised quality of diagnostics as key factor to improve quality of primary data to monitor COVID-19.
BY-COVID Industry event – Data driven innovation for combating infectious diseases; JAN 24, 2023; 2023. [Onlinepräsentation]
FullText

Zatloukal, K Bigpicture Digital Pathology and AI Interaction Platform: Status and further goal of the Interaction Platform.
European Congress of Pathology; SEP 9-13, 2023; Dublin, IRELAND. 2023. [Oral Communication]

Zatloukal, K Possible Contribution to Austrian Cohorts : Health Data and Cybersecurity.
Austrian Cohort Research Days; APR 25-26, 2023; Vienna, AUSTRIA. 2023. [Oral Communication]

Zatloukal, K Panel Session: Personal Protective Equipment Research and Innovation.
World Association for Disaster and Emergency Medicine’s 23rd scientific congress; MAY 8-12, 2023; Killarney, IRELAND. 2023. [Oral Communication]

Zatloukal, K NWIP for Standard on Digital Pathology and Al algorithm-based image analysis update.
ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems / Working Group 4 – Microbiology and molecular diagnostics ; OCT 4, 2023; Lund, SCHWEDEN. 2023. [Onlinepräsentation]

Zatloukal, K Pandemic Preparedness and Bio Defence Plenary.
Science Summit at the United Nations General Assembly (UNGA78); SEP 12-13, 2023; New York, USA. 2023. [Oral Communication]

Zatloukal, K SY-04 Standardisation of molecular pathology at the European level: "Reference Materials for Standardisation".
European Congress of Pathology; SEP 9-13, 2023; Dublin, IRELAND. 2023. [Oral Communication]

Groiss,S; Föderl-Höbenreich, E; Hardt, M; Pabst, D; Beller, M; Korfhage, C; Zatloukal, K Quantitative spatial mapping of complex host response dynamics to SARS-CoV-2 infection.
Advances in Genome Biology and Technology (AGBT); JUN 6-9, 2022; Orlando, FL. 2022. [Poster]

Hardt, M; Groiss, S; Gruber, K; Zatloukal, K Impact of SARS-CoV-2 variants on virus entry and replication
Doctoral Day ; FEB 11, 2022; Graz, AUSTRIA. 2022. [Poster]

Zatloukal, K Digitale Pathologie - KI-unterstützte Diagnostik.
Pathologie.Recht.2022; JAN 10-11, 2022; Altenmarkt/Zauchensee, AUSTRIA. 2022. [Oral Communication]

Zatloukal, K Standardized quality of diagnostics as key factor to improve quality of primary data to monitor COVID-19.
BY-COVID Industry webinar – Data driven innovation for combating infectious diseases; JAN 24, 2023; Uppsala, SWEDEN. 2022. [Onlinepräsentation]

Zatloukal, K Erfahrungen mit Innovation Procurement: Instand-NGS4P.
Innovation Procurement in Horizon Projekten; SEP 21, 2022; Vienna, AUSTRIA. 2022. [Onlinepräsentation]

Zatloukal, K Biobanking and the exposome.
Symposium Frontiers in Human Exposome Research; JUN 1, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

Zatloukal, K Trust as a basis for innovation.
Science at the US-Africa Leaders Summit: Assessing the global regulatory environment and the implications for research collaboration with Africa and the US: European Health Data Space (EHDS); DEC 16, 2022; Washington, USA. 2022. [Onlinepräsentation]

Zatloukal, K Regulatory challenges for AI-based diagnostics.
9th Digital Pathology & AI Congress Europe; DEC 7-9, 2022; London, UNITED KINGDOM. 2022. [Oral Communication]

Zatloukal, K Chair: Regulatory and Legal.
European Congress on Digital Pathology; JUN 17, 2022; Berlin, GERMANY. 2022.

Zatloukal, K Chair: Firmensymposium Roche: Modern Pathologist - How AI-driven revolution in medicine places pathologists in the centre of personalised healthcare.
ÖGPath Frühjahrstagung 2022; MAR 11-12, 2022; Vienna, AUSTRIA. 2022.

Zatloukal, K Sharing healthcare data; Biobanks.
Cybersecurity in Healthcare: elearning (CybeRIS); NOV 17, 2022; Vienna, Austria . 2022. [Onlinepräsentation]

Zatloukal, K BSL-3 und BSL-4 Labore: Eine kritische Infrastruktur für Pandemien und biologische Disaster.
DCNA Disaster Research Days 2022; OCT 14, 2022; Innsbruck, AUSTRIA. 2022. [Oral Communication]

Zatloukal, K Trusted Data Environment for Digital Transformation of Health Systems.
UNGA 77 SS Digital Health Plenary; SEP 26, 2022; New York, USA. 2022. [Oral Communication]

Zatloukal, K Challenges and requirements for clinical slides.
Launch of the Digital Pathology and AI Interaction Platform; SEP 5, 2022; Basel, SWITZERLAND. 2022. [Oral Communication]

Zatloukal, K Preanalytics.
European Congress of Pathology; SEP 5-7, 2022; Basel, SWITZERLAND. 2022. [Oral Communication]

Zatloukal, K A new role model for biobanks in medical research.
BioBANC Symposium; SEP 2, 2022; Galway, IRELAND. 2022. [Onlinepräsentation]

Zatloukal, K Digital Pathology.
BBMRI.it National Day; OCT 12, 2022; Genoa, ITALY. 2022. [Onlinepräsentation]

Zatloukal, K Einfluss von Forschungsinfrastrukturen auf die Innovationslandschaft: Erfahrungsberichte.
Exposome Austria - Launch Event; MAY 31, 2022; Vienna, AUSTRIA. 2022. [Oral Communication]

Zatloukal, K The Innovative Data Environment @ Styria.
Roundtable "The Innovative Data Environment @ Styria"; MAY 25, 2022; Brussels, BELGIUM. 2022. [Oral Communication]

Zatloukal, K AI-based diagnostics: opportunities and challenges.
dHealth 2022; MAY 4, 2022; Vienna, AUSTRIA. 2022. [Keynote lecture]

Zatloukal, K IVDRsq 21b Companion Diagnostics and IVDRsq17 Biological Safety.
IVDRsq 21b Companion Diagnostics and IVDRsq17 Biological Safety (QMD Services Training); APR 11, 2022; Vienna, AUSTRIA. 2022. [Onlinepräsentation]

Zatloukal, K Chair: SY-20 symposium on Molecular Pathology.
European Congress of Pathology; SEP 5-7, 2022; Basel, SWITZERLAND. 2022.

Zatloukal, K Standardization of Pre-Analytics and Sample Quality; Increasing Role of Data.
Université Cote d´Azur MSc Biobanks and Complex Data Management; NOV 18, 2022; Nice, FRANCE. 2022. [Onlinepräsentation]

Zatloukal, K Digital Pathology and AI.
Roche Digital Pathology Webinar; OCT 19, 2022; 2022. [Onlinepräsentation]
FullText

Zatloukal, K Covid-19 Pandemie: Beiträge der Pathologie.
Clemens von Pirquet Symposium: Covid-19 Pandemie und das Impfwesen einst und heute ; SEP 29-30, 2022; Vienna, AUSTRIA. 2022. [Oral Communication]

Zatloukal, K Panelist: European approach to accelerate research on epidemic-prone pathogens: coordinated access to high containment facilities and integrated services.
BSL4ZNET International Conference: Emerging and Re-emerging Pathogens: Current Research, Challenges and Future; SEP 15, 2022; Ottawa, CANADA. 2022. [Onlinepräsentation]

Groiss, S; Pabst, D; Faber, C; Meier, A; Bogdoll, A; Unger, C; Nilges, B; Föderl-Höbenreich, E; Hardt, M; Geipel, A; Korfhage, C; Reinecke, F; Zatloukal, K Molecular Cartography: a multiplexed high resolution transcriptomics approach to spatially analyze rare events demonstrated in an infection model of SARS-CoV-2.
ASHG2021 Webpage/Onlineplanner.. 2021; -ASHG 2021; OCT 18-22, 2021; Montréal, CANADA. [Poster]
FullText

Groiss, S; Pabst, D; Föderl-Höbenreich, E; Hardt, M; Zatloukal, K Specific SARS-CoV-2 Research
Cell Culture Days 2021; OCT 4-5, 2021; Graz, AUSTRIA. 2021. [Onlinepräsentation]

Gülly, C; Zatloukal, K “Biobank Graz: Biobanking on demand – Showcase Covid-19 convalescent cohort“.
Sience Breakfast; JAN 13, 2021; Graz, AUSTRIA. 2021. [Onlinepräsentation] [Science to Public]

Popper, H; Zacharias, M; Brcic, L; Marsh, L; Lehrach, H; Schutte, M; Kwapiszewska, G; Timmermann, B; Kashofer, K; Nerlich, A; Regitnig, P; Kenner, L; Zatloukal, K Different types of immune system regulations in severe Coronavirus disease 2019
VIRCHOWS ARCH. 2021; 479(SUPPL 1):S50-S50. [Onlinepräsentation]
Web of Science

Sheppard, E; Zatloukal, K ISO/FDIS 20166-4: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue for in situ detection techniques.
ISO/TC 212/WG 4 "Microbiology and molecular diagnostics"; MAY 19, 2021; Geneva, SWITZERLAND. 2021. [Oral Communication]

Zatloukal, K Vaccine Manufacturing in Africa. Convened by ONE Foundation and Med Uni Graz.
Aerap Science Africa-Europe Science and Innovation Summit; JUN 14-18, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Zatloukal, K Regulation and Data.
Curam Webinar: A Research Agenda for Medical Devices in the EU; FEB 16, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Zatloukal, K Biobanks as health data infrastructures.
2nd IBCQ International Biobanking Conference ; MAR 8-10, 2021; Doha, QATAR. 2021. [Oral Communication]

Zatloukal, K COVID-19: Contribution from the Research Infrastructures BBMRI.at & ERINHA.
Science Breakfast 2021: How can BBMRI.at and Biobank Graz support my research?" & "Biobanking on demand at Biobank Graz: Showcase COVID-19 covalescent cohort".; JAN 13, 2021; Graz, AUSTRIA. 2021. [Keynote lecture]

Zatloukal, K Biobanking Infrastructure.
Biobanking am CCC: Tissue-Liquid-Imaging-Clinical Data; MAR 4, 2021; Vienna, AUSTRIA. 2021. [Oral Communication]

Zatloukal, K FprCEN/TS 17626 (WI 00140127), Molecular in vitro diagnostic examinations —Specifications for pre-examination processes for human specimen — Isolated microbiome DNA.
35th Plenary Meeting of CEN/TC 140 “In vitro diagnostic medical devices”; FEB 25, 2021; Berlin, GERMANY. 2021. [Oral Communication]

Zatloukal, K High Throughput Digitalisation for Training of ML Algorithms.
Digital Pathology & Image Analysis Training School ; FEB 12, 2021; Vienna, AUSTRIA. 2021. [Oral Communication]

Zatloukal, K Pre-Analytical Requirements for In Vitro Diagnostic Medical Devices.
Precision Diagnostics Europe 2021 ; MAY 28, 2021; Göteborg, SWEDEN. 2021. [Oral Communication]

Zatloukal, K WISSENSCHAFTLICHE UND MEDIZINISCHE RELEVANZ VON STANDARDS IN DER MOLEKULAREN ANALYTIK.
BBMRI.at - Christian Doppler Gesellschaft; APR 26, 2021; Vienna, AUSTRIA. 2021. [Keynote lecture]
FullText

Zatloukal, K Biobanking for Innovative Cancer Care.
Autumn Academy of Oncologists of the Russian Federation; OCT 29-30, 2021; Sochi, Russian Federation. 2021. [Oral Communication]

Zatloukal, K Regulatory challenges of digital pathology and AI-based in vitro diagnostic medical devices.
8th Digital Pathology & AI Congress ; DEC 1-2, 2021; London, ENGLAND. 2021. [Oral Communication]

Zatloukal, K The role of RMs in clinical translation of human genomics.
EASI-GENOMICS: REFERENCE MATERIALS FOR GENOMICS: PRINCIPLES AND PRACTICE ; NOV 10, 2021; London, ENGLAND. 2021. [Oral Communication]

Zatloukal, K 1. Biobanking: why is it important? 2. Artificial intelligence and big data in oncology.
Institute of Cancer Research (IRC) ADVANCED COURSE ON CANCER BIOLOGY AND THERAPY; OCT 22, 2021; Fez, MOROCCO. 2021. [Oral Communication]

Zatloukal, K Perspectives on BBMRI Membership for Precision Oncology Ireland
Precision Oncology Ireland Biobanking Working Group; OCT 22, 2021; Dublin, IRELAND. 2021. [Keynote lecture]

Zatloukal, K Chair, ‘Building a Trusted Research Environment’
BBMRI-ERIC Workshop ‘Building a Trusted Research Environment’ ; OCT 18, 2021; Graz, AUSTRIA. 2021.

Zatloukal, K Trusted Data Environments for Digital Transformation of Health Systems.
United Nations General Assembly –Science Summit Digital Health Plenary; SEP 28, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Zatloukal, K Biobanking and Biomolecular Resources Research Infrastructure [BBMRI].
UNGA: South-South/North Science Capacity Building and Research Collaboration for the SDGs ; SEP 22, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Zatloukal, K Introduction to the BSL-3 Laboratory.
Visit to Graz of the Public Health Authority of the Slovak Republic; JUL 20, 2021; Graz, AUSTRIA. 2021. [Oral Communication]

Zatloukal, K A new paradigm for health research with Africa.
Aerap Science Africa-Europe Science and Innovation Summit; JUN 14-18, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Zatloukal, K Africa-Europe Science Innovation Summit: Opening Plenary session.
Aerap Science Africa-Europe Science and Innovation Summit; JUN 14-18, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Zatloukal, K Roundtable: Impact of GDPR on EU-US science collaboration and global science.
AERAP SCIENCE Africa-Europe Science and Information Summit; JUN 14-18, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Zatloukal, K Covid-19 research activities at the Institute of Pathology, Med Uni Graz.
Visit of Latin American Ambassadors to Graz; OCT 15, 2021; Graz, AUSTRIA. 2021. [Oral Communication]

Zatloukal, K Präanalytische Anforderungen für In vitro Diagnostika.
LISAvienna Regulatory Konferenz für Medizinprodukte und In-vitro Diagnostika; OCT 12, 2021; Vienna, AUSTRIA. 2021. [Oral Communication]

Zatloukal, K Digital pathology and AI: from research to medical application.
Master Course in AI & Digital Pathology, University College Dublin; JUL 12, 2021; Dublin, IRELAND. 2021. [Keynote lecture]

Zatloukal, K EU regulations cannot be allowed to block health research cooperation between Europe and Africa: GDPR, IVDR need to consider Health for Africa in their applications.
Aerap Science Africa-Europe Science and Innovation Summit; JUN 14-18, 2021; Brussels, BELGIUM. 2021. [Oral Communication]

Riegman, P; Zatloukal, K Training on the international standard: Molecular in vitro diagnostic examination - Specification for pre-examination processes - Frozen tissue – RNA & Protein; Formalin-fixed and paraffin-embedded tissue – RNA & Protein & DNA.
SPIDIA-4P Web Conference Series on pre-analytical ISO Standards 20184 : 20166 : 20186 ; OCT 13, 2020; Graz, AUSTRIA. 2020. [Onlinepräsentation]

Zatloukal, K Importance of pre-analytics in the context of companion diagnostics and digital pathology.
Seminar Roche Tissue Diagnostics; JAN 21, 2020; Tucson, USA. 2020. [Keynote lecture]

Zatloukal, K Genomics & Health Data for Sustainable Health Systems.
Webinar: Genomic Medicine and Horizon Europe: making the promise real; JUL 16, 2020; Brussels, BELGIUM. 2020. [Oral Communication]

Zatloukal, K Eine Zuverlässige und vertrauenswürdige Umgebung für Patientendaten bildet die Basis für Forschung und Entwicklung in der Medizin.
Information Security in Healthcare Conference; AUG 12, 2020; Rotkreuz, SWITZERLAND. 2020. [Keynote lecture]
FullText

Zatloukal, K The European Biobanking Research Infrastructure for Precision Medicine.
CARO-2020; NOV 27, 2020; USBEKISTAN. 2020. [Onlinepräsentation]

Zatloukal, K Integrated and STANDardizedNGS workflows FOR Personalized Therapy.
Plenary Meeting of the ISO/TC 215 SC1 Genomics Informatics; NOV 19, 2020; -, KOREA. 2020. [Onlinepräsentation]

Zatloukal, K Key Area 1: Public Health.
AERAP Zoom Meeting: Opportunities for Enhanced STI Cooperation between the EU & Africa; NOV 18, 2020; Brussels, BELGIUM. 2020. [Onlinepräsentation]

Zatloukal, K Chair of Topic 4: Disease-based biobanking: paving the way for improved clinical practice.
Europe Biobank Week; NOV 17-20, 2020; Graz, AUSTRIA. 2020.

Zatloukal, K Health Data forSustainable Health Systems.
ScienceDigital@UNGA75; SEP 24-25, 2020; Brussels, BELGIUM. 2020. [Onlinepräsentation]

Zatloukal, K Panelist in Plenary Session: AERAP: a Vision for Future Africa-EU Science Cooperation.
AERAP Virtual Conference: A new era for Africa-EU Science and Innovation Partnerships (Africa, Horizon Europe and Development Cooperation) ; SEP 9-10, 2020; Brussels, BELGIUM. 2020. [Onlinepräsentation]

Zatloukal, K Introduction to Instand-NGS4P.
Instand-NGS4P Kick-off Meeting; JAN 30-31, 2020; Graz, AUSTRIA. 2020. [Oral Communication]

Zatloukal, K Welcome and Introduction to the INSTAND-NGS4P Satellite Workshop: NGS for Personalized Medicine.
INSTAND-NGS4P Satellite Workshop: NGS for Personalized Medicine; JAN 29, 2020; Graz, AUSTRIA. 2020. [Oral Communication]

Zatloukal, K Anforderungen an Prä-Analytik und Biosafety für Covid-19-Diagnostik.
Die CE-Kennzeichnung als ausreichendes Gütesiegel von IVD Tests?; JUN 5, 2020; Vienna, AUSTRIA. 2020. [Oral Communication]
FullText

Zatloukal, K Chair at AICI Forum Digital.
; OCT 30, 2020; Klagenfurt, AUSTRIA. 2020.

Zatloukal, K Role of biobanks in personalized medicine.
MSc Biobanks & Complex Data Management; OCT 15, 2020; Nice, FRANCE. 2020. [Onlinepräsentation]

Zatloukal, K Wissenschaftliche und Medizinische Relevanz von Standards in der Diagnostik.
LISAvienna Regulatory Conference for in-vitro Diagnostics; OCT 21, 2020; Vienna, AUSTRIA. 2020. [Oral Communication]
FullText

Zatloukal, K Requirements for training of machine learning algorithms for digital pathology.
Annual Meeting and Industry Fair Swiss Digital Pathology Consortium (SDiPath); JAN 16, 2020; Bern, SWITZERLAND. 2020. [Keynote lecture]

Zatloukal, K Lightning talk: Health and AI.
GIN & AI; JAN 28, 2020; Vienna, AUSTRIA. 2020. [Oral Communication]

Holzinger, A; Zatloukal, K Weakly supervised learning from Whole Slide Images.
AICI Forum Villach; DEC 6-7, 2019; Villach, AUSTRIA. 2019. [Oral Communication]

Kara-Borni, M; Plattner, K; Marold, A; Hartl, G; Vogl, F; Story, P; Zatloukal, K; Hofman, P; Sargsyan, K Stakeholder Analysis of a Clinical Academic Biobank.
SCIENTIFIC PROGRAM, Page 54. 2019; -ISBER; May 7-10, 2019; Shanghai. [Poster]

Martina Loibner, Christine Ulz, Angelika Zinterl, Peter Abuja, Kurt Zatloukal, Rainer Hofmann-Wellenhof, Edith Arzberger, Teresa Deinlein, Elena Eber, Ellen Heitzer Assessment of DNA from epidermal skin cells collected by tape-stripping as an innovative method to screen for melanoma related genes
International Evaluation of the Christian Doppler Laboratory for Liquid Biopsies for early Detection of Cancer; June 24, 2019; Graz, Austria. 2019. [Oral Communication]

Martina Loibner, Kurt Zatloukal Chemical Shower for Development and Validation of Decontamination Protocols
EXPO Lounges, Karlsruhe, 2019. 2019; -EXPO Lounges; Feb 5-7, 2019; Karlsruhe, Germany. [Poster]

Pohn, B ; Kargl, M ; Reihs, R ; Holzinger, A ; Zatloukal, K ; Müller, H Towards a deeper understanding of how a pathologist makes a diagnosis: Visualization of the diagnostic process in histopathology
Proceedings of the 2019 IEEE Symposium on Computers and Communications (ISCC). 2019; 1081-1086.-2019 IEEE Symposium on Computers and Communications (ISCC); 29 June-3 July 2019; Barcelona, Spain, Spain. (ISBN: 978-1-7281-2999-0 ) [Oral Communication]
FullText

Pohn, B ; Mayer, MC ; Reihs, R ; Holzinger, A ; Zatloukal, K ; Müller, H Visualization of Histopathological Decision Making Using a Roadbook Metaphor.
Proceedings of the 2019 23rd International Conference Information Visualisation (IV). 2019; 392-397.-2019 23rd International Conference Information Visualisation (IV); 2-5 July 2019; Paris, France, France. (ISBN: 978-1-7281-2838-2 ) [Oral Communication]
FullText

Reihs, R; Pohn, B; Zatloukal, K; Holzinger, A; Müller, H NLP for the Generation of Training Data Sets for Ontology-Guided Weakly-Supervised Machine Learning in Digital Pathology
Proceedings of the 2019 IEEE Symposium on Computers and Communications (ISCC). 2019; 1072-1076.-2019 IEEE Symposium on Computers and Communications (ISCC); 29 June-3 July 2019; Barcelona, Spain. (ISBN: 978-1-7281-2999-0 ) [Oral Communication]
FullText

STUMPTNER, C; EDER, J; FELT, U; FERENT, L; GOEBEL, G; GRUBER, F; GÜLLY, C; HAAN, S; HASLACHER, H; HOFER, P; KEDENKO, L; KOFLER, R; METZLER, I; NEURURER, S; RUCKENBAUER, C; PAULWEBER, B; PERZ, V; SHEKHOVTSOV, V; WALTER, I; WIESER, M; ZATLOUKAL, K BBMRI.at – Biobanking research infrastructure & partner for research using biological samples.
Nicht im Programm. 2019; -Europe Biobank Week; 8-11 October, 2019; Lübeck, Germany. [Poster]

STUMPTNER, C; J. EDER, U. FELT, L. FERENT, G. GOEBEL, F. GRUBER, C. GÜLLY, S. HAAN, H. HASLACHER, P. HOFER, P. HOFER, L. KEDENKO, R. KOFLER, I. METZLER, S. NEURURER, C. RUCKENBAUER, B. PAULWEBER, V. PERZ, V. SHEKHOVTSOV, I. WALTER, M. WIESER, K. ZATLOUKAL BBMRI.at Biobanking Research Infrastructure & Partner for Research Using Biological Samples
https://cloudius.meduniwien.ac.at/index.php/s/TowyVSDAeRMjr9o . 2019; -Annual Meeting of the Austrian Platform for Personalized Medicine (ÖPPM); Oct 14-15, 2019; Medical University of Vienna. [Poster]

Zatloukal, K Imaging data and biobanking.
Meeting of the Biobanking Research Infrastructures of Austria, Italy, Cyprus & Czech Republic; DEC 9-11, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

Zatloukal, K p62 in protein aggregation diseases.
Seminar at EPFL, Lausanne; FEB 15, 2019; Lausanne, SWITZERLAND. 2019. [Oral Communication]

Zatloukal, K ISO for the preanalytical phase in pathology.
Workshop of the Working Group for Pathology and Biobanking; JAN 18, 2019; Candiolo, ITALY. 2019. [Oral Communication]

Zatloukal, K Biobanking in Biomedical Research.
2nd International Forum on Oncology and Radiology ; SEP 25, 2019; Moscow, RUSSIAN FEDERATION. 2019. [Oral Communication]

Zatloukal, K Next Generation Sequencing.
National Cancer Institute Directors Meeting; JUL 10-12, 2019; Lyon, FRANCE. 2019. [Oral Communication]

Zatloukal, K Why do we need artificial intelligence in medicine?
TEDx MedUniGraz: Think Creative! Be Innovative!; SEP 13, 2019; Graz, AUSTRIA. 2019. [Science to Public]

Zatloukal, K Der digitale Zwilling: Herausforderungen und mögliche Anwendungen.
dHealth 2019; MAY 28-29, 2019; Vienna, AUSTRIA. 2019. [Oral Communication]

Zatloukal, K Training of machine learning algorithms for computer-assisted pathological diagnostics.
Digital Pathology Workshop; MAY 17, 2019; Vienna, AUSTRIA. 2019. [Oral Communication]

Zatloukal, K Biobanking BBMRI-ERIC.
21st Genomic Standards Consortium Meeting; MAY 20-23, 2019; Vienna, AUSTRIA. 2019. [Keynote lecture]

Zatloukal, K Biobanking for cancer. First things first.
Biobanking and the Cyprus Human Genome Project CY-Biobank, Kick-Off Meeting; NOV 26-27, 2019; Nicosia, CYPRUS. 2019. [Keynote lecture]

Zatloukal, K Requirements for high throughput scanning for machine learning.
3DHISTECH’s 5th International Digital Pathology User Conference ; DEC 4, 2019; London, UNITED KINGDOM. 2019. [Oral Communication]

Zatloukal, K Presentation of Biobank Graz: History, Experience and Perspectives.
1st National Symposium on Biobanks 2019; NOV 12-13, 2019; Rabat, MOROCCO. 2019. [Oral Communication]

Zatloukal, K Biobanking: key to the implementation of standards in personalised medicine.
Tackling Issues of in vitro diagnostics for personalized medicine, SPIDIA4P; MAR 5, 2019; Brussels, BELGIUM. 2019. [Keynote lecture]

Zatloukal, K Biobanking and Innovation.
ISENET Biobanking Inauguration & Workshop on Biobanking in the era of Personalized Medicine; FEB 25, 2019; Milan, ITALY. 2019. [Oral Communication]

Zatloukal, K Digitale Pathologie und Künstliche Intelligenz: medizinische, technische und ethische Herausforderungen.
Pathologie.Recht.2019; JAN 13-16, 2019; Altenmarkt/Zauchensee, AUSTRIA. 2019. [Oral Communication]

Zatloukal, K Presentation of Projects BBMRI.at, INSTAND-NGS4P, ERINHA-Advance.
Scientific Team Retreat; OCT 1, 2019; Brodersdorf, AUSTRIA. 2019. [Oral Communication]

Zatloukal, K Observations from participation in several research programs.
Seminar Seminar “Understanding the impacts of GDPR on health research collaboration” ; NOV 19, 2019; Brussels, BELGIUM. 2019. [Keynote lecture]

Zatloukal, K Bio-Banking in Biomedical Research.
2nd International Forum of Oncology and Radiology; SEP 24-29, 2019; Moscow, RUSSIAN FEDERATION. 2019. [Oral Communication]

Zatloukal, K Biobanking relevant CEN and ISO Standards.
MSc Biobanks and Complex Data Management ; OCT 10, 2019; Nice, FRANCE. 2019. [Oral Communication]

Zatloukal, K Pre-analytical standards and regulatory requirements.
International Lung Cancer Diagnostics Workshop; SEP 16-17, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

Zatloukal, K Biobank Graz, high throughput scanning facility, approaches in machine learning.
Visit to Perspectum Diagnostics; Jul 30, 2019; Oxford, UNITED KINGDOM. 2019. [Oral Communication]

Zatloukal, K Institute of Pathology and Trends in Digital Imaging.
Moroccan Network of Biological Resource Centres in Oncology; JUL 18, 2019; Graz, Austria. 2019. [Oral Communication]

Zatloukal, K Pre-analytics in Biobank and pathology Department.
1st National Symposium on Biobanks 2019; NOV 12-13, 2019; Rabat, MOROCCO. 2019. [Oral Communication]

Zatloukal, K Relevance of sample quality in personalized medicine.
Cancer-Related Biobanks: a Value for Translational Research and Precision Oncology; MAR 21, 2019; Milan, ITALY. 2019. [Keynote lecture]

Zatloukal, K Pre-analytical factors in biobanking, medical research and diagnostics.
International Biobanking Conference Qatar; MAR 25-27, 2019; Doha, QATAR. 2019. [Oral Communication]
FullText

Zatloukal, K Health Data and UN Sustainable Development Goals.
CLASS Seminar: Data for sustainable health development: the example of digital pathology and AI.; APR 2, 2019; Dublin, IRELAND. 2019. [Keynote lecture]

Zatloukal, K Panel Discussion.
AICI Forum Villach; DEC 6-7, 2019; Villach, AUSTRIA. 2019. [Oral Communication]

Zatloukal, K Presentation of WP3
Biobanking and the Cyprus Human Genome Project CY-Biobank, Kick-Off meeting ; NOV 26-27, 2019; Nicosia, CYPRUS. 2019. [Oral Communication]

Zatloukal, K Impacts of biobanks on regional research and innovation.
Biobanking and the Cyprus Human Genome Project CY-Biobank, Kick-Off Meeting ; NOV 26-27, 2019; Nicosia, CYPRUS. 2019. [Keynote lecture]

Abuja, PM; Pabst, D; Ulz, C; Kufferath, I; Loibner, M; Fackelmann, U; Stumptner, C; Krämer, R; Zatloukal, K Influence of dehydration protocol on residual humidity and quality of nucleic acids in fixed tissue.
Der Pathologe. 2018; 39(5):480-480.-Herbsttagung der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA. [Poster]

Abuja, PM; Pabst, D; Ulz, C; Kufferath, I; Loibner, M; Fackelmann, U; Stumptner, C; Krämer, R; Zatloukal, K Influence of Dehydration Protocol on Residual Humidity and Quality of Nucleic Acids in Fixed, Paraffin-embedded Tissue
Europe Biobank Week; Sep 4-7, 2018; Antwerp, BELGIUM. 2018. [Oral Communication]

Haslacher, H; Bayer, M; Fiegl, H; Gerner, M; Hofer; P; Korb, M; Neururer, S; Perkmann, T; Plattner, K; Sargsyan, K; Steiner, E; Stumptner, C; Walter, I; Wieser, M; Wagner, O; Zatloukal, K Five years of QM-harmonization in BBMRI.at – Review and Outlook.
Europe Biobank Week; SEP 4-7, 2018; Antwerp, BELGIUM. 2018. [Poster]

Haslacher, H; Bayer, M; Fiegl, H; Gerner, M; Hofer, P; Korb, M; Neururer, S; Plattner, K; Steiner, E; Stumptner, C; Wieser, M; Wutte, A; Zatloukal, K; Goebel, G Tackling irreproducibility of research by harmonized standardization of pre-analytical processes within the Austrian Biobank network BBMRI.at.
Abstract Book. 2018; 198-198.-10th ÖGMBT Annual Meeting ; SEP 17-20, 2018; Vienna, AUSTRIA. [Poster]
FullText

MÜLLER, H; MERINO MARTINEZ, R; REIHS, R; PLASS, M; HOLUB, P; ZATLOUKAL, K Biobanking in a box.
Europe Biobank Week; SEP 4-7, 2018; Antwerp, BELGIUM. 2018. [Poster]

Müller, H; Merino Martinez, R; Reihs, R; Plass, M; Zatloukal, K Digital Pathology in a Box
Proceedings of the 14th European Congress on Digital Pathology. 2018; -14th European Congress on Digital Pathology; 29 May to 1 June, 2018; Helsinki, FINNLAND. [Poster]

Müller, H; Merino Martinez, R; Reihs, R; Plass, M; Zatloukal, K An app store for digital pathology.
Der Pathologe. 2018; 39(5):485-485.-Herbsttagung der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA. [Poster]

Steinacher, D; Traussnig, S; Halilbasic, E; Paternostro, R; Stumptner, C; Haslacher, H; Zatloukal, K; Trauner, M The influence of sampling time of liver tissue from biopsy to freezing on RNA quality.
51. Jahrestagung der Österreichische Gesellschaft für Gastroenterologie & Hepatologie; JUN 14-16, 2018; Salzburg, AUSTRIA. 2018. [Poster]

Stumptner, C; Eder, J; Goebel, G; Goisauf, M; Gülly, C; Haschke-Becher, E; Haslacher, H; Neururer, S; Ruckenbauer, C; Öchsner, S; Story, P; Walter, I; Wieser, M; Zatloukal, K Austrian Biobanking and Biomolecular resources Research Infrastructure BBMRI.at – a partner for research using biological samples.
LISAvienna Business Treff: Regulatory Konferenz für Medizinprodukte und IVD ; NOV 6, 2018; Vienna, AUSTRIA. 2018. [Poster]

Stumptner, C; Eder, J; Goebel, G; Goisauf, M; Gülly, C; Haschke-Becher, E; Haslacher, H; Neururer, S; Ruckenbauer, C; Öchsner, S; Story, P; Walter, I; Wieser, M; Zatloukal, K Austrian Biobanking and Biomolecular resources Research Infrastructure BBMRI.at – a partner for research using biological samples.
Abstract book of the 10th ÖGMBT. 2018; -10th ÖGMBT Annual Meeting; SEP 17-20, 2018; Vienna, AUSTRIA. [Poster]
FullText

Stumptner, C; Oelmueller, U; Becker, KF; Betsou, F; Bonin, S; Ciniselli, C; Dagher, G; Fonseca, C; Forshew, T; Foy, C; Gainaux, A; Gelmini, S; Groelz, D; Hartman, C; Kofanova, O; Krieger, L; Kubista, M; Kungl, P; Marchio, C; Parkes, H; Pazzagli, M; Plebani, M; Pinzani, P; Pugh, M; Riegman, PHJ; Rodenkirchen, K; Sapino, A; Schmitz, M; Schröder, U; Sjobac, R; Stanta, G; Steinfelder, E; Taussig, M; Trombetta, A; Turano, P; Verderio, P; Wutte, A; Zatloukal, K Upcoming quality requirements for molecular pathology.
Der Pathologe. 2018; 39(5):488-488.-Herbsttagung 2018 der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA. [Poster]

Stumptner, C; Wutte, A; Neururer, S; Göbel, G; Zatloukal, K Online Self-Assessment Tool for Molecular Diagnostics to Check Pre-Analytical Workflows.
Austrian Platform for Personalized Medicine (ÖPPM); OCT 11-12, 2018; Graz, AUSTRIA. 2018. [Poster]

Stumptner, C; Wutte, A; Neururer, S; Göbel, G; Zatloukal, K Online self-assessment tool for molecular pathology to check pre-analytical workflows.
Der Pathologe. 2018; 39(5):488-488.-Herbsttagung der ÖGPath/IAP Austria; SEP 27-28, 2018; Graz, AUSTRIA. [Poster]

Stumptner, C; Zatloukal, K BBMRI.at SEAB & ACP Meeting #24
; DEC 4, 2018; Vienna, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K Biobanking and Digital Pathology.
Symposium Bridging Biobanks in Mena Countries to promote Research and Healthcare; MAY 4, 2018; Izmir, TURKEY. 2018. [Oral Communication]

Zatloukal, K High throughput scanning in digital pathology.
5th Digital Pathology and AI Congress; DEC 6-7, 2018; London, UNITED KINGDOM. 2018. [Oral Communication]

Zatloukal, K BBMRI - Goals, Status and Activities.
1st Joint Austrian ERIC Workshop: Biobanking (BBMRI) - Bioinformatics (ATBI) - BioImaging (CMI); OCT 29, 2018; Vienna, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K Standardisation of sample pre-analytics for medical research and diagnostics.
Biobank Bern; AUG 2-3, 2018; Bern, SWITZERLAND. 2018. [Oral Communication]

Zatloukal, K Pre-analytical Standards for Biobanking and Biomarker Development.
45th ISOBM (International Society of Oncology & BioMarkers) 2018 CONGRESS HAMBURG; NOV 24-27, 2018; Hamburg, GERMANY. 2018. [Oral Communication]

Zatloukal, K Update on the Digital Pathology competition and Expert Centres.
ADOPT BBMRI-ERIC Project Meeting; OCT 9, 2018; London, UNITED KINGDOM. 2018. [Oral Communication]

Zatloukal, K Chair: Fostering diversity and overcoming inequality in the development and use of RIs.
International Conference on Research Infrastructures 2018; SEP 12-14, 2018; Vienna, AUSTRIA. 2018.

Zatloukal, K Future in Biobanking.
MSc in Biobanking - 4th Face to face course; SEP 10, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K Chair: Session 6C – Biospecimen and Pre-Analytics Research for Reproducibility – from Sampling to Scientific Discovery.
Europe Biobank Week; SEP 4-7, 2018; Antwerp, BELGIUM. 2018.

Zatloukal, K Digital pathology and developments in machine learning.
Österreichische Gesellschaft für Pathologie/Österreichische Abteilung der IAP: Herbsttagung 2018; SEP 27-28, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K ISO/NP 20166-4, Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissues -- Part 4: in situ detection techniques.
Meeting ISO/TC212, Clinical laboratory testing and in vitro diagnostic test systems - WG4, Microbiology and molecular diagnostics; OCT 16-18, 2018; Seoul, SOUTH KOREA. 2018. [Oral Communication]

Zatloukal, K Biobanking-relevant CEN and ISO Standards.
MSc Biobanks and Complex Data Management; SEP 28, 2018; Nice, FRANCE. 2018. [Oral Communication]

Zatloukal, K Biospecimen research: from bio-sample to data.
Diagnostic and Research Center for Molecular BioMedicine Scientific Retreat: Genetic and Environmental Mechanisms of Disease; AUG 31- SEP 1, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K Innovations in Biobanking - how can imaging data contribute?
3rd CBmed Biomarker Conference; MAR 14-16, 2018; Vienna, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K The science behind sample pre-analytics.
Eröffnung des CD-Labors für Liquid Biopsies zur Früherkennung von Krebs; MAR 22, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K Internationale Standards für pre-Analytik, Analyseservices für klinische Studien, IVDR und GDPR compliance, Validierungsstudien.
F&E Round-Table - Besuch der VelaLabs GmbH; APR 9, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K International standards are indispensable for reproducible research.
Course: CEN and ISO Standards for Pre-analytical Processes in Industrial Development and Medical Diagnostics; MAY 16, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Zatloukal, K Biomarkers and Sample Preanalytics.
Open Medical Institute Biomedical Workshop; MAY 28, 2018; Vienna. AUSTRIA. 2018. [Keynote lecture]

Zatloukal, K Digital Pathology and Machine Learning.
National Cancer Institute of Directors Meeting; JUL 11-13, 2018; Lyon, FRANCE. 2018. [Oral Communication]

Zatloukal, K Interoperability of Expert Centres.
ADOPT BBMRI-ERIC Expert Centre Workshop; JUN 25, 2018; Milan, ITALY. 2018. [Oral Communication]

Zatloukal, K Panel discussion: The Contribution of EU Research and Innovation to the UN SDGs.
Seminar "The Contribution of the European Union´s FP9 to the United Nations Sustainable Development Goals"; MAY 22, 2018; Brussels, BELGIUM. 2018. [Science to Public]

Zatloukal, K EU in vitro Diagnostika Richtlinie und Neue Erfordernisse für die Überprüfung und Validierung der Performanz von diagnostischen Tests.
LISA Dachmarken Workshop; JUL 4, 2018; Linz, AUSTRIA. 2018. [Oral Communication]

Denk, H: Zatloukal, K Die Grazer Sicht und Möglichkeiten.
3. Heidelberger Expertentreffen; SEP 8-9, 2017; Heidelberg, GERMANY. 2017. [Oral Communication]

Hämäläinen, I; Törnwall, O; Simell, B; Zatloukal, K; Perola, M; van Ommen, G Biobanking and Public-Private Partnerships.
Global Biobank Week - Towards Harmony in Biobanking; SEP 13-15, 2017; Stockholm, SWEDEN. 2017. [Poster]
FullText

Jalanko, A; Zatloukal, K IVD Regulation and guide for biobanks.
ADOPT BBMRI-ERIC Meeting; MAY 16, 2017; Lausanne, SWITZERLAND. 2017. [Oral Communication]

Loibner, M; Oberauner-Wappis L; Ulz, C; Abuja, PM; Grölz, D; Krenz, T; Wieczorek, G; Oelmüller, U; Zatloukal, K Analysis of diverse clinical cancer samples with the GeneReader NGS system
n.a.. 2017; -29th European Congress of Pathology; Sept 4-6 2017; Amsterdam, The Netherlands. [Oral Communication]

Neururer, S; Wutte, A; Hofer-Picout, P; Müller, H; Reihs, R; Stumptner, C; Zatloukal, K; Göbel, G Implementation of Self-Assessment Surveys Based on the CEN/TS for Pre-Examination Processes.
Global Biobank Week - Towards Harmony in Biobanking; SEP 13-15, 2017; Stockholm, SWEDEN. 2017. [Oral Communication]
FullText

Oberauner-Wappis, L; Loibner, M; Ulz, C; Abuja, PM; Grölz, D; Krenz, T; Wieczorek, G; Oelmüller, U; Zatloukal, K Application of the GeneReader NGS system in analyzing a diverse set of cancer samples
http://gcmp.amp.org/. 2017; -AMP GLOBAL 2017 - Global Congress on Molecular Pathology; APR 3-5, 2017; Berlin, GERMANY. [Poster]

Oberauner-Wappis, L; Ulz, C; Loibner, M; Wieczorek, G; Abuja, PM; Oelmüller, U; Zatloukal, K Next generation sequencing as a tool in molecular pathology
2nd CBmed Biomarker Conference; FEB 13, 2017; Graz, AUSTRIA. 2017. [Poster]

Zatloukal, K BBMRI.at.
Immunoanalytical Days; APR 23-25, 2017; Pilsen, CZECH REPUBLIC. 2017. [Oral Communication]

Zatloukal, K First results with the new 3DHISTECH Pannoramic 1000 and the Austrian national digital pathology platform.
3DHistech´s 4th International Digital Pathology Workshop; NOV 29, 2017; London, UNITED KINGDOM. 2017. [Oral Communication]

Zatloukal, K Pathology competition and Expert Centre process.
ADOPT BBMRI-ERIC Project Meeting; OCT 10, 2017; Wroclaw, POLAND. 2017. [Oral Communication]

Zatloukal, K The Austrian national digital pathology infrastructure: Links to molecular pathology and biobanking - a role model for Europe?
ECP 2017; SEP 2-6, 2017; Amsterdam, THE NETHERLANDS. 2017. [Oral Communication]

Zatloukal, K WP3 Status Report: Implementation and Dissemination of Standards & External Quality Assurance Schemes.
SPIDIA4P Consortium Meeting; SEP 18-20, 2017; Florence, ITALY. 2017. [Oral Communication]

Zatloukal, K Innovative Technology and its contribution to biobanking.
Global Biobank Week; SEP 12-15, 2017; Stockholm, SWEDEN. 2017. [Oral Communication]

Zatloukal, K Overview on BBMRI-ERIC and BBMRI.at.
BBMRI.at 15. Management Committee Meeting; APR 3, 2017; Innsbruck, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K GDPR.
ISC GDPR Seminar: The Impact of the EU´s General Data Protection Regulation on collaborative science in Europe and globally; MAR 3, 2017; Dublin, IRELAND. 2017. [Oral Communication]

Zatloukal, K The Changing Innovation Environment of Drug Manufacturing.
(Bio)Pharma Ireland High-Level Seminar: The Future of (Bio)Pharmaceutical Manufacturing; FEB 28, 2017; Brussels, BELGIUM. 2017. [Oral Communication]

Zatloukal, K BBMRI-ERIC - Resource for Pharmaceutical & Biotech Industries.
The impact of Biobanking in Qatar- Precision Medicine Initiative; MAR 14-15, 2017; Doha, QATAR. 2017. [Oral Communication]

Zatloukal, K Overall Progress and Status of BBMRI.at.
BBMRI.at Evaluation Panel Meeting; DEC 11, 2017; Vienna, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K Documentation requirements & quality control for pre-analytical procedures.
Pre-Analytical Sample Processing in Biobanking (Practical Laboratory Course ; FEB 8-10, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K The case for sample preanalytics, quality and data management.
Pre-Analytical Sample Processing in Biobanking (Practical Laboratory Course ; FEB 8-10, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K Data in Medical R&D and Health Care: Impact of the GDPR.
Kapsch Workshop zum Thema Datenschutzverordnung und Einführungskriterien/ Security; MAY 12, 2017; Vienna, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K Biobanks: Samples, Data and Governance.
Symposium der Österreichischen Gesellschaft für Humangenetik ; SEP 28, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K Digital Pathology and Biobanking.
4th Digital Pathology Congress; NOV 29-DEC 1, 2017; London, UNITED KINGDOM. 2017. [Oral Communication]

Zatloukal, K Sitzung der Kommission für die Beteiligung an internationaler Großforschung.
Sitzung der Kommission für die Beteiligung an internationaler Großforschung; JAN 20, 2017; Vienna, AUSTRIA. 2017.

Zatloukal, K Pre-analytical impact of ischemia and fixation.
Pre-Analytical Sample Processing in Biobanking (Practical Laboratory Course ; FEB 8-10, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K Processing of medical data: The case for code-of-conducts.
Industry GDPR: Code of Conduct Roundtable; FEB 1, 2017; Brussels, BELGIUM. 2017. [Oral Communication]

Zatloukal, K Forschung an humanen biologischen Proben und Daten.
Aufbau Forschung: Good Scientific Practice; NOV 28, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K The European Biobanking Research Infrastructure BBMRI-ERIC: how can biomedical research benefit.
Neue Ansätze in der hepatobiliären Zelltypisierung; JAN 27-28, 2017; Heidelberg, GERMANY. 2017. [Oral Communication]

Zatloukal, K Konstituierende Sitzung der Arbeitsgruppe "Erhebung der finanziellen Auswirkungen von Großforschung" der Kommission für die Beteiligung an internationaler Großforschung.
Konstituierende Sitzung der Arbeitsgruppe "Erhebung der finanziellen Auswirkungen von Großforschung" der Kommission für die Beteiligung an internationaler Großforschung; JAN 20, 2017; Vienna, AUSTRIA. 2017.

Zatloukal, K Long-term archiving of digital slides: Challenges and Opportunities.
Luncheon Symposium at ECP 2017; SEP 4, 2017; Amsterdam, THE NETHERLANDS. 2017. [Oral Communication]

Zatloukal, K The Role of Biobanks in Personalized Medicine.
Österreichische Plattform für Personalisiertes Medizin - Auftaktveranstaltung und wissenschaftliches Symposium; OCT 19-20, 2017; Vienna, AUSTRIA. 2017. [Oral Communication]

Zatloukal, K How European RIs can boost Open Science and Open Innovation.
CORBEL Workshop: How European Biological and Medical Sciences Research Infrastructures boost Innovation by Open Access; JUN 20, 2017; Brussels, BELGIUM. 2017. [Oral Communication]

Zatloukal, K; Rath, A Rare diseases research in the future: Perspectives, needs and opportunities.
Integrating Research and Healthcare for Rare Diseases: a structured cooperation with high community added value ; MAR 20, 2017; Valletta, MALTA. 2017. [Oral Communication]
FullText

Zatloukal, K; Stumptner, C BBMRI.at – the Austrian National Node of BBMRI-ERIC.
Österreichische Plattform für Personalisiertes Medizin - Auftaktveranstaltung und wissenschaftliches Symposium; OCT 19-20, 2017; Vienna, AUSTRIA. 2017. [Poster]

Abuja, PM; Christiansen, N; Gieger, Ch; Kozera, L; Leego, M; Laiho, P; Goldberg, M; Polasek, O; Anton, G; Klovins, J; Wichmann, E; Luchinat, C; Zatloukal, K Influence of Preanalytical Treatment of Serum or Plasma on the Metabolome.
Europe Biobank Week; SEP 13-16, 2016; Vienna, AUSTRIA. 2016. [Keynote lecture]

Abuja, PM; Oberauner-Wappis, L; Ulz, C; Greenberg, J; Abraham, R; Oelmüller, U; Zatloukal, K Next generation sequencing-based biomarkers in molecular pathology
1st CBmed Biomarker Conference ; FEB 11, 2016; Graz. 2016. [Poster]

C. Stumptner, P.Birner, A.Durnova, J.Eder, M.Gerner, G.Goebel, M.Goisauf, E.Haschke-Becher, H.Haslacher, B.Huppertz, C.Kienbacher, S.Neururer, T.Perkmann, H.Pichler, C.Ruckenbauer, J.Starkbaum, P.Story, M.Trauner, O.Wagner, I.Walter, H.Wiedemann, M.Wieser, J.Zschocke, K.Zatloukal BBMRI.at – the Austrian National Node of BBMRI-ERIC
Europe Biobank Week; SEP 13-16, 2016; Vienna, AUSTRIA. 2016. [Poster]
FullText

H. Müller, R. Reihs, A.E. Posch, A. Kremer, D. Ulrich, K. Zatloukal Data Driven GUI Design and Visualization for a NGS Based Clinical Decision Support System
Information Visualisation (IV), 2016 20th International Conference DOI: 10.1109/IV.2016.79. 2016; -0th International Conference Information Visualisation (IV); JUL 2016; Lisabon. (ISBN: 978-1-4673-8942-6 ) [Oral Communication]
FullText

Heimo Müller, Robert Reihs, Kurt Zatloukal Design, User Experience and Usability Requirements for NGS Workflows in Clinical Applications
XIV Mediterranean Conference on Medical and Biological Engineering and Computing 2016, pp.540-544, DOI: 10.1007/978-3-319-32703-7_105 . 2016; 57: 540-544.-XIV Mediterranean Conference on Medical and Biological Engineering and Computing 2016; JAN 2016; CYPRUS. (ISBN: 978-3-319-32701-3 ) [Oral Communication]
FullText

Oberauner-Wappis, L; Loibner, M; Ulz, C; Abuja, P; Wieczorek, G; Groelz, D; Krenz, T; Wieczorek, G; Oelmueller, U; Zatloukal, K Application of the GeneReader NGS System in Analyzing a Diverse Set of Cancer Clinical Samples
J MOL DIAGN. 2016; 18(6):1038-1038.-Meeting of the Association-for-Molecular-Pathology; NOV 10-12, 2016; Charlotte, NC. [Poster]
Web of Science

Safari, Z; Kashofer, K; Moissl-Eichinger, C; Höfler, G; Zatloukal, K Investigation of the possible link between genetic background, gut microbiota and metabolism using the AJ/C57 chromosome substitution strains (CSSs)
Proceedings of The keystone symposium, Microbiota. 2016; -5. Z. Safari. Keystone Symposium, Microbiota , Rhode Island, US (Poster).; April 17-21, 2016; Rhode Island, USA . [Poster]

Viertler, C; Kap, M; Kruhoffer, M; Svec, D; Sjoback, R; Wagner, K; Bernhardt, G; Mischinger, HJ; Becker, KF; Riegman, P; Medizin, KZ Comprehensive characterization of ischemia effects on gene expression in human liver
VIRCHOWS ARCH. 2016; 469: S197-S197. [Poster]
Web of Science

Zatloukal, K New European Biomarker Quality Standards.
1st CBmed Biomarker Conference Graz: From Biomarker Research to Personalized Medicine; FEB 11, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K Introduction BBMRI.at, the AT NN of BBMRI-ERIC.
Bioethics Workshop; SEP 15, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K The case of health data for research in a regulated cloud.
ISC GDPR Seminar: The Impact of General Data Protection Regulation on future collaborative science in Europe; OCT 18, 2016; Brussels, BELGIUM. 2016. [Oral Communication]

Zatloukal, K ISO/DIS 20166-3 Molecular in vitro diagnostic examinations - Specifications for preexamination processes for formalin-foxed and paraffin-embedded (FFPE) tissue - Part 3: Isolated DNA
ISO/TC 212 WG4; OCT 12-14, 2016; Berlin, GERMANY. 2016. [Oral Communication]

Zatloukal, K Update on WP5-WP8.
ADOPT BBRMI-ERIC Annual Meeting; OCT 10, 2016; Prague, CZECH REPUBLIC. 2016. [Oral Communication]

Zatloukal, K The Spidia experience in pre-analytical conditions of tissues.
XXXI International Congress of the IAP and 28th Congress of the European Society of Pathology; SEP 25-29, 2016; Cologne, GERMANY. 2016. [Oral Communication]

Zatloukal, K The value of data: enabling medical science to address global challenges.
UN General Assembly Seminar: Science for Development: Data and Capacity; SEP 23, 2016; New York, USA. 2016. [Keynote lecture]

Zatloukal, K Introduction BBMRI.at, the AT NN of BBMRI-ERIC.
1st Translational Science Forum; SEP 14, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K Introduction to the Concept of the Expert Centre.
CORBEL Workshop: Explore the Concept of the Expert Centre; JUN 29-30, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K Overall Progress and Status of BBMRI.at.
BBMRI.at 3rd SEAB and ACP Meeting; NOV 28, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K Quality defined Bio-samples for Biomarker Validation.
Biomarker Summit: 5th Biomarkers in Diagnostics; OCT 5-7, 2016; Berlin, GERMANY. 2016. [Oral Communication]

Zatloukal, K Patient Data: new paradigms in Europe.
EAPM High-Level Workshop: Taking Stock - The role of science to realize a healthier world in the personalised medicine era; SEP 23, 2016; New York, USA. 2016. [Oral Communication]

Zatloukal, K BBMRI-ERIC Services and Expert Centers as instruments to improve translational medicine efficacy.
Europe Biobank Week; SEP 13-16, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K PAXgene.
QIAGEN Preanalytix Corporate Workshop: PAXgene Tissue: Multimodality, Non-Crosslinking Tissue Fixation Technology; New Protocol Developments and Pathogen Inactivating Properties; SEP 14, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K BBMRI-ERIC 2nd B Workshop.
; APR 12-13, 2016; Uppsala, SWEDEN. 2016.

Zatloukal, K The Austrian national infrastructure.
Biobanking National Infrastructures meeting; MAY 17-19, 2016; Nice, FRANCE. 2016. [Oral Communication]

Zatloukal, K How to define sample quality in rapidly developing field?
Biobanking National Infrastructures Meeting; MAY 17-19, 2016; Nice, FRANCE. 2016. [Oral Communication]

Zatloukal, K CORBEL WP8/Task 4: Expert Centres, update status and next steps.
CORBEL WP8 Accelerating Innovation Project Meeting; FEB 9, 2016; Amsterdam, THE NETHERLANDS. 2016. [Oral Communication]

Zatloukal, K ERINHA2 Kick-off Meeting.
ERINHA2 Kick-off Meeting; JAN 19, 2016; Paris, FRANCE. 2016.

Zatloukal, K Chair: Keynote II: Liron Patanowitz: Strategies and demands for digital pathology.
European Conference on Digital Pathology 2016; MAY 25-28, 2016; Berlin, GERMANY. 2016.

Zatloukal, K Sample pre-analytics in molecular pathology.
The 12th Symposium on Molecular Pathology and Histo(cyto)chemistry; JUN 2-3, 2016; Olomouc, CZECH REPUBLIC. 2016. [Oral Communication]

Zatloukal, K Forschungsinfrastrukturen als Innovationsenabler.
Wozu interdisziplinäre Forschungskooperationen – Last – Herausforderung - Mehrwert; JUN 13, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K Chair: Stem Cell Research Scientists meet Ethicists.
International Association of Bioethics (IAB) Satellite Symposium: Exploring International Policy Development Surrounding Innovative Technologies in Health; JUN 14, 2016; Edinburgh, SCOTLAND. 2016.

Zatloukal, K A BBMRI Model for Clinical Research.
OECI Pathology Day: Clinical Research and Applied Oncology: an integrated and indissoluble process; JUN 15, 2016; Brussels, BELGIUM. 2016. [Oral Communication]

Zatloukal, K Big data hype in cancer.
National Cancer Institute Directors Meeting; JUL 11-13, 2016; Lyon, FRANCE. 2016. [Oral Communication]

Zatloukal, K Overview on BBMRI-ERIC and BBMRI.at.
11th Management Committee meeting BBMRI.at; MAR 18, 2016; Innsbruck, AUSTRIA. 2016. [Oral Communication]

Zatloukal, K Developing a strategy for big health data integration.
BBMRI-ERIC Management Committee 14th Meeting & Scientific Retreat; MAY 23, 2016; Athens, GREECE. 2016. [Oral Communication]

Zatloukal, K Mid-term Evaluation of the National Infrastructures in Biology and Health.
; MAR 22-23, 2016; Paris, FRANCE. 2016.

Zatloukal, K WP6 (Biomarkers).
ADOPT BBMRI-ERIC Project Meeting; MAR 16, 2016; Valletta, MALTA. 2016. [Oral Communication]

Zatloukal, K Zukunftsstrategie Life Sciences und Medizinstandort Österreich: 3. Meeting des Sounding Board
; MAR 14, 2016; Vienna, AUSTRIA. 2016.

Zatloukal,K Evaluator.
Evaluation Panel Meeting: "Enabling German Biobank Sites to Connec to BBMRI"; APR 19-20, 2016; Berlin, GERMANY. 2016.

Denk, H; Zatloukal, K Zukunftsaspekte morphologischer (bildgebender)Diagnostik in der Medizin.
Osterreichische Akademie der Wissenschaften Öffentliche Gesamtsitzung; DEC 18, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

Loibner, M; Buzina, W; Viertler, C; Groelz, D; Hausleitner, A; Siaulyte, G; Kufferath, I; Kölli, B; Zatloukal, K Sample stabilization: PAXgene pathogen inactivation efficiency and pathogen detection sensitivity
Wissenschaftliche Evaluierung des Christian Doppler Labors für biologische Proben und Biobanktechnologien; AUG 4, 2015; Graz. 2015. [Oral Communication]

Oberauner-Wappis, L; Bordag, N; Zatloukal K Translational Research
EUCelLEX. 2015; -1st EUCelLEX International Consensus Conference; MÄR 30-31, 2015; Toulouse, France. [Poster]
FullText

Somlapura, M; Lahiri, P; Krausova M; Kufferath, I; Ruelicke, T; Zatloukal, K Analysis of the role of p62/Sequestosome-1 in α-synuclein mediated protein aggregation
5th Scientific Retreat of the Doctoral College Metabolic & Cardiovascular Disease; OCT 28-30, 2015; Seggau, AUSTRIA. 2015. [Poster]

Somlapura, M; Lahiri, P; Krausova M; Kufferath, I; Ruelicke, T; Zatloukal, K Analysis of the role of p62/Sequestosome-1 in α-synuclein mediated protein aggregation
Doctoral Day; DEZ 11, 2015; Graz, AUSTRIA. 2015. [Poster]

Zatloukal, K P U B L I K I N The Public Library for Knowledge and Information
European Commission; JAN 16, 2015; Brussels, BELGIUM. 2015. [Oral Communication]

Zatloukal, K Heterogeneity in tumour tissues: A challenge for clinical research.
Virchows Arch Supplement. 2015; -27th European Congress of Pathology; SEP 5-9, 2015; Belgrade, SERBIA. [Oral Communication]

Zatloukal, K Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.
Scientific evaluation of the CD Laboratory for Biospecimen Research and Biobanking Technologies ; AUG 4, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K Personalised Medicine and Junker Plan.
BMS RI Meeting with H2020 SC; JUL 15, 2015; Brussels, BELGIUM. 2015.

Zatloukal, K CE and ISO Standards for Pre-Analytics for DNA and RNA.
Advances in Diagnostic Molecular Pathology ; JUL 13-14, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K GDPR and Data for Health.
Data for Health and Science Day of Action; JUN 16, 2015; Brussels, BELGIUM. 2015.

Zatloukal, K Expertenrunde: Beantwortung von Fragen aus der Praxis.
Infoveranstaltung: Verwendung Medizinischer Proben & Daten; JUL 7, 2015; Graz, AUSTRIA. 2015.

Zatloukal, K .
BioSHaRE Meeting - Latest Tools and Services for Data Sharing; JUL 28, 2015; Milan, ITALY. 2015.

Zatloukal, K Introduction to the CD Laboratory and its activities, introduction to the presentations
Scientific evaluation of the CD Laboratory for Biospecimen Research and Biobanking Technologies. ; AUG 4, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K MUG: our role and tasks in the project. Plan for implementation.
Biobanking and the Cyprus Human Genome Project: Workshop; JUN 9, 2015; Nicosia, CYPRUS. 2015. [Oral Communication]

Zatloukal, K The roles of national nodes in BBMRI-ERIC, lessons learned from BBMRI.at.
Biobanking and the Cyprus Human Genome Project: Kick-off meeting; JUN 10, 2015; Nicosia, CYPRUS. 2015. [Oral Communication]

Zatloukal, K ISO/TC 212 Working Group 4 Microbiology and Molecular Diagnostics
; APR 22, 2015; Berlin, GERMANY. 2015.

Zatloukal, K Joint Meeting of BBMRI.at and BBMRI-ERIC national nodes
; MAR 12-14, 2015; Obergurgl, AUSTRIA. 2015.

Zatloukal, K BBMRI-LPC Annual Consortium and General Assembly Meeting
; APR 13-14, 2015; Barcelona, SPAIN. 2015.

Zatloukal, K Metabolomics for the advancement of personalized medicine and disease prevention
Science Europe Workshop "The Relationship between Health, Food and the Environment"; MAY 12-13, 2015; Milan. 2015. [Oral Communication]

Zatloukal, K Disease Biobank: TMA Key Technology For Biomarker validation and discovery.
Qatar Biobank Inaugural Conference: Biobanking in the Context of Personalized Healthcare; FEB 8-9, 2015; Doha, QATAR. 2015. [Oral Communication]

Zatloukal, K Biobanking 2.0: Lessons learned from Graz and Europe.
Kick-Off Meeting Gewebsbiobank der MUW; DEC 2, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K BBMRI-LPC Steering Committee Meeting.
BBMRI-LPC Steering Committee Meeting; NOV 27, 2015; Copenhagen, DENMARK. 2015.

Zatloukal, K Working Group 4, Microbiology and Molecular Methods.
ISO Technical Committee 212 on clinical laboratory testing and in vitro diagnostic test systems: Plenary and working group meetings; NOV 11-13, 2015; Geel, BELGIUM. 2015.

Zatloukal, K BMS Relationships.
4th MIRRI General Meeting; OCT 8, 2015; Amsterdam, THE NETHERLANDS. 2015. [Keynote lecture]

Zatloukal, K Workshop 1: Personalisierte Medizin.
Strategische Vernetzung der Forschung in Österreich; OCT 13, 2015; Vienna, AUSTRIA. 2015.

Zatloukal, K The Austrian node of BBMRI-ERIC.
"How to build a biobank" Course; SEP 18, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K Efficient Development of clinical biomarkers under Good Biomarker Practive
European Biomarker Factory Proposal Meeting; Jan 9, 2015; Amsterdam, NETHERLANDS. 2015.

Zatloukal, K Molecular In Vitro Diagnostic Examinations: Specifications for Pre-examination Processes
29th Plenary Meeting of CEN/TC 140 "In vitro Diagnostic Medical Devices" and CEN/TC140/WG3 "Quality Management in the medical laboratory"; FEB 2-4, 2015; Berlin, DEUTSCHLAND. 2015.

Zatloukal, K The "virtual human" for fully autonomous medical care.
100YSS 2015 Public Symposium; OCT 29- NOV 1, 2015; Santa Clara, UNITED STATES. 2015. [Oral Communication]

Zatloukal, K Impulsreferat: Management von medizinischen und patientenbezogenen Daten.
Zukunftsstrategie Life Sciences und Medizinstandort Österreich Round Table 3.1 Forschungsinfrastruktur ; DEC 16, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K DEDIPAC Meeting
; JUL 17, 2015; Schwechat, AUSTRIA. 2015.

Zatloukal, K WP6 (Biomarkers) Overview.
ADOPT BBMRI-ERIC Kick-off Meeting; OCT 20-21, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K Big Data and Analytics im Healthcare.
Workshop mit IBM; NOV 10, 2015; Vienna, AUSTRIA. 2015.

Zatloukal, K Scientific Success Story I: "Biobanking: from a personal collection to a research infrastructure.
BBMRI-LPC Forum Meeting; SEP 24-25, 2015; Budapest, HUNGARY. 2015. [Oral Communication]

Zatloukal, K Global Health Challenges and Biobanking
HandsOn: Biobanks; JUL 29-31, 2015; Milan, ITALY. 2015. [Keynote lecture]

Zatloukal, K BBMRI-ERIC Assembly of Members #4
; APR 27, 2015; Vienna, AUSTRIA. 2015.

Zatloukal, K Disruptive innovation in health care
ES:GC2 2015; MAR 4-6, 2015; Brussels, BELGIUM. 2015. [Oral Communication]

Zatloukal, K WP 7: Coordination of the national network and operation of the national node.
BBMRI.at 8th Management Committee Meeting; JUL 2, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K ERINHA2 Steering Committee Meeting.
ERINHA2 Steering Committee Meeting; DEC 14, 2015; Paris, FRANCE. 2015.

Zatloukal, K Assessment and analysis of health data from environmental and infectious diseases and patient studies.
COP21 Responding to Health and Data Challenges. Case for Climate Change and Atmospheric Pollution; DEC 4, 2015; Paris, FRANCE. 2015. [Oral Communication]

Zatloukal, K BBMRI-ERIC Management Committee 12th Meeting.
BBMRI-ERIC Management Committee 12th Meeting; NOV 30- DEC 1, 2015; Amsterdam, THE NETHERLANDS. 2015.

Zatloukal, K Management of the Biological Resources.
Biobanks for biological samples: regulations, organization and scientific aspects; NOV 16-17, 2015; Bologna, ITALY. 2015. [Oral Communication]

Zatloukal, K BBMRI-ERIC Assembly of Members 5th Session.
BBMRI-ERIC Assembly of Members 5th Session; OCT 27, 2015; Vienna, AUSTRIA. 2015.

Zatloukal, K WP 7: Coordination of the national network and operation of the national node.
BBMRI.at 2nd SEAB & ACP Meeting 2015 with 10th MC Meeting; DEC 15, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K 100 Year Starship Virtual Human Crucible.
100 Year Starship Virtual Human Crucible; NOV 18-20, 2015; Styria, AUSTRIA. 2015.

Zatloukal, K Molecular in vitro diagnostic examinations - Specifications for pre-examination processes.
Meeting of CEN/TC 140/WG3; NOV 23-24, 2015; Florence, ITALY. 2015.

Zatloukal, K Integrated workflow for pathogen detection and analysis: sample management for high infectious diseases.
Scientific evaluation of the CD Laboratory for Biospecimen Research and Biobanking Technologies; AUG 4, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K Sample stabilization: PAXgene impact on preservation of cell structure and antigenicity for ELMI, IF, FACS and IHC applications.
Scientific evaluation of the CD Laboratory for Biospecimen Research and Biobanking Technologies.; AUG 4, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K Qualitätskontrollierte Biomaterialien als Voraussetzung für verlässliche Forschungsdaten.
Biomaterial-Wertvolle Forschungswerkzeuge sinnvoll und sicher nützen; JUN 29, 2015; Vienna, AUSTRIA. 2015. [Oral Communication]

Zatloukal, K Heterogeneity in Clinical Research
OECI Pathology Days: Tumour Heterogeneity and NGS: Morphology and Technology; JUN 22-24, 2015; Porto, PORTUGAL. 2015. [Oral Communication]

Zatloukal, K BBMRI-ERIC Scientific Retreat
; JUN 1-3, 2015; Sebersdorf, AUSTRIA. 2015.

Zatloukal, K BBMRI.at Management Committee Meeting #9
; OCT 6, 2015; Salzburg, AUSTRIA. 2015.

Zatloukal, K Biomedical Research Infrastructures for Africa: The Example of BBMRI-ERIC.
Science Forum South Africa; DEC 8-9, 2015; Pretoria, SOUTH AFRICA. 2015. [Oral Communication]

Zatloukal, K; Speaker at Panel II: Policy requirements to achieve enhanced cooperation.
Transatlantic Science Forum; JAN 13, 2015; USA, Washington D.C. 2015. [Oral Communication]

Ciniselli, C.M.; Pizzamiglio, S; Viertler, C; Zatloukal, K; Gündisch, S; Becker, K.-F.; Kap, M; Riegman, P; Verderio, P A Comparison Between Conventional Formalin and Novel Paxgene Tissue Fixation: the European Spidia Morphology Ring Trials Experience.
27th International Biometric Conference; JUL 6-11, 2014; Florence, ITALY. 2014. [Poster]

Dieber-Rotheneder, M; Wallner-Liebmann, S; Luchinat, C; Konrad, M; Hofmann, P; Tenori, L; Gralka, E; Turano, P; Zatloukal, K Effects of short-term standardized diet and exercise on the urinary and salivary metabolomic profiles of healthy humans.
Symposium on Personalized Medicine; JULY 17-18, 2014; Graz. 2014. [Poster]

Gündisch, S; Slotta-Huspenina, J; Verderio, P; Ciniselli, C.M.; Pizzamiglio, S; Schott, C; Drecoll, E; Viertler, C; Zatloukal, K; Kap, M; Riegman, P; Esposito, I; Specht, K; Babaryka, G; Asslaber, M; Bodo, K; den Bakker, M; den Hollander, J; Fend, F; Neumann, J; Reu, S; Perren, A; Langer, R; Lugli, A; Becker, I; Richter, T; Kayser, G; May, A.M.; Carneiro, F; Lopes, J.M.; Sobin, L; Höfler, H; Becker, K.-F. Evaluation of colon cancer morphology: a comparison between conventional formalin and novel PAXgene tissue fixation by an international ring trial
Pathologe 2014 · [Suppl 1] · 35:6–164 DOI 10.1007/s00292-014-1944-9 © Springer-Verlag Berlin Heidelberg 2014. 2014; -98. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V.; JUN 12-15, 2014; Berlin, GERMANY. [Poster]
FullText

Heimo MÜLLER , Robert REIHS , Kurt ZATLOUKAL Beschreibung und Vergleich von Probensammlungen mit Glyph Visualisierung
Tagungsband des 3. Nationales Biobank Symposium (2014). 2014; -3. Nationales Biobank Symposium; DEZ 3-4, 2014; Berlin, GERANY. [Poster]

Hofmann, P; Mueller, A; Moser, O; Tschakert, G; Wallner-Liebmann, SJ; Dieber-Rotheneder, M; Konrad, M; Zatloukal, K Mid-point Between Lactate Turn Points Exercise Intensity Prescription Compared to Standard Models in Untrained Females
MED SCI SPORT EXER. 2014; 46(5):846-846.-61st Annual Meeting of the American-College-of-Sports-Medicine; APR 01-04, 2014; Atlanta, GA. Doi: 10.1249/01.mss.0000496037.28838.b7 [Poster]
Web of Science FullText FullText_MUG

Lahiri, P; Smole, C; Kufferath, I; Schmidt, V; Ruelicke, T; Strnad, P; Froehlich, L; Zatloukal, K P62/SEQUESTOSOME-1 ACTS AS A GLUE IN THE MATURATION OF MALLORY–DENK BODIES
Journal of Hepatology. 2014; 60(1):S174--Abstracts of The International Liver Congress™ 2014 – 49th Annual meeting of the European Association for the Study of the Liver ; April 9-13, 2014; London, United Kingdom. [Poster]

Moser, O; Muller, A; Wallner-Liebmann, SJ; Dieber-Rotheneder, M; Konrad, M; Zatloukal, K; Tschakert, G; Hofmann, P Blood Glucose Decrease During Constant Load Exercise With Standardized Diet is Dependent on Resting Glucose
MED SCI SPORT EXER. 2014; 46(5):157-157.-61st Annual Meeting of the American-College-of-Sports-Medicine; APR 01-04, 2014; Atlanta, GA. Doi: 10.1249/01.mss.0000493644.81245.b5 [Poster]
Web of Science FullText FullText_MUG

Müller, H; Reihs, R; Zatloukal K Characterization and Comparison of Sample Collections Using Glyph Visualization
Biobanken-Forschung in Deutschland: Vom Konzept zur Realisierung. 2014; 177-180.-3. Nationales Biobanken-Symposium; DEZ 3-4, 2014; Berlin. (ISBN: 2198-0845 ) [Poster]

Quan, P; Moinfar, F; Kufferath, I; Absenger, M; Kueznik, T; Denk, H; Zatloukal, K; Haybaeck, J Targeting Endometrial Stromal Sarcoma Cells Via Histone Deacetylase and the PI3K/AKT/mTOR Pathway
Anticancer Research. 2014; 34(10):5943-5943.-9th International Conference of Anticancer Research; OCT 6-10, 2014; Sithonia, Greece. [Poster]
Web of Science

Viertler, C; Verderio, P; Ciniselli, C.M.; Gündisch, S; Kap, M; Amendoeira, I; Andreu, J; den Bakker, M; Bianchi, S; Branton, P; Bussolati, G; Callagy, G; Castellano, I; Chmielik, E; Cordoba, A; Cserni, G; van Deurzen, C; Foschini, M.P.; Grazio, S.F.; Kulka, J; Liepniece-Karele, I; Moinfar, F; Reiner, A; Ryska, A; Sapino, A; Tavassoli, F; Varga, Z; Zolota, V; Riegman, P; Becker, K.-F.; Zatloukal, K; Regitnig, P Evaluation of breast cancer morphology in PAXgene tissue fixed compared to formalin fixed samples by an international ring trial
Pathologe 2014 · [Suppl 1] · 35:6–164 DOI 10.1007/s00292-014-1944-9 © Springer-Verlag Berlin Heidelberg 2014. 2014; -98. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V.; JUN 12-15, 2014; Berlin, GERMANY. [Poster]
FullText

Viertler, C; Verderio, P; Ciniselli, CM; Pizzamiglio, S; Gundisch, S; Kap, M; Riegman, P; Becker, KF; Zatloukal, K; Regitnig, P International ring trial for evaluation of breast cancer morphology in PAXgene fixed tissue compared to formalin fixed samples
VIRCHOWS ARCH. 2014; 465: S105-S105.-26th European Congress of Pathology; AUG 30-SEP 3, 2014; London, United Kingdom. [Poster]
Web of Science

Wallner-Liebmann,S;Gralka, E;Tenori, L;Dieber-Rotheneder, M;Konrad, M;Hofmann, P;Turano,P;Luchinat, C;Zatloukal,K The impact of multiple urine sampling on metabolome recognition accuracy after short-term standardized lifestyle
NUTRIGENOMICS OF FOOD NuGOweek2014 Book of abstracts. 2014; -11th NuGOweek NUTRIGENOMICS OF FOOD; SEPT 8-11, 2014; Napoli, ITALY. [Poster]

Zatloukal, K Contributions of BBMRI-ERIC
DEDIPAC kick off meeting ; FEB 13-14, 2014; Lyon, FRANCE. 2014. [Oral Communication]

Zatloukal, K Metabolomics offers new opportunities for personalised medicine and disease prevention
European Alliance for Personalised Medicine, Internal Meeting; DEZ 10, 2014; Brussels, BELGIUM. 2014. [Oral Communication]

Zatloukal, K BBMRI.at: Example of Member State participation in BBMRI-ERIC
Partner Meeting BBMRI-ERIC and South-East European States; OKT 6-7, 2014; Split, CROATIA. 2014. [Oral Communication]

Zatloukal, K The case for better standardized sample pre-analytics
Oncology Clinical Development Group Workshop ; OKT 1-2, 2014; Murnau, GERMANY. 2014. [Oral Communication]

Zatloukal, K Expert Centres for Improved Access to Research Infrastructures
HandsOn Biobanks (HOBB) 2014; SEP 24-25, 2014; Helsinki, FINLAND. 2014. [Oral Communication]

Zatloukal, K Plan B: Humanity's Health Panelist
100 Years Starship Symposium 2014; SEP 17-21,2014; Houston, USA. 2014. [Oral Communication]

Zatloukal, K Interstellar Enhancing Life on Earth
100 Years Starship Symposium 2014; SEP 17-21, 2014; Houston, USA. 2014. [Oral Communication]

Zatloukal, K Molecular diagnostics in personalized medicine
OMI Workshop; JUN 23, 2014; Wien, AUSTRIA. 2014. [Oral Communication]

Zatloukal, K Possible issues and strategies in the transtional research
International Symposium on Clinical an Translational Medicine ; MAI 28-30, 2014; Shanghai, CHINA. 2014. [Oral Communication]

Zatloukal, K Chair of the Governing Board meeting
Bioshare Annual Meeting; NOV 13, 2014; Athens, GREECE. 2014.

Zatloukal, K Investing in Research Infrastructures to Build a Knowledge-based Economy in Africa
US-African Leader Summit; AUG 1-7, 2014; Washington, USA. 2014. [Oral Communication]

Zatloukal, K Quality Control in Molecular Cancer Diagnostics
NCID-Meeting; JUL 10-11, 2014; Lyon, FRANCE. 2014. [Oral Communication]

Zatloukal, K Review of the work done in WP2 (Network expansion, structuring and harmonization)
BBMRI-LPC Midterm Review Meeting; NOV 27, 2014; Brussels, BELGIUM. 2014.

Zatloukal, K What existing ESFRI Infrastructures can offer to the systems bio-medicine community.
EC-CASYM Workshop; JUL 1, 2014; Brussels, BELGIUM. 2014. [Oral Communication]

Zatloukal, K BBMRI.ERIC in a Global Setting: Africa
Biobanking; a Gateway for Health Future Direction for one of Europe´s Largest Health Research Infrastructures; NOV 18, 2014; Brussels, BELGIUM. 2014. [Oral Communication]

Zatloukal, K Role of Biobanks in Personalized Medicine
KHCCBIO Conference; APR 10-12, 2014; Amman, JORDAN. 2014. [Oral Communication]

Zatloukal, K „Venture Capital for Innovation“ (Presentation on the importance of investment in health research infrastructures in Africa)
Innovation Convention & Bilateral Africa Meeting; MAR 11, 2014; Brussels. 2014. [Oral Communication]

Zatloukal, K. Biobanking and Biomarker Initiatives
TCRM Symposium; OKT 29, 2014; Munich, GERMANY. 2014. [Oral Communication]

Zatloukal, K; Electronic Health Records - Panel
RD-Connect Annual Meeting; FEB 02, 2014; Heidelberg, GERMANY. 2014.

Zatloukal, K; Dialog zu Personalisierter Medizin
Grazer Dialog zu Personalisierter Medizin; MAR 17, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

Zatloukal K Transatlantic Health Research Collaboration
Transatlantic Science Forum @ 100YSS Symposium; SEP 20, 2014; Houston, USA. 2014. [Oral Communication]

Zatloukal, K; Turano, P Scientific Links between metabolomics and Biobanks
EXCEMET Meeting; NOV 14, 2014; Oudergemselaan, BRUSSELS. 2014. [Oral Communication]

Bettermann, K; Kuldeep Mehta, A; Lederer, E; Ernst, C; Kessler, SM; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, N; Fuchs, B; Tanabe, KK; Müller, H; Svendova, V; Schimek, MG; Mach, M; Speicher, M; Divoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Smole, C; Stojakovic, T; Scheideler, M; Nilsson, KPR; Kolbe, T; Rülicke, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, C; Trauner, M; Spilka, R; Kiemer, A; Teufel, A; Maass, T; Grabe, N; Müller, KM; Themanns, M; Moriggl, R; Campbell, J; Thorgeirsson, S; Pasparakis, M; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Denk, H; Lackner, C; Haybaeck, J Dysbalanced keratins drive steatohepatitis-associated liver carcinogenesis
8th European Conference of Intermediate filaments in health and disease. 2013; -8th European Conference of Intermediate filaments in health and disease; SEP 18-21, 2013; Amsterdam, Netherlands. [Poster]

Bettermann, K; Kuldeep Mehta, A; Lederer, EM; Ernst, C; Kessler, SM; Kojima, K; Cheng, X; Hoshida, Y; Bardessy, NM; Fuchs, BC; Tanabe, KK; Müller, HH; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Smole, C; Stojakovic, T; Scheideler, M; Nilsson, KPR; Kolbe, T; Rülicke, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Grabe, N; Müller, KM; Themanns, M; Moriggl, R; Campbell, JS; Thorgeirsson, S; Pasparakis, M; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Denk, H; Lackner, C; Haybaeck, J Dysbalanced Keratins promote Steatohepatitis-associated Liver Carcinogenesis
Der Pathologe, FP 08. 2013; 34(Issue6):591-591.-Joined Annual Meeting of the Swiss and Austrian Society for Pathology; NOV 7-9, 2013; Baden, Switzerland. [Oral Communication]

Bettermann, K; Mehta, AK; Lederer, E; Ernst, C; Kessler, SM; Chen, X; Hoshida, Y; Bardeesy, N; Fuchs, BC; Tanabe, KK; Müller, H; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Mahajan, V; Stumptner, C; Thueringer, A; Stojakovic, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Moriggl, R; Campbell, JS; Thorgeirsson, SS; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Lackner, C; Haybäck, J Steatohepatitis-associated Hepatocellular Carcinoma: Evidence of a Keratinopathy.
HEPATOLOGY. 2013; 58(S1):543A-543A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA. [Poster]
Web of Science

Bettermann, K; Mehta, AK; Lederer, EM; Ernst, C; Kessler, SM; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Fuchs, BC; Tanabe,KK; Müller, H; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Smole, C; Stojakovic, T; Scheideler, M; Nilsson, K. P. R.; Kolbe, T; Schmidt, V; Rülicke, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Grabe, N; Mueller, KM; Themanns, M; Moriggl, R; Campbell, JS; Thorgeirsson, SS; Pasparakis, M; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Denk, H;Lackner, C and Haybaeck, J Steatohepatitits-associated Hepatocellular Carcinoma: new insights in keratin function
Arbeitssitzung des Leberforschungsnetzwerkes ; 19.06.2013; Graz, Austria. 2013. [Oral Communication]

Groelz, D; Viertler, C; Gündisch, S; Kap, M; Wyrich, R; Rainen, L; Zatloukal, K; Riegman, P; Becker, KF Evaluation of a Formalin-free Tissue Fixation Method for Multimodal Biomarker Analysis within the EU Consortium SPIDIA.
MipTec 2013 Drug Discovery International Abstract Supplementum. . 2013; -MipTec 2013 Conference and Exhibition - The Leading European Event for Drug Discovery; SEP 24-26. 2013; Basel, SWITZERLAND. [Poster]
FullText

Oelmueller, U; Becker, KF; Heinrich, M; Krieger, L; Kubista, M; Pazzagli, M; Riegman, P; Turano, P; Viertler, C; Zatloukal, K SPIDIA Dissemination of Results into CEN Technical Specifications for Biospecimen Handling.
Presentations delivered at Markers in Cancer, including the special EORTC session on Biospecimen Pre-Analytical Stability and Diagnostics.. 2013; -Markers in Cancer, Joint Meeting by ASCO, EORTC and NCI; Nov 7-9, 2013; Brussels, BELGIUM. [Oral Communication]
FullText

Trierweiler, C; Hockenjos, B; Zatloukal, K; Blum, HE; Wagner, EF; Hasselblatt, P THE TRANSCRIPTION FACTOR c-JUN/AP-1 PROMOTES HBV-RELATED LIVER TUMORIGENESIS IN MICE
J HEPATOL. . 2013; 58: S38-S38.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60087-2 [Poster]
Web of Science FullText FullText_MUG

Univ. Prof. Dr. Kurt Zatloukal BBMRI expert centres & public/private partnership
Brocher Workshop ; JUN 12-14, 2013; Genf. 2013. [Oral Communication]

Univ.-Prof. Dr. Kurt Zatloukal The 50 year roadmap for the future of medicine: supporting the development in the African Union Commission
Global Science Collaboration: Science Capacity Building & the Implications for the Development Process; JUN 27-28, 2013; Addis Abeba, Ethiopia. 2013. [Oral Communication]

Univ.-Prof. Dr. Kurt Zatloukal The Biobanking and Biomolecular Resources Research Infrastructure: Opportunities of Collaborations with Africa
Global Science Collaboration: Science Capacity Building and the Implications for the Development Process; JUN 27-28, 2013; Addis Abeba, Ethiopia. 2013. [Oral Communication]

Viertler, C; Groelz, D; Verderio, P; Kashofer, K; Gündisch, S; Kap, M; Riegman, P; Becker, KF; Oelmüller, U; Regitnig, P; Zatloukal, K Comprehensive evaluation of a new technology for simultaneous high quality preservation of biomolecules and morphology in tissues.
Joint Annual Meeting of the Swiss and Austrian Societies of Pathology (SGPath/SSPath and ÖGP). Der Pathologe, 2014.. 2013; -Joint Annual Meeting of the Swiss and Austrian Societies of Pathology; Nov 7-9, 2013; Baden, SWITZERLAND. [Oral Communication]

Wallner-Liebmann, SJ; Luchinat, C; Konrad, M; Hofmann,P; Dieber-Rotheneder, M; Gralka, E; Turano, P; Zatloukal, K Effects of short-term standardized diet on the urinary metabolomic profiles of exercising humans
NuGo Week; SEPT 9-13, 2013; München, Germany. 2013. [Poster]

Zatloukal, K An update on the BBMRI-ERIC project
ESBB Annual Meeting; OCT 8-11, 2013; Verona, ITALY. 2013. [Keynote lecture]

Zatloukal, K The role of ESFRI research infrastructures in EU-US collaboration in health R&D: The example of BBMRI-ERIC
TÉLÉCOMS SANS FRONTIÈRES at the European Parliament; NOV 12, 2013; Brussels, BELGIUM. 2013. [Oral Communication]

Zatloukal, K Health and its implications on the economy
Transatlantic Science Forum; SEP 19-21, 2013; Washington DC, USA. 2013. [Oral Communication]

Zatloukal, K BBMRI: focussing on the present status of the project, main challenges and next steps.
Symposium - EU Research Infrastructure networks in biomedical sciences and national research centers in Turkey: prospects of collaboration; Feb 7-8, 2013; Izmir, TURKEY. 2013. [Oral Communication]

Zatloukal, K Evidence-based biobanking
Tag des Biobankings/ 1. Sitzung des Advisory Boards der BMBH; SEP 10, 2013; Heidelberg. 2013. [Oral Communication]

Zatloukal, K Die Beteiligung österreichischer Universitäten an der europäischen Forschungsinfrastuktur BBMRI
Rektorat - Medizinische Universität Innsbruck; Jän 31, Feb 01, 2013; Innsbruck. 2013. [Keynote lecture]

Zatloukal, K Presentation and Interview Biobanking and Biomolecular Resources Research Infrastructure
Ad hoc panel review proposal BBMRI; DEZ 3-4, 2013; Brussels, BELGIUM. 2013. [Oral Communication]

Zatloukal, K. Tissue Banking - European perspectives
97. Jahrestagung der Deutschen Gesellschaft für Pathologie; Mai 23-26, 2013; Heidelberg, Deutschland. 2013. [Oral Communication]

Zatloukal, K. Session Leader, Innovative mechanisms for building trust when bridging biobanks with industrial partners
Brocher Workshop; JUN 12-14, 2013; Genf. 2013.

Zatloukal, K; Viertler, C Evaluation of novel alternatives to formalin fixation for companion diagnostics
Presentations delivered at Markers in Cancer, including the special EORTC session on Biospecimen Pre-Analytical Stability and Diagnostics.. 2013; -Markers in Cancer, Joint Meeting by ASCO, EORTC and NCI ; Nov 7-9, 2013; Brussels, BELGIUM. [Oral Communication]
FullText

Zatloukal, Kurt European and other international governance initiatives for biobanks
4th Symposium of the Swiss Clinical Trial Organisation (SCTO) and the University Hospitals Geneva (HUG); JUN 20, 2013; Geneva, Swiss. 2013. [Oral Communication]
FullText

Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Hayback, J; Denk, H; Lackner, C Prognostic relevance of Mallory-Denk and intracytoplasmic hyaline bodies in hepatocellular carcinoma
HEPATOLOGY. 2012; 56: 474A-475A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

Aigelsreiter, A; Neumann, J; Pichler, M; Halasz, J; Zatloukal, K; Berghold, A; Lederer, E; Haybaeck, J; Denk, H; Lackner, C PROGNOSTIC RELEVANCE OF MALLORY-DENK BODIES AND INTRACELLULAR HYALINE BODIES IN HEPATOCELLULAR CARCINOMA
J HEPATOL. 2012; 56: S287-S287. Doi: 10.1016/S0168-8278(12)60741-7 [Oral Communication]
Web of Science FullText FullText_MUG

Bettermann, K; Kuldeep Mehta, AK; Lederer, E; Diwoky, C; Thüringer, A; Mueller, H; Mahajan, V; Stumptner, C; Kolbe, T; Magin, TM; Denk, H; Lackner, C; Zatloukal, K; Haybaeck, J Molecular pathogenesis and genetic susceptibility to steatohepatitis induced liver cancer
ÖGGH (Österreichische Gesellschaft für Gastroenterologie und Hepatologie) 45. Jahrestagung mit 23. Fortbildungskurs Thema: Der Gastroenterologe und das Mikroskop ; JUN 14-16, 2012; Wels, Austria. 2012. [Poster]

Bettermann, K; Mehta, AK; Lederer, E; Diwoky, C; Thüringer, A; Müller, H; Mahajan, VS; Stumptner, C; Kolbe, T; Magin, TM; Denk, H; Lackner, C; Zatloukal, K; Haybaeck, J Contribution of keratin-18 on steatohepatitis and liver cancer
45. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 14-16, 2012; Wels, Austria. 2012. [Poster]

Bettermann, K; Mehta, AK; Lederer, E; Diwoky, C; Thuringer, A; Muller, H; Mahajan, VS; Stumptner, C; Kolbe, T; Magin, TM; Denk, H; Lackner, C; Zatloukal, K; Haybaeck, J; Steatohepatitis-driven hepatocellular carcinoma.
INT J MOL MED. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE30: S6-S6. ATHENS: SPANDIDOS PUBL LTD; [Oral Communication]
Web of Science

Chowdhury, P; Smole, C; Kufferath, I; Schmidt, V; Rülicke, T; Fröhlich, LF; Zatloukal, K Functional Analysis of the Role of p62/Sequestsome-1 in Mallory Denk body formation
FASEB Summer Research Conference on Liver Growth, Injury and Metabolism: Basic and Applied Biology; 29 July-3 August; Snowmass Village, Colorado, USA. 2012. [Poster]
FullText

Fröhlich, LF; Mrakovcic, M; Smole, C; Chowdhury, P; Fröhlich, E; Zatloukal, K TP53 mutational status determines uterine tumor cell response towards histone deacetylase inhibitor induced apoptosis or autophagy
Gordon Research Conference on "Cell Death"; JULY 15-20, 2012; Barga, ITALY. 2012. [Poster]

Fröhlich LF, Mrakovcic M, Smole C, Chowdhury P, Fröhlich E, Zatloukal K TP53 mutational status determines uterine tumor cell response towards histone deacetylase inhibitor induced apoptosis or autophagy
4th Annual Meeting of the Austrian Association of Molecular Life Sciences and Biotechnology; SEP 17-19, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

Fröhlich, LF; Mrakovcic, M; Smole, C; Lahiri, P; Fröhlich, E; Zatloukal, K P53 determines histone deacetylase inhibitor induced cytotoxic tumor cell response
ZMF Days 2012; NOV 8, 2012; Graz, Austria. 2012. [Oral Communication]

Fröhlich LF, Smole C, Moser M, Kashofer K, Osprian I, Zatloukal K Different susceptibility to Mallory-Denk body (MDB) formation in substrains of C57BL/6 mice
SYSGENET COST ACTION BM0901 Scientific Meeting; DEC 10-12; Bilbao, Spain. 2012. [Poster]

Groelz, D; Viertler, C; Gündisch, S; Becker, KF; Zatloukal, K; Wyrich, R; Rainen, L Formalin-free Tissue Fixation for Multimodal Biomarker Analysis.
Association for Molecular Pathology, Annual Meeting Abstracts. JMD November 2012. 2012; 14(6):731-731.-Association for Molecular Pathology (AMP) 2012 Annual Meeting on Genomic Medicine ; Oct 25-27, 2012; Long Beach, California, USA. [Poster]
Web of Science FullText

Kap, M; Verhoef, C; Kruhoffer, M; Guendisch, S; Viertler, C; Zatloukal, K; Becker, KF; de Jong, B; Oelmüller, U; Riegman, P Evidence Based Biobanking; From Patient to Storage.
5th Annual Biospecimen Research Network (BRN) Symposium "Advancing Cancer Research Through Biospecimen Science" ; FEB 22-23, 2012; Bethesda, Maryland, USA. 2012. [Poster]

Lahiri, P; Smole, C; Fröhlich, LF, Zatloukal, K Functional Analysis of the Role of p62/Sequestosome-1 in Mallory-Denk Body Formation in mouse models of Non Alcoholic Steatohepatitis (NASH)
4th ÖGMBT Annual Meeting; SEP 17-19, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

Lahiri, P; Smole, C; Fröhlich, LF, Zatloukal, K Functional Analysis of the Role of p62/Sequestosome-1 in Mallory-Denk Body (MDB) formation in mouse models of Non Alcoholic Steatohepatitis.
Liver Biology: Fundamental Mechanisms & Translational Applications; JUL 29-AUG 3, 2012; Snowmass Village, CO, USA. 2012. [Poster]

Lahiri, P; Smole, C; Fröhlich, LF; Zatloukal, K Functional Analysis of the Role of p62/Sequestosome-1 in Mallory-Denk Body (MDB) formation in mouse models of Non Alcoholic Steatohepatitis.
4th ÖGMBT Annual Meeting; SEP 17-19, 2012; Graz, Austria. 2012. [Poster]

Lahiri, P; Smole, C; Kufferath, I; Schmidt, V; Ruelicke, T; Froehlich, LF, Zatloukal, K p62/Sequestosome-1: A crucial player of Mallory-Denk body formation
2nd Scientific Retreat of the Doctoral College "Metabolic & Cardiovascular Disease"; OCT 25th-27th, 2012; Seggau Castle, Austria. 2012. [Poster]

Mahajan, V; Kingstedt, T; Simon, R; Nilsson, P; Thueringer, A; Kashofer, K; Denk, H; Zatloukal, K; Haybaeck, J Leuchtiende konjugierte Oligothiophene: Neuartige optische Sonden, die Beta-Faltblatt-Konformationen von Einschlusskörpern "in situ" erkennen
Konferenzband Seite 124. 2012; -96. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V.; MAY 31- JUN 3, 2012; Berlin, Germany . [Poster]

Mahajan, V; Nikam, A; Anita K., Mehta; Karl, Kashofer; Martin, Gauster; Berthold, Huppertz; Helmut, Denk; Kurt, Zatloukal; Johannes, Haybaeck INTERPLAY OF AUTOPHAGY AND APOPTOSIS IN STEATOHEPATITIS AND HEPATOCELLULAR CARCINOMA
45. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie ; JUN 14-16, 2012; Wels, Austria . 2012. [Poster]

Mahajan, V; Stumptner, C; Thueringer, A; Kingstedt, T; Nilsson, P; Mechtler, K; Kashofer, K; Denk, H; Zatloukal, K; Haybaeck, J Ubiquitin, SH2- und UBA-Domänen von p62 regulieren die Interaktion von p62 mit K8/18 und deren Aggregationseigenschaften
Konfernezband Seite 129. 2012; -96. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V.; MAY 31- JUN 3, 2012; Berlin, Germany. [Poster]

Mahajan, V; Stumptner, C; Thüringer, A; Klingstedt, T; Simon, R; Peter, K; Nilsson, R; Mechtler, K; Kashofer, K; Denk, H; Zatloukal, K; Haybaeck, J Ubiquitin, SH2 and UBA domain of p62 regulate aggregation properties of p62 and different types of Mallory-Denk Body formation
2012 Cold Spring Harbor Asia Conference; May 21-25, 2012; Souzhou, China. 2012. [Poster]

Mehta, A K; Bettermann, K; Lederer, E; Diwoky, C; Thüringer, A; Stumptner, C; Mueller, H; Kolbe, T; Magin, T M; Lackner, C; Denk, H; Zatloukal, K; Haybaeck, J Contribution of keratin-18 in SH and SH induced HCC development
96. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. ; MAY 31 - JUN 3, 2012; Berlin, Germany. 2012. [Oral Communication]

Mehta, AK; Bettermann, K; Lederer, E; Diwoky, C; Thüringer, A; Stumptner, C; Mueller, H; Kolbe, T; Magin, TM; Lackner, C; Denk, H; Zatloukal, K; Haybaeck, J Molecular pathogenesis and genetic susceptibility to steatohepatitis induced liver cancer
40th Keystone Symposia Conference on Molecular and Cellular Biology: Cancer and Metabolism; FEB 12-17, 2012; Banff Springs, Alberta, CANADA. 2012. [Poster]
FullText

Nikam, A; Abuja, PM; Patankar, JV; Fechter, K; Lackner, C; Schöck, E; Kratky, D; Zatloukal, K Mitochondrial Dysfunction at the Transition between Acute and Adaptive Long-term Hepatotoxicity in Mice.
4th ÖGMBT Annual Meeting; SEP 17-19, 2012; Graz. 2012. [Poster]

Nikam, A; Patankar, JV; Schöck, E; Kashofer, K; Zatloukal, K; Abuja, PM Peroxisome proliferator-activated receptor alpha, a key modulator in oxidative stress and impaired mitochondrila function in a mouse model of DDC-induced hepatotoxicity
4th ÖMBGT Annual Meeting; SEP 17-19, 2012; Graz. 2012. [Oral Communication]

Nikam, AP; Patankar, J; Schöck, E; Kashofer, K; Zatloukal, K; Abuja, PM Peroxisome proliferator activated receptor-á a key modulator in oxidative stress and impaired mitochondrial function in a mouse model of DDC induced hepatotoxicity.
Free Radical Biology and Medicine. 2012; 53, suppl. 1: S40-S41.-Society for Free Radical Research International 16th Biennial Meeting; Sep 3-9, 2012; London, UK. [Oral Communication]

Quan, P; Lederer, E; Halbwedl, ; Moinfar, F; Denk, H; Zatloukal, K; Haybaeck, J Endometriales Stromasarkom: Histondeacetylase und PI3K/Akt/mTOR-Signalweg
96. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. ; MAY 31 - JUN 3, 2012; Berlin, Germany . 2012. [Oral Communication]

Quan, P; Lederer, E; Halbwedl, I; Denk, H; Zatloukal, K; Haybaeck, J; Targeting endometrial stromal sarcoma: Histone deacetylase and PI3K/Akt/mTOR signaling.
VIRCHOWS ARCHIV. VIRCHOWS ARCHIV461: S31-S31. NEW YORK: SPRINGER; [Oral Communication]
Web of Science

Reihs, R; Muller, H; Sauer, S; Zatloukal, K; Challenges and solutions in the setup of a findings database for a large scale tissue collection.
VIRCHOWS ARCHIV. VIRCHOWS ARCHIV461: S26-S26. NEW YORK: SPRINGER; [Oral Communication]
Web of Science FullText

Smole C, Moser M, Kashofer K, Osprian I, Fröhlich LF, Zatloukal K Different susceptibility to Mallory-Denk body (MDB) formation in substrains of C57BL/6 mice
4th Annual Meeting of the Austrian Association of Molecular Life Sciences and Biotechnology; SEP 17-19; Graz, Austria. 2012. [Poster]

Viertler, C; Groelz, D; Kashofer, K; Gündisch, S; Reischauer, B; Riegman, P; Winther, R; Wyrich, R; Kruhoffer, M; Walch, A; Becker, KF; Oelmüller, U; Zatloukal, K; A new technology for simultaneous preservation of biomolecules and morphology in tissues facilitates biomarker development.
10th Austrian Proteomic Research Symposium (APRS); SEP 24-26, 2012; Graz, AUSTRIA. 2012. [Poster]

Viertler, C; Groelz, D; Kashofer, K; Gündisch, S; Riegman, P; Winther, R; Wyrich, R; Kruhoffer, M; Becker, KF; Oelmüller, U; Zatloukal, K A New Tissue Stabilisation Technology for High-Quality Tissue-Based Molecular Studies.
4th Annual Meeting of the Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT); SEP 17-19, 2012; Graz, AUSTRIA. 2012. [Poster]

Viertler, C; Groelz, D; Kashofer, K; Gündisch, S; Riegman, P; Winther, R; Wyrich, R; Kruhoffer, M; Becker, KF; Oelmüller, U; Zatloukal, K The impact of tissue pre-analytics and a new stabilisation technology on the quality of tissue-based molecular studies.
Abstracts from the 5th Annual Biospecimen Research Network (BRN) Symposium. Advancing Cancer Research Through Biospecimen Science. Biopreservation and Biobanking. June 2012, 10(3): 309-309. doi:10.1089/bio.2012.1034.. 2012; -5th Annual Biospecimen Research Network (BRN) Symposium "Advancing Cancer Research Through Biospecimen Science" ; FEB 22-23, 2012; Bethesda, Maryland, USA. [Poster]
FullText

Viertler, C; Groelz, D; Kashofer, K; Gündisch, S; Riegman, P; Winther, R; Wyrich, R; Kruhoffer, M; Becker, KF; Oelmüller, U; Zatloukal, K Improvements of Tissue Pre-Analytics for High Quality Tissue-Based Molecular Studies
SPIDIA WORKSHOP.. 2012; -EU FP7 SPIDIA Open Workshop "Standardisation of Sample Pre-Analytics for Molecular Diagnostics and Biomarker Development"; OCT 10, 2012; Graz, AUSTRIA. [Oral Communication]
FullText

Viertler, C; Zatloukal, K Progress Report: Validation of Tissue-Related Technologies and Documentation for Standardisation Activities.
SPIDIA M42 EMB Meeting; APR 17-20, 2012; Florence, ITALY. 2012. [Oral Communication]

Zatloukal, K International Network of Biobanks and Expert Centres
National Cancer Institute Directors Meeting; Juli, 11,2012; Lyon, FRANCE. 2012. [Oral Communication]

Zatloukal, K International view of biobank activities.
45. Jahreskongress der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI); SEP 11-14, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

Zatloukal, K European perspective on biobanking
Methodology of cancer clinical trials; Dezember, 12-13,2012; Brussels, BE. 2012. [Keynote lecture]

Zatloukal, K standards and regulation in biological and medical sciences and relevance to EU-US cooperation
Presentations of IT FoM, BBMRI, ECRIN and ERINHA; Juni, 4-6, 2012; Washington DC, USA. 2012. [Oral Communication]

Zatloukal, K Metabolic disorders in interaction with cancer: linking tissue to prognosis
Multiscale systems biology cancer Workshop; November, 12-13, 2012; Leiden, NETHERLANDS. 2012. [Oral Communication]

Zatloukal, K Challenges in member state engagement to establish a real pan-European research infrastructure
ESFRI Implementation Workshop; September, 4, 2012; Brussels, BE. 2012. [Oral Communication]

Zatloukal, K Biobanking and the future of medicine & standardization and interoperability in biobanking
China Biobank development Strategy Workshop; Nov, 08-11, 2102; Shanghai, China. 2012. [Keynote lecture]

Zatloukal, K The effects of Tissue biobank on translational medical research
2nd annual Biobank China - Ethics Construction and information management for biobank; Juli, 5-8, 2012; Shanghai, China. 2012. [Keynote lecture]

Zatloukal, K Biobanks a key resource for Biomarker Development
Biomarker Symposium; Oktober, 3, 2012; Wien. 2012. [Oral Communication]

Zatloukal, K Transborder flows of samples an daccompanying data
Biobanks and Biomedical collections -an ethical framework for future research; Juni, 18-20 2012; Straßburg. 2012. [Oral Communication]

Zatloukal, K Gewebebanken: Chancen und Risiken für die Genomforschung
EURAT Sympsoium; 15.03.2012; Heidelberg. 2012. [Oral Communication]

Zatloukal, K How to Improcve Interoperability of Biobankds: European and International Initiatives.
European Lab Automation; MAY 30-31, 2012; Hamburg, GERMANY. 2012. [Keynote lecture]
FullText

Zatloukal, K Addressing global health challenges through research collaboration: the examples of IT FoM and BBMRI
European Health Forum - Gastein; Oktober, 4-5, 2012; Gastein. 2012. [Keynote lecture]

Zatloukal, K Key Infrastructre for personalized medicine
ÖAW Symposium Personalisierte Medizin; Januar, 13-14, 2012; Wien. 2012. [Oral Communication]

Zatloukal, K The role of biobanking in personalized medicine
Translational Reserch in Oncology - a new approach to personalized medicine; Mai, 8-9, 2012; Forli, ITALY. 2012. [Oral Communication]

Zatloukal, K The European Biobanking and Biomolecular Resources Research Infrastructure BBMRI: Oppertunities and global challenges
International Symposium - National Biobank of Korea; April 25-27, 2012; Korea. 2012. [Keynote lecture]

Zatloukal, K Sustainability:ESFRI integration
EVA-BBMRI Meeting; Dezember, 6, 2012; Berlin, GERMANY. 2012. [Oral Communication]

Chowdhury, P; Smole, C; Schmidt, V; Rülicke, T; Fröhlich, LF; Zatloukal, K Functional analysis of the role of p62/Sqstm1 in Mallory-Denk Body (MDB) formation in Non Alcoholic Steatohepatitis
1st Scientific Retreat of the Doctoral College "Metabolic & Cardiovascular Disease"; OCT 20-22, 2011; Seggau Castle, Austria. 2011. [Oral Communication]

Chowdhury, P; Smole, C; Schmidt, V; Rülicke, T; Fröhlich, LF; Zatloukal, K; Functional analysis of the role of p62/Sqstm1 in Mallory-Denk Body (MDB) formation in Non Alcoholic Steatohepatitis.
Doctoral Day 2011; Nov 4, 2011; Graz, Austria. 2011. [Oral Communication]

Chowdhury, P; Smole, C; Schmidt, V; Rülicke, T; Fröhlich, LF; Zatloukal, K; Functional analysis of the role of p62/Sqstm1 in Mallory-Denk Body (MDB) formation in Non Alcoholic Steatohepatitis.
1st Scientific Retreat of the Doctoral College "Metabolic & Cardiovascular Disease"; OCT 20-22, 2011; Seggau Castle, Austria . 2011. [Poster]

Gündisch, S; Hauck, S; Sarioglu, H; Viertler, C; Kap, M; Schott, C; Riegman, P; Zatloukal, K; Becker, KF Impact of delayed fixation on protein profiles in clinical tissue specimen.
Reverse Phase Protein Array Global Workshop.; OCT 10-11, 2011; MD Anderson Cancer Center, Houston, Texas, USA. 2011. [Poster]

Gundisch, S; Hauck, SM; Sarioglu, H; Viertler, C; Kap, M; Schott, C; Riegman, P; Zatloukal, K; Becker, KF; Impact of delayed fixation on protein profiles in clinical tissue samples.
VIRCHOWS ARCHIV. 2011; 459: S316-S316.-23rd European Congress of Pathology of the European Society of Pathology (ESP); AUG 27- SEP 1, 2011; Helsinki, FINLAND. [Poster]
Web of Science

Gündisch, S; Hauck, SM; Sarioglu, H; Viertler, C; Schott, C; Zatloukal, K; Becker, KF Investigating the Impact of Pre-Analytical Variables on Protein Quality of Human Tissue Samples.
2011 BRN Symposium2011; -4th Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science ; MARCH 28-29, 2011; Bethesda, Maryland, USA. [Poster]
FullText

Gündisch, S; Hauck, SM; Sarioglu, H; Viertler, C; Schott, C; Zatloukal, K; Becker, KF Investigating the Impact of Pre-Analytical Variables on Protein Quality of Human Tissue Samples.
OBBR, 4th Annual BRN Symposium. 2011; -4th Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science ; March 28-29, 2011; Bethesda, Maryland, USA. [Oral Communication]
FullText

Gündisch, S; Reischauer, B; Meding, S; Langer, R; Kap, M; Viertler, C; Schott, C; Ferch, U; Riegman, P;Zatloukal, K; Walch, A; Becker, KF Evaluation of PAXgene-fixed, paraffin-embedded tissues for proteomic applications
Der Pathologe, Supplement 1, April 2011, Sa-066. 2011; -95. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V.; JUN 16-19, 2011; Leipzig, GERMANY. [Oral Communication]
FullText

Gündisch, S; Schott, C; Meding, S; Langer, R; Viertler, C; Kap, M; Riegman, P; Zatloukal, K; Walch, A; Becker, KF A novel fixative allows morphological and molecular analysis from the same clinical tissue specimen.
Reverse Phase Protein Array Global Workshop.; OCT 10-11, 2011; MD Anderson Cancer Center, Houston, Texas, USA. 2011. [Poster]

Gündisch, S; Schott, C; Reischauer, B; Meding, S; Langer, R; Kap, M; Viertler, C; Ferch, U; Riegman, P; Zatloukal, K; Walch, A; Becker, KF Evaluation of PAXgene-fixed, paraffin-embedded tissues for morphological and molecular analysis
53rd Symposium of the Society for Histochemistry.; OCT 12-15, 2011; Munich, GERMANY. 2011. [Oral Communication]
FullText

Haybaeck, J; Bettermann, K; Mashta, A; Reddy A B; Lederer, E Diwoky, C; Müller, H; Thüringer, A; Stumptner, C; Kolbe, T; Magin, T M; Lackner C, Denk, H; Zatloukal K Lack of hepatocellular keratin 18 triggers liver carcinogenesis in mice
7th European Conference on Intermediate Filaments in Health and Disease ; JUN 16-19, 2011; Mykonos, Greece. 2011. [Poster]

Kap, M; Smedts, F; Oosterhuis, W; Winther, R; Christensen, N; Reischauer, B; Viertler, C; Groelz, D; Becker, KF; Zatloukal, K; Langer, R; Slotta-Huspenina, J; Bodo, K; De Jong, B; Oelmüller, U; Riegman, P PAXgene Tissue System in Routine Pathology: Increase Biobanking Opportunities of the Pathology Archive.
Biopreservation and Biobanking (BIO).2011; -ISBER 2011 Annual Meeting&Exhibits. Impact and Public Benefits of Biorepositories.; MAY 15-18, 2011; Arlington, Virginia, USA. [Oral Communication]

Kap, M; Winther, R; Gundisch, S; Viertler, C; Groelz, D; Oosterhuis, W; Zatloukal, K; Becker, KF; Oelmueller, U; Riegman, P; Implementation of the PAXgene tissue system in routine pathology.
VIRCHOWS ARCHIV. 2011; 459: S203-S204.-23rd European Congress of Pathology of the European Society of Pathology (ESP); AUG 27- SEP 1, 2011; Helsinki, FINLAND. [Poster]
Web of Science

Lehrach; Westerhoff; Hubbard; Brand; Boyle; Zatloukal, K ITFoM - IT Future of Medicine (FET Flagship Project)
Science beyond fiction; May 4-6,2011; Budapest, HUNGARY. 2011. [Oral Communication]

Mahajan, V; Klingstedt, T; Simon, R; Nilsson, KPR; Thüringer, A; Kashofer, K; Haybaeck, J; Denk, H; Abuja, PM; Zatloukal, K Cross beta-sheet conformation of Keratin 8 as hallmark of Mallory-Denk bodies
7th European Conference on Intermediate Filaments in Health and Disease.; June 16-19, 2011; Mykonos, Greece. 2011. [Poster]

Matak, A; Pabst D; Kashofer, K; Haybaeck, J; Zatloukal, K Stochastic epigenetic events lead to heterogeneous keratin 7 expression in a new cell line established from human intrahepatic cholangiocellular carcinoma
Gordon Conference on Epigenetics; August 7-12, 2011; Easton Massachusetts USA. 2011. [Poster]

Müller, H; Maurer, H; Reihs, R; Sauer, S; Zatloukal, K Adaptive Visual Symbols for Personal Health Records
IV '11 Proceedings of the 2011 15th International Conference on Information Visualisation IEEE Computer Society Washington, DC, USA ©2011. 2011; 220-225.-15th International Conference on Information Visualisation (IV); JUL , 12-15, 2011; London. (ISBN: 78-1-4577-0868-8 ) [Keynote lecture]
FullText

Nikam, A; Schock, E; Kashofer, K; Lackner, K; Zatloukal, K; Abuja, PM PPAR alpha and Nrf2 Govern Metabolic Deregulation and Oxidative Stress in a Murine Model for Nonalcoholic Steatohepatitis (NASH)
FREE RADICAL BIO MED. 2011; 51: S64-S64.-18th Annual Meeting of the Society-for-Free-Radical-Biology-and-Medicine (SFRBM); NOV 16-20, 2011; Atlanta, GA. Doi: 10.1016/j.freeradbiomed.2011.10.166 [Oral Communication]
Web of Science FullText FullText_MUG

Nikam, A; Schoeck, E; Fechter, K; Kashofer, K; Zatloukal, K; Abuja, PM Time-Course of Liver Damage and Associated Pattern of Redox Regulation in Mouse Model for Non-alcoholic Steatohepatitis (NASH).
Gordon Research Conference: Oxidative Stress and Diseases; MARCH 13-18, 2011; Ventura, USA. 2011. [Poster]
FullText

Viertler, C; Groelz, D; Kashofer, K; Gundisch, S; Riegman, P; Winther, R; Wyrich, R; Kruhoffer, M; Becker, KF; Oelmuller, U; Zatloukal, K A new technology for simultaneous preservation of biomolecules and morphology in tissues.
VIRCHOWS ARCH. 2011; 459: S318-S318.-23rd European Congress of Pathology.; AUG 27- SEP 1, 2011; Helsinki, FINLAND. [Poster]
Web of Science

Viertler, C; Groelz, D; Kashofer, K; Wyrich, R; Oelmueller, U; Zatloukal, K PRE-ANALYTICAL PARAMETERS IMPACTING ON TISSUE-BASED BIOMARKERS
CLIN CHEM LAB MED. 2011; 49: S126-S126. [Oral Communication]
Web of Science FullText

Viertler, C; Groelz, D; Kashofer, K; Zatloukal, K The Impact of Tissue Pre-Analytics on Molecular Analyses.
TATAA Biocenter qPCR symposium Developments in Real-time PCR From Preanalytics to Molecular Diagnostics; JUN 13-17, 2011; Prague, CZECH REPUBLIC. 2011. [Oral Communication]

Zatloukal The pan-European research Infrastructure for Biobanking and Biomolecular Resources: Opportunities for Internatinal Collaboration
The International Conference for Biobank Management and QC; July 8-10, 2011; Shanghai, China. 2011. [Keynote lecture]
FullText

Zatloukal, K Biobank
ESGo-European Society of Gynaecological Oncology; FEB 6-9, 2011; Obergurgl, AUSTRIA. 2011. [Oral Communication]

Zatloukal, K Biobank Graz
-. 2011; -Progress Meeting Nürnberg_Private Gen; 15-16.06.2011; Nürnberg, GERMANY. [Oral Communication]

Zatloukal, K Biobanking and the future of medicine
Seminar in Basel - Pathology; Dec 5, 2012; Basel. 2011. [Oral Communication]

Zatloukal, K Geschichte und Europäische Dimension der Biobank Graz
Mini Enquete der Biobank Graz; Nov 29, 2011; Graz. 2011. [Oral Communication]

Zatloukal, K Closing the health gab between European Union states. European successes in public health.
http://www.solidarity-in-health.pl/. 2011; -Solidarity in halth; Nov 7-8,2011; Poznan, POLAND. [Oral Communication]

Zatloukal, K Next steps in biobank networking and harmonisation
Internet. 2011; -ESBB Meeting; Nov 16-19, 2011; Marseille, FRANCE. [Oral Communication]
FullText

Zatloukal, K The future of personalised medicine
http://www.esf.org/publications.html. 2011; -ESF European Science Foundation: Workshop on "The future technologies for personlised medicine"; Sept, 19-20,2011; London. [Oral Communication]
FullText

Zatloukal, K Panel: Promoting Innovative Cancer REsearch in Europe
http://www.esmo.org/events/stockholm-2011-congress.html. 2011; -ECCO European Multidisciplinary Cancer Congress; Sep 24-27, 2011; Stockholm.
FullText

Zatloukal, K Ethics in Cancer Biobanking
http://www.esmo.org/events/stockholm-2011-congress.html. 2011; -ECCO-European Multidisciplinary Cancer Congress; Sep 24-27, 2011; Stockholm. [Oral Communication]
FullText

Zatloukal, K BBMRI-ERIC: The concept for a pan-European biobank and biomolecular resource
ECP - European Congress of Pathology; August 27 - September 1,2011; Helsinki - FINNLAND. 2011. [Oral Communication]
FullText

Zatloukal, K Biomedical research infrastructures: a perspective from the European Strategy Forum on Research Infrastructures
Infectious Diseases Emergence: New Perspectives? Session Global surveillance: capacity and response; 30.3 - 01.04. 2011; Annecy/FRANCE. 2011. [Keynote lecture]

Zatloukal, K Die Rolle der Forschungsinfrastrukturen in der medizinischen und biologischen Forschung
Klassenpräsidiums der mathematisch-naurwissenschaftlichen Klasse_ Österreichische Akademie der Wissenschaft; März 10; Vienna, Austria. 2011. [Keynote lecture]

Zatloukal, K. Girolami, M. Solchenbach, K. Overall Aim and Expected Result, Expected impact on science, technology and society, international perspective, Governance, Implementation and Management; ICT challenges; Innovation Concept; Stakeholders - the industry perspective
FET Flagship Pilots midterm conference; Nov 23-25, 2011; Warsaw. 2011. [Oral Communication]
FullText

Abuja, PM; Fechter, K; Stumptner, C; Denk, H; Zatloukal, K A Novel Antioxidant Mechanism of Bilirubin: Inhibition of the Production of Reactive Oxygen Species (ROS) by Cytochromes P450 2A5 and 2E1 in Endoplasmic Reticulum and Inner Mitochondrial Membrane
1. International Pediatric Biomarker Symposium; FEB 4-6, 2010; Innsbruck-Igls, Austria. 2010. [Oral Communication]

Haybaeck, J; Matak, A; Thüringer, A; Stumptner, C; Kolbe, T; Magin, T M; Denk, H; Zatloukal, K Lack of keratin 18 drives liver carcinogenesis in mice
Poster Board Number 46, Pg. 88 in Abstract book2010; -EASL Special Conference, Hepatocellular Carcinoma: from Genomics to Treatment; June 25-26, 2010; Dubrovnik, Croatia. [Poster]

Haybaeck, J; Zeller, N; Wolf, M; Weber, A; Wagner, U; Kurrer, M; Bremer, J; Iezzi, G; Graf, R; Thimme, R; Blum, H; Nedospasov, S; Zatloukal, K; Ramzan, M; Ciesek, S; Pietschmann, T; Marche, P; Karin, M; Kopf, M; Browning, J; Aguzzi, A; Heikenwalder, M On the role of Lymphotoxin in promoting liver carcinogenesis. Of viruses, mice and men
IMMUNOLOGY. 2010; 131: 3-3. [Poster]
Web of Science

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Petru, E; Zatloukal, K; Denk, H Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
EJC SUPPL. 2010; 8(5): 248 Doi: 10.1016/S1359-6349(10)71055-7
Web of Science FullText FullText_MUG

Kashofer, K; Ulbel, B; Siaulyte, G; Fröhlich, LF; Abuja; PM; Denk, H; Starmann, J; Sulten, M; Osprian, I; Deigner, HP; Sültmann, H; Lehrach, H; Zatloukal, K Idividual Risk Factors for Steatohepatitis-Identifying Sensitizer Genes Using Chromosome Substitution Strains in Combination with Dietary Models for Metabolic Disease
1st SYSGENET Meeting (European system Genetics Network for the study of Complex Genetic Human Diseases using Mouse Genetic Reference Populations); APR 7-9, 2010; Braunschweig, GERMANY. 2010. [Oral Communication]

Mahajan, V; Klingstedt, T; Nilsson, KP; Abuja, PM; Kashofer, K; Haybaeck, J; Denk, H; Zatloukal, K Conformation of misfolded proteins in liver disease:cross-beta sheet conformation is characteristic for Mallory-Denk bodies but not for other hepatocytic aggregates
1. International Pediatric Biomarker Symposium; FEB 4-6, 2010; Innsbruck-Igls, Austria. 2010. [Oral Communication]

Mahajan, V; Klingstedt, T; Nilsson, KP; Fuchsbichler, A; Kashofer, K; Denk, H; Abuja, PM; Haybaeck, J; Zatloukal, K Structural characteristics of misfolded proteins in liver disease: evidence for cross b-sheet conformation in Mallory-Denk Bodies but not in other hepatocytic aggregates.
International Liver Congress ; April 14-18, 2010; Vienna . 2010. [Poster]

Mahajan, V; Klingstedt, T; Simon, R; Nilsson, KP; Thueringer, A; Kashofer, K; Haybaeck, J; Denk, H; Abuja, PM; Zatloukal, K Luminescent Conjugated Oligothiophenes: A novel class of affinity binders for characterization of inclusions in diseased liver.
Biobanking for Science; September 22-25,2010; Amsterdam. 2010. [Poster]

Mahajan, VS; Klingstedt, T; Nilsson, KPR; Fuchsbichler, A; Kashofer, K; Abuja, PM; Denk, H; Zatloukal, K STRUCTURAL CHARACTERISTICS OF MISFOLDED PROTEINS IN LIVER DISEASE: EVIDENCE FOR CROSS beta-SHEET CONFORMATION IN MALLORY-DENK BODIES BUT NOT IN OTHER HEPATOCYTIC AGGREGATES
J HEPATOL. 2010; 52: S308-S308.-45th Annual Meeting of the European Association for the Study of the Liver.; April14-18,2010; Vienna. Doi: 10.1016/S0168-8278(10)60794-5 [Poster]
Web of Science FullText FullText_MUG

Matak, A, Pabst, D, Kashofer, K, Zatloukal, K, Cell line established from human cholangiocarcinoma: revealing features of stochastic gene expression.
ZMF day; 5 to 6 November, 2010; Graz, Austria. 2010. [Poster]

Mayrhofer, MT; Zatloukal, K Biobanking - EU Structures
Kick-off Meeting K-Projekt; NOV 30, 2009; Graz, Austria. 2010. [Oral Communication]

Müller, H; Reihs, R; Sauer, S; Gros, O; Heidtke, K; Zatloukal, K Data Integration and Visual Analytics for Large Scale Biobanking.
BBMRI Biobanking for Science Conference; September 23-25, 2010; Amsterdam. 2010. [Oral Communication]

Müller, H; Sauer, S; Zatloukal, K; Bauernhofer, T Interactive Patient Records.
Proceedings of IV'10 - 14th International Conference on Information Visualization, London, England, 20102010; 252-257.-14th International Conference on Information Visualization IV10; JUL, 27-29, 2010; London, UK. (ISBN: 978-1-4244-7846-0 ) [Oral Communication]
FullText

Nikam, A; Fechter, K; Schöck, E; Zatloukal, K; Abuja, PM ROS Production During a Time Course Study in a Mouse Model for Non-Alcoholic Steatohepatitis (NASH)
Annual Meeting of the ÖGMBT; SEP 27-29, 2010; Vienna. 2010. [Poster]

Reihs, R; Sauer, S.; Müller, F.; Zatloukal, K Challenges and solutions in the setup of a findings database for a large scale tissue collection
Abstracts of the Joint ZMF & Doctoral Days 20102010; -Joint ZMF & Doctoral Days 2010; NOV 5-6 2010 ; Graz, AUSTRIA. [Poster]

Viertler, C; Kashofer, K; Groelz, D; Kurzmann, N; Moser, M; Pabst, D; Ergin, B; Kap, M; Wyrich, R; Christensen, N; Riegman, P; Becker, KF; Zatloukal, K A new method for simultaneous preservation of morphology and biomolecules in tissues.
BBMRI - Biobanking for Science; SEP 23-25, 2010; Amsterdam, NETHERLANDS. 2010. [Poster]

Zatloukal, K Biobank and Biomolecular Resources Research Infrastructure.
Intercongress Meeting for the European Society of Pathology; AUG 31-SEP 3, 2010; Krakow, POLAND. 2010. [Oral Communication]

Zatloukal, K New Models for Industry-Biobank Collaboration: The Experts Centre Concept.
P3G Annual Meeting; APR 26-27, 2010; Montreal, CANADA. 2010. [Oral Communication]

Zatloukal, K Overview and update of BBMRI: Statutes and Funding schemes for BBMRI-ERIC.
EATRIS Meeting; APR 14, 2010; Rome, ITALY. 2010. [Oral Communication]

Zatloukal, K Validation of tissue-related technologies and documentation for standardisation activity.
SPIDIA - Executive Management Board M20; May 5-6, 2010; Prague, CZ. 2010. [Oral Communication]

Zatloukal, K Vernetzte Biobanken.
Wissenschaftsgespräche; May 18, 2010; Graz, Austria. 2010. [Keynote lecture]

Zatloukal, K New models for industry-biobank collaboration: the BBMRI experts centre's concepts.
Biobank Meeting; APR 12-13, 2010; Florence, ITALY. 2010. [Oral Communication]

Zatloukal, K Standardiesierung der Biobanken in Europa.
Biobanken Symposium; APR 29-30, 2010; Innsbruck, AUSTRIA. 2010. [Oral Communication]

Zatloukal, K Biobanking in Biomarker Research.
International Pediatric Biomarker Symposium; FEB 4-6, 2010; Innsbruck, AUSTRIA. 2010. [Oral Communication]

Zatloukal, K Forschung an menschlichem Gewebe (Biobanken) zwischen Forschungsfreiheit und Kontrolle.
Ethik und Recht in der Humanforschung; JAN 14-15, 2010; Vienna, AUSTRIA. 2010. [Oral Communication]

Zatloukal, K European Strategy in Biobanking.
Biobanking Meeting; JAN 13, 2010; Brno, CZECH REPUBLIC. 2010. [Oral Communication]

Zatloukal, K Introduction of the correlation between infectious diseases, biobanks and BBMRI .
Biobanking for infectious diseases and medium/high risk pathogens; JUN 18, 2010; Rome, ITALY. 2010. [Oral Communication]

Zatloukal, K BBMRI-ERIC - Towards Implementation.
BBMRI Stakeholder's Forum Meeting; JUN 8-10, 2010; Brussels, BELGIUM. 2010. [Oral Communication]

Zatloukal, K The Biobanking and Biomolecular Resources Research Infrastructure: BBMRI.
1st European Veterinary Biobanking Meeting; JUL 9, 2010; Vienna, AUSTRIA. 2010. [Keynote lecture]

Zatloukal, K Biobanking.
IPRI-Dundee Summer School 2010; JUN 28-JUL 1, 2010; Dundee, UK. 2010. [Keynote lecture]

Zatloukal, K How to Improve Intraoperability of Biobanks: The Role of Standardization of Preanalytical Variables.
3rd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science; March 24-25, 2010; Bethesda, USA. 2010. [Oral Communication]

Zatloukal, K Initial Overview of the Institute of Pathology at MUG; Background on the Biobanking Infrastructure.
Biobanking Meeting; JAN 21, 2010; Siena, ITALY. 2010. [Oral Communication]

Zatloukal, K Biobanking and its perspective in Europe.
IIBL Inauguration Conference; FEB 25-26, 2010; Luxembourg, LUXEMBOURG. 2010. [Keynote lecture]

Zatloukal, K The Pan-European Infrastructure for Biobanking and Biomolecular Resources (BBMRI) as the European Part of a GBRCN for the Human Domain.
GBRCN Meeting; FEB 23-25, 2010; Braunschweig, GERMANY. 2010. [Oral Communication]

Haybaeck, J; Zeller, N; Wolf, MJ; Wagner, U; Kurrer, MO; Bremer, J; Weber, A; Iezzi, G; Graf, R; Clavien, PA; Thimme, R; Blum, H; Nedospasov, S; Zatloukal, K; Karin, M; Kopf, M; Aguzzi, A; Heikenwalder, M Lymphotoxin-driven hepatocellular cancer
published as Abstract in Virchow`s Arch (2009), 455 (Suppl 1): S21 S22 [Abstr.]2009; 455(sup1):S21-S22.-22nd European Congress of Pathology, Florence, Italy, September 4-9, 2009; September 4-9, 2009; Florence, Italy. [Oral Communication]

Haybaeck, J; Zeller, N; Wolf, MJ; Weber, A; Wagner, U; Kurrer, MO; Bremer, J; Iezzi, G; Graf, R; Clavien, PA; Thimme, R; Blum, H; Nedospasov, SA; Zatloukal, K; Ramzan, M; Ciesek, S; Pietschmann, T; Marche, PN; Karin, M; Kopf, M; Browning, JL; Aguzzi, A; Heikenwalder, M A lymphotoxin-driven pathway to hepatocellular carcinoma
8th DAY OF CLINICAL RESEARCH of the University Hospital Zürich 2009; -8th DAY OF CLINICAL RESEARCH of the University Hospital Zürich ; April 2009; University Hospital Zürich, Switzerland . [Poster]

Haybaeck, J; Zeller, N; Wolf, MJ; Weber, A; Wagner, U; Kurrer, MO; Bremer, J; Iezzi, G; Graf, R; Clavien, PA; Thimme, R; Blum, H; Nedospasov, SA; Zatloukal, K; Ramzan, M; Ciesek, S; Pietschmann, T; Marche, PN; Karin, M; Kopf, M; Browning, JL; Aguzzi, A; Heikenwalder, M A lymphotoxin-driven pathway to hepatocellular carcinoma.
Oral presentation and Poster for ALPINE MEETING MOLECULAR BASIS OF DISEASE, Schwarzenberg, July 23rd to 26th, 2009, Switzerland, Titel: ; July 23rd to 26th, 2009; Schwarzenberg, Switzerland. 2009. [Oral Communication]

Klingstedt, T; Ausland, A; Simon, R; Mahajan V; Kostareva, A; Sjoberg, G; Zatloukal, K; Hammerstorm, P; Nilsson, K The usage of novel luminescent oligothiophenes as conformation sensitive optical probes in the characterization of Intermediate filament related protein aggregates.
1st Scandinavian Symposium Molecular Mechanisms of Amyloid Formation and Causes of Amyloid degenerative Diseases; Sept 30-2, 2009; Hemavan, SWEDEN. 2009. [Poster]

Mahajan, V; Klingsted, T; Nilsson, KPR; Fuchsbichler, A; Kashofer, K; Abuja, PM; Denk, H; Zatloukal, K Imaging distinct conformational states of protein aggregates in Steatohepatitis using novel luminescent probes.
Amyloid Fibril Formation and Protein Misfolding: Molecular Mechanisms and Cellular Effects; JUN 28 - JUL 3, 2009; Aspen, Colorado, USA. 2009. [Poster]

Mahajan, V; Klingstedt, T; Nilsson, KRP; Fuchsbichler, A; Kashofer, K; Abuja, PM; Denk, H; Zatloukal, K Conformational features of hepatocytic protein aggregates.
Annual Meeting of the Austrian Association for Molecular Life Sciences and Biotechnology and Austrian Society for Molecular Bioscience and Biotechnology; SEP 21 - 23, 2009; Innsbruck, Austria. 2009. [Oral Communication]

Matak, A; Kashofer, K; Zoranovic, T; Penninger, J; Zatloukal, K CHARACTERISATION OF NOVEL TUMOR SUPPRESSOR GENES IN COLORECTAL AND HEPATOCELLULAR CARCINOMA
ZMF DAY 2009; 4.11.2009; Graz. 2009. [Poster]

Matak, A; Kashofer, K; Zoranovic, T; Penninger, J; Zatloukal, K; CHARACTERIZATION OF NOVEL TUMOR SUPPRESSOR GENES IN COLORECTAL AND HEPATOCELLULAR CARCINOMA
ZMF DAY; NOV 4-6, 2009; Graz. 2009. [Poster]

Müller, H; Reihs, R; Sauer, S; Zatloukal, K; Streit, M; Lex, A; Schlegl, B; Schmalstieg, D Connecting Genes with Diseases
Proceedings of the 2009 13th International Conference Information Visualisation2009; 323-330.-13th International Conference Information Visualisation ; July 14-17, 2009; Barcelona, SPAIN. (ISBN: 978-0-7695-3733-7 ) [Oral Communication]

Schmid, K; Schmidt-Gann, G; Zatloukal, K; van der Nest, DG; Redl, H; van Griensven, M EARLY VERSUS LATE RESPONSE TO GRAM-POSITIVE AND GRAM-NEGATIVE SEPSIS IN BABOONS: CUSTOM-DESIGNED MICROARRAYS
SHOCK. 2009; 32: 8-8. [Poster]
Web of Science

Schmid, K; Schmidt-Gann, G; Zatloukal, K; van der Nest, DG; van Griensven, M; Redl, H LATE RESPONSE TO GRAM plus AND GRAM - SEPSIS IN BABOONS: CUSTOM-DESIGNED MICROARRAYS
SHOCK. 2009; 31: 19-20. [Poster]
Web of Science

Steiner, W; Sauer, S; Bauernhofer, T; Müller, H; Zatloukal, K Interactive Patient Records
Joint ZMF and doctoral day, Medical University Graz; 2009; Graz. 2009. [Poster]

Viertler, C; Zatloukal, K Validation of tissue-related technologies and documentation for standardisation activities
SPIDIA M13 Meeting; NOV 4-6, 2009; Copenhagen, DENMARK. 2009. [Oral Communication]

Zatloukal, K Die Verantwortung des Wissenschaftlers für den wissenschaftlichen Nachwuchs.
Österreichischer Wissenschaftstag; OCT 24, 2008; Semmering, AUSTRIA. 2009. [Oral Communication]

Zatloukal, K Key Features of the Prototype.
BBMRI Prototype Meeting; DEC 1-2, 2009; Munich, GERMANY. 2009. [Oral Communication]

Zatloukal, K Introduction: Concept of the Prototype.
BBMRI Prototype Meeting; DEC 1-2, 2009; Munich, GERMANY. 2009. [Oral Communication]

Zatloukal, K Expert Centres for Biobanking.
Expert Centres; DEC 15, 2009; Paris, FRANCE. 2009. [Oral Communication]

Zatloukal, K The European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI): Its possible impact on science, industry and health care.
Inauguration of the DaVinci European Biobank; Sep 21, 2009; Florence, ITALY. 2009. [Keynote lecture]

Zatloukal, K BBMRI: Towards Implementation.
BBMRI Stakeholder's Forum Meeting; SEP 15-17, 2009; Brussels, BELGIUM. 2009. [Oral Communication]

Zatloukal, K Biobanking
Austro-Hungarian Pathology Congress; OCT 1-3, 2009; Sorpon, HUNGARY. 2009. [Oral Communication]

Zatloukal, K BBMRI - The European Biobanking and Biomolecular Ressources Research Infrastructure.
Genebank; MAY 18, 2009; Leuven, THE NETHERLANDS. 2009. [Keynote lecture]

Zatloukal, K Biobank quality management and harmonization: current guidelines, evidence-based standards.
Pro.M. in "Biobanking"; JUNE 4, 2009; Siena, ITALY. 2009. [Keynote lecture]

Zatloukal, K The European Research Infrastructure for Biobanking and Biomolecular Resources: New opportunities for R&D in infectious diseases.
NOVARTIS Seminar; JUNE 4, 2009; Siena, ITALY. 2009. [Oral Communication]

Zatloukal, K BBMRI: Biobanking and Biomolecular Ressources Research Infrastructure, a European Network Initiative.
Swiss National Workshop on Biobanks; JUNE 17, 2009; Bern, SWITZERLAND. 2009. [Keynote lecture]

Zatloukal, K The European Research Infrastructure for Biobanking and Biomolecular Resources.
CERM Meeting; JUNE 3, 2009; Florence, ITALY. 2009. [Oral Communication]

Zatloukal, K A communication strategy for BMS infrastructures.
ECRIN Communication Meeting; MAY 20, 2009; Milano, ITALY. 2009. [Oral Communication]

Zatloukal, K How do biobanks support biomedical research?
Pro.M. in "Biobanking".; JUNE 5, 2009; Siena, ITALY. 2009. [Keynote lecture]

Zatloukal, K BBMRI - The European Research Infrastructure for Biobanking and Biomolecular Resources.
4th BIONET Workshop. Biobanking & Personal Genomics: Challenges - Futures for EU-China Collaborations; APRIL 27-29, 2009; Shenzhen, CHINA. 2009. [Keynote lecture]

Zatloukal, K BBMRI - The European Biobanking and Biomolecular Ressources Research Infrastructure.
Euromedlab; JUNE 8, 2009; Innsbruck, AUSTRIA. 2009. [Oral Communication]

Zatloukal, K Current developments and outlook: status of BBMRI, emerging European scientific landscape.
Pro.M. in "Biobanking".; JUNE 5, 2009; Siena, ITALY. 2009. [Keynote lecture]

Zatloukal, K BBMRI - The European Research Infrastructure for Biobanking and Biomolecular Resources.
ESFRI Meeting; APRIL 30, 2009; London, UNITED KINGDOM. 2009. [Oral Communication]

Zatloukal, K The BBMRI Project.
La realidad de los Biobancos a la luz del nuevomarco normativo: retos e implicaciones; Oct 21, 2009; Salamanca, Spain. 2009. [Keynote lecture]

Zatloukal, K Automatisierung der Gewebsprozessierung zur Hochdurchsatz-Phänotypisierung.
6. Jahrstagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin; Oct 7-10, 2009; Leipzig, Germany. 2009. [Oral Communication]

Zatloukal, K BBMRI - Model for distributed research infrastructures.
NFFA Meeting Institute of Biophysics and Nanosystems Research; JUL 1-2, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

Zatloukal, K BBMRI and the BMSvresearch infrastructures
Role of researcher infrastructures for a competitive knowledge economy (ESFRI); JUN 29-30, 2009; Brussels, BELGIUM. 2009. [Oral Communication]

Zatloukal, K BBMRI-Prototyp: Vorgaben, Erwartungen und internationales Umfeld
Abstimmungsgespräch über einen möglichen Beitrag der CRIP zum BBMRI-Prototypen; MAI 15, 2009; Berlin, GERMANY. 2009. [Oral Communication]

Zatloukal, K Tissue Banking
P3G Biobank Summer School; JUL 1-5, 2009; Hinxton, Cambridge, UNITED KINGDOM. 2009. [Oral Communication]

Zatloukal, K ESFRI: European Research Infrastructure.
Nordic Centre of Excellence; June 11-12, 2009; Soria Moria, Norway. 2009. [Keynote lecture]

Zatloukal, K Introduction of BBMRI with all its working packages.
Meeting on Expert Centres; Oct 20, 2009; Paris, France. 2009. [Keynote lecture]

Zatloukal, K Biobanks as key resource for biomarker discovery and validation.
IARC - Austrian Cancer Workshop; Oct, 19, 2009; Vienna, Austria. 2009. [Oral Communication]

Zatloukal, K Biobanken - Anforderungen für die internationale Zusammenarbeit.
BEK-Klausurtagung; Nov 6, 2009; Mauerbach, Austria. 2009. [Keynote lecture]

Zatloukal, K Workshop on tissues.
QIAGEN Workshop; o 4-5, 2009; Kopenhagen, Denkmark. 2009. [Oral Communication]

Zatloukal, K Impact of the European Biobanking and Biomolecular Resources Research INfrastructure on Biobanking and life science landscape.
QIAGEN Workshop; Oct 8, 2009; Hilden, Germany. 2009. [Oral Communication]

Zatloukal, K EU Biobanking and Biomolecular Resources Research Infrastructure.
Conference of Technology Platforms in Biomedical Research; JAN 27-28, 2009; Madrid, SPAIN. 2009. [Oral Communication]

Abuja, PM; Fechter, K; Denk, H; Zatloukal, K Bilirubin Strongly Inhibits Formation of H2O2 in Endoplasmic Reticulum and Mitochondria From Mouse Liver
Gordon Research Conference Oxygen Radicals; FEB 3-8, 2008; Ventura, California, USA. 2008. [Poster]

Arlt, D; Sauermann, M; Sahin, O; Majety, M; Zatloukal, K; Fuzesi, L; Sultmann, H; Wiemann, S; Poustka, A The role of the transmembrane protein Vmp1 in the formation of cell-cell contacts
EUR J CELL BIOL. 2008; 87: 43-43. [Poster]
Web of Science

Fechter, K; Zatloukal, K; Denk, H; Abuja, PM H2O2 and Mitochondrial O2.- production.
Life Sciences 2008; SEP 22-24, 2008; Graz, AUSTRIA. 2008. [Poster]

Fickert, P; Moustafa, T; Fuchsbichler, A; Claudel, T; Halilbasic, E; Zatloukal, K; Denk, H; Trauner, M Differential effects of nor UDCA and UDCA in the treatment of fatty liver and arteriosclerosis in western chow-fed ApoE knock out mice
J HEPATOL. 2008; 48: S42-S42.-Annual Meeting, EASL; April 2008; Milann, Italy. Doi: 10.1016/S0168-8278(08)60100-2 [Oral Communication]
Web of Science FullText FullText_MUG

Hasselblatt, P; Zatloukal, K; Blum, HE; Wagner, EF The Transcription Factor C-JUN/AP-1 Controls HBV-Related Liver Tumorigenesis in Mice.
HEPATOLOGY. 2008; 48(4):1492--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Poster]
Web of Science

Karbiener, M; Opriessnig, P; Göschl, M; Paar, C; Mlecnik, B; Prokesch, A; Aigelsreiter, A; Preindl, G; Bernhardt, GA; Ailhaud, G; Dani, C; Amri, EZ; Zatloukal, K; Trajanoski, Z; Scheideler, M; Evaluation of adipo- and obesity-associated microRNAs in mouse and human
KEYSTONE SYMPOSIA MEETING: RNAI, MICRORNA, AND NON-CODING RNA; MAR 25-30, 2008; Whistler, British Columbia, Canada. 2008. [Poster]

Mahajan, V; Kashofer, K; Hrzenjak, A; Abuja, PM; Denk, H; Zatloukal, K Molecular Pathogenesis of Liver Disease Stetaohepatitis - Role of p62 as a Stress Modulator.
ZMF Research Day; NOV 12, 2008; Graz, AUSTRIA. 2008. [Poster]

Mahajan, V; Kashofer, K; Hrzenjak, A; Abuja, PM; Denk, H; Zatloukal, K Molecular Pathogenesis of Liver Disease Steatoheapatitis - Role of p62 as a Stress Modulator.
1st Doctoral Day of the Medical University of Graz; OCT 15, 2008; Graz, AUSTRIA. 2008. [Poster]

Schmid, K; Schuller, M; Panzitt, K; Zatloukal, K; van der Nest, DG; van Griensven, KN; Redl, H; Schmidt-Gann, G Comparison of gene expression patterns in Gram plus versus Gram-induced sepsis using different approaches
SHOCK. 2008; 29: 105-106.
Web of Science

Schmidt-Gann, G; Schuller, M; Schmid, K; Zatloukal, K; van der Nest, DG; Furst, W; van Griensven, M; Redl, H Differential gene expression in different organs after Gram+/-induction in primates
SHOCK. 2008; 29: 105-105.
Web of Science

Steiner, W; Sauer, S; Müller, H; Zatloukal, K Medical Icons
ZMF.Day 2008; November 12, 2008; Graz. 2008. [Poster]

Streit, M; Lex, A; Schmalstieg, D; Müller, H; Sauer, S; Steiner, W; Zatloukal, K CALEYDO
ZMF.Day 2008; November 12, 2008.; Graz. 2008. [Poster]

Zatloukal, K The European Biobank and Biomolecular Resources research Infrastructure.
Conference on Biobanks; JAN 17, 2008; Uppsala, SWEDEN. 2008. [Oral Communication]

Zatloukal, K Von Mallory zu Mallory Denk Körpern.
From Disease to Molecules to Disease. Symposium in honour of Prof. Dr. Helmut Denk; Oct 11, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

Zatloukal, K The Biobanking and Biomolecular Resources Research Infrastructure.
IPPOSI, clinical research infrastructure in Ireland. building a roadmap to success; MAY 13, 2008; Dublin, IRELAND. 2008. [Oral Communication]

Zatloukal, K European Research Infrastructure, Biobanking and Biomolecular Resources.
Biobanking 2008; SEPT 17-18, 2008; London, UNITED KINGDOM. 2008. [Oral Communication]

Zatloukal, K BBMRI: The European Research Infrastructure for Biobanks and Biomolecular Resources.
Needs and Challenges in Translation Medicine: Filling the Gap between Basic Research and Clinical Applications.; OCT 1-3, 2008; Rome, ITALY. 2008. [Keynote lecture]

Zatloukal, K BBMRI - Aufbau einer gesamteuropäischen Forschungsinfrastuktur für Biobanken und biomolekulare Ressourcen.
Woche der Pathologie; MAY 15-18, 2008; Berlin, GERMANY. 2008. [Oral Communication]

Zatloukal, K Das OECD globale Ressourcen-Zentren-Netzwerk.
OECD-Guidelines zu Biobanken; SEP 9, 2008; Berlin, GERMANY. 2008. [Oral Communication]

Zatloukal, K The European Research Infrastructure for Biobanks and Biomolecular Resources.
ISBER 2008 Annual Meeting; MAY 18-21, 2008; Bethesda, USA. 2008. [Oral Communication]

Zatloukal, K BBMRI - Aufbau einer gesamteuropäischen Forschungsinfrastruktur für Biobanken und biomolekulare Ressourcen.
Forum Forschung; MAR 5, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

Zatloukal, K The Pan-European Infrastructure for Biobanking and Biomolecular Resources.
VII. National Meeting of the Hungarian Society for Human Genetics; JULY 11-13, 2008; Pécs, HUNGARY. 2008. [Oral Communication]

Zatloukal, K The Biobanking and Biomolecular Resources Research Infrastructure.
Implementation of guidelines for clinical proteomics; April 24-25, 2008; Copenhagen, DENMARK. 2008. [Oral Communication]

Zatloukal, K BBMRI.
Greek BBMRI Kick-off; DEC 4-5, 2008; Athens, GREECE. 2008. [Keynote lecture]

Zatloukal, K The Pan-European Research Infrastructure for Biobanks and Biomolecular Resources
Needs and Challenges in Translational Medicine ; OCT 3, 2008 ; Rome, ITALY. 2008. [Oral Communication]

Zatloukal, K The European BBMRI project.
ESF-UB Conference in Biomedicine ; NOV 1-6, 2008; Sant Feliu de Guixols, SPAIN . 2008. [Keynote lecture]

Zatloukal, K The BBMRI project.
Networking Meeting for EU-funded Biobanking Projects; NOV 20-21, 2008 ; Brussels, BELGIUM. 2008. [Oral Communication]

Zatloukal, K Presentation of the BBMRI project.
Satellite meeting on participance of associated organisations and Governance Council of BBMRI; APRIL 16, 2008; Florence, ITALY. 2008. [Oral Communication]

Zatloukal, K A Communication Strategy for Life Sciences Research Infrastructures.
ESFR-BRS Road Map Working Group Meeting; DEC 12, 2008; Versailles, FRANCE. 2008. [Oral Communication]

Zatloukal, K BBMRI - European Research Infrastructure for Biobanks and Biomolecular Resources.
Future perspectives, benefits, bottlenecks and costs of Neuro-Biobanks; APRIL 10-11, 2008; Vienna, AUSTRIA. 2008. [Oral Communication]

Aigelsreiter, A; Halasz, J; Lackner, C; Sostaric, J; Reihs, R; Stark, K; Kufferath, I; Pichler, M; Stumptner, C; Zatloukal, K; Denk, H Hepatocellular carcinomas with Mallory bodies and/or Intracellular hyaline bodies: Correlation with steatohepatitic features
Virchows Archive . 2007; 451(2):370-370.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, TURKEY. [Poster]
Web of Science

Aigelsreiter, A; Janig, E; Halasz,, J; Lackner, C; Sostaric, J; Pichler, M; Stumptner,, C; Unterthor, D; Kufferath,, I; Zatloukal, K; Denk, H Clusterin expression in cholestasis and liver fibrosis
Virchows Archive. 2007; 451(2):132-132.-21th European Congress of Pathology; SEPT 8-13; Istanbul, TURKEY. [Oral Communication]
Web of Science

Fechter, K; Zatloukal, K; Abuja, PM Dependence of mitochondrial superoxide production on exogenous H2O2 concentrations
3rd International Symposium of the HNMRC, Hermann Esterbauer Memorial Meeting; Oct 15 18, 2007; Graz, Austria. 2007. [Poster]

Halilbasic, E; Fickert, P; Fuchbichler, A; Langner, C; Gumhold, J; Silbert, D; Maitra, U; Zatloukal, K; Denk, H; Trauner, M Taurine-conjugation critically determines the therapeutic effectiveness of 24-nor-ursodeoxycholic acid (norUDCA) in the treatment of sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
J HEPATOL. 2007; 46: S51-S51.-EASL; April 11-15, 2007; Doi: 10.1016/S0168-8278(07)61714-0 [Oral Communication]
Web of Science FullText FullText_MUG

Hasselblatt, P; Rath, M; Komnenovic, V; Zatloukal, K; Wagner, E Hepatocyte survival in acute hepatitis is due to C-Jun/AP-1-dependent expression of inducible nitric oxide synthase
HEPATOLOGY. 2007; 46(4):690A-691A. [Poster]
Web of Science

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Staber, PB; Zatloukal, K; Denk, H Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells
Frühjahrstagung der Österreichischen Gesellschaft für Pathologie; 8.-10. März 2007; Vienna, AUSTRIA. 2007. [Oral Communication]

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Zatloukal, K; Denk, H Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cells in vitro
VIRCHOWS ARCHIV. 2007; 451(2):401-401.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, Turkey. [Oral Communication]
Web of Science

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Zatloukal, K; Denk, H Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cell in vitro.
15th International Meeting of the European Society of Gynaecological Oncology (ESGO); October 28 - November 1, 2007; Berlin, GERMANY. 2007. [Poster]

Janig, E; Haslbeck, M; Buchner, J; Aigelsreiter, A; Denk, H; Zatloukal, K; Wolf, P Association of the extracellular chaperone clusterin with altered elastic fibers in vivo and in vitro
J INVEST DERMATOL. 2007; 127: S45-S45. [Poster]
Web of Science

Janig, E; Haslbeck, M, Buchner, J, Aigelsreiter, A, Denk, H, Zatloukal, K, Wolf, P, Association of the extracellular chaperone clusterin with altered elastic fibers in vivo and in vitro
.2007; -ESP Meeting, European Society for Photobiology; SEPT 1-6, 2007; Bath, UK. [Oral Communication]

Lackner, C; Zatloukal, K; Stumptner, C; Denk, H Keratin immunostaining as objective marker of hepatocyte ballooning in steatohepatitis.
J HEPATOL. 2007; 46: S266-S266. Doi: 10.1016/S0168-8278(07)62303-4 [Poster]
Web of Science FullText FullText_MUG

Pichler, M; Abuja, P; Aigelsreiter, A; Mischinger, HJ; Denk, H; Zatloukal, K Overexpression of glutathione synthesizing enzymes in a mouse model fur drug-induced steatohepatitis
Virchows Archive . 2007; 451(2):567-567.-21th European Congress of Pathology ; SEPT 8-13, 2007; Istanbul, TURKEY. [Poster]
Web of Science

Pichler, M; Hatz, M; Aigelsreiter, A; Mischinger HJ; Denk, H; Zatloukal, K Altered S-Adenosylmethionine metabolism in a Mallory body mouse model
Virchows Archive . 2007; 451(2):377-378.-21th European Congress of Pathology; SEPT 8-13, 2007; Istanbul, Turkey. [Poster]
Web of Science

Pichler, M; Mischinger, HJ; Ratschek, M; Hatz, M; Hrzenjak, A; Zatloukal, K A real-time qPCR-based assay for assessment of mRNA quality derived from paraffin-embedded tissues
PATHOL RES PRACT. 2007; 203(5):396-396.-91. Jahrestagung der Deutschen Gesellschaft für Pathologie.; MAY 30 - JUN 2, 2007; Magedeburg, GERMANY. [Poster]
Web of Science

Quan, P; Richtig, E; Seidl, H; Stefan, M; Tilz, H; Asslaber, M; Schmidbauer, U; Zatloukal, K; Kerl, H; Schaider, H Expression profiles of chemokine receptors in melanoma metastases
EXP DERMATOL. 2007; 16(3):227-227. [Poster]
Web of Science

Wagner, M; Moustafa, T; Fickert, P; Zollner, G; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Absence of FXR protects mice from bile-infarcts in biliary obstruction by reduction of bile acid-independent bile flow: Implications for targeting FXR in treatment of cholestasis?
J HEPATOL. 2007; 46: S5-S5.-42th Annual Meeting, European Association for the Study of the Liver; April, 11-15, 2007; Barcelona, Spain. Doi: 10.1016/S0168-8278(07)61603-1 [Oral Communication]
Web of Science FullText FullText_MUG

Zatloukal, k European Biobanks. ESFRI Initiative.
Biobanks in Oncology as a Tool for Diagnosis and Therapy; March 8, 2007; Genoa, ITALY. 2007. [Oral Communication]

Zatloukal, K Molekularpathologie und Systembiologie als Wegbereiter der personalisierten Medizin
48. Österreichischer Chirurgenkongress; June 7-9, 2007; Graz, AUSTRIA. 2007. [Keynote lecture]

Zatloukal, K General Conclusions and Perspectives.
Brocher Foundation: Translational Medicine in Public Health Policy: Lessons from Biobanks - Ethical, Legal and Social Issues (ELSI); Dec 6-7, 2007; Geneva, SWITZERLAND. 2007. [Oral Communication]

Zatloukal, K European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI).
Conferenc by the Irish Department of Health and Children. ; Dec 10, 2007; Dublin, IRELAND. 2007. [Oral Communication]

Zatloukal, K Tissue Banks as Key Resources for the Advancement of Personalized Medicine and Discovery of Gene-Environment Interactions.
Biobank Environment; June 1, 2007; Vienna, AUSTRIA. 2007. [Oral Communication]

Zatloukal, K Joint Technology Initiatives and European Research Infrastructures: New Chances for R&D in Medicine.
Forum Alpbach; Aug 23, 2007; Alpbach, AUSTRIA. 2007. [Oral Communication]

Zatloukal, K Personalized Medicine.
Diagnostische Molekularpathologie, Jahrestagung der Österreichischen Gesellschaft für Pathologie ÖGP; Oct 19-20, 2007; Bad Ischl, AUSTRIA. 2007. [Oral Communication]

Zatloukal, K European Research Infrastructure for Biobanking and Biomolecular Resources.
Proteome Binders Reporting Meeting & ESF Proteome Binders Workshop Affinity Proteomics; March 12-13, 2007; Alpbach, AUSTRIA. 2007. [Oral Communication]

Zatloukal, K Biobank networks: New challenges for science and society.
Gerechtigkeitskonflikte um Biobanken, Internationale Tagung für Nachwuchswissenschaftler; Oct 9-10, 2007; Marburg, SLOVENIA. 2007. [Keynote lecture]

Zatloukal, K Pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI: Opportunities for Tissue Banks).
Tissue Banking Symposium; Dec 4, 2007; Manchester, UNITED KINGDOM. 2007. [Oral Communication]

Zatloukal, K The plan for a pan-European Research Infrastructure for Biobanking and Biomolecular Resources (BBMRI): How many international biobanks come together and how can both industrial and academic biobanks get involved.
Post-conference Symposium on Biobanking and Biorepositories; Nov 15, 2007; Munich, GERMANY. 2007. [Oral Communication]

Zatloukal, K Infrastructure for Biological Resource Centres
IARC Final General Assembly; Nov 19, 2007; Lyon, FRANCE. 2007. [Oral Communication]

Zatloukal, K Biobanks: current bioethics and organizational issues.
EuroBio 2007; Sept 26-27, 2007; Lille, FRANCE. 2007. [Oral Communication]

Zatloukal, K Challenges for tissue banks in the 21st century.
Biomedical Tissue Management; March 2, 2007; Düsseldorf, GERMANY. 2007. [Oral Communication]

Zatloukal, K Pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI).
EUROCAN; Nov 19, 2007; Lyon, FRANCE. 2007. [Oral Communication]

Zatloukal, K Pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI).
6th Biobank Conference; Sept 28, 2007; Paris, FRANCE. 2007. [Oral Communication]

Zatloukal, K Molekulargenetische Analyse, Methoden der Chiptechnologie und Interpretation der Ergebnisse.
ÖÄK-Diplomkurs Genetik 2007, Österreichische Akademie der Ärzte, Fortbildungskurs für das ÖÄK-Diplom Genetik ; JAN 20, 2007; Vienna, AUSTRIA. 2007. [Oral Communication]

Zatloukal, K Neue Strategien zur Prädiktion des Metastasierungsmusters kolorektaler Karzinome
48. Österreichischer Chirurgenkongress; JUNE, 7-9, 2007; Graz, AUSTRIA. 2007. [Keynote lecture]

Zatloukal, K Hepatocellular carcinoma: From human disease to validated animal models.
International Meeting on "A Translational Worldwide Perspective for Liver Cancer".; JULY 9-10, 2007; Lyon, FRANCE. 2007. [Oral Communication]

Zatloukal, K Cooperation of Biobanks and Linkage with Secondary Data Providers-Bottlenecks and Perspectives.
Workshop on "Sample and Data Use and Protection in Biobanking in Europe: Legal Issues"; March 29, 2007; Sevilla, SPAIN. 2007. [Keynote lecture]

Zatloukal, K Tissue banks in personalised medicine: Experiences from the Genome Austria Tissue Bank.
International Conference: Biobank governance in comparative perspective. Strategies, ethics, resistance. ; June 19, 2006; Vienna, AUSTRIA. 2007. [Oral Communication]

Zatloukal, K Tissue banks as key resources for the advancement of personalized medizine and discovery of gene-environment interactions.
Consequences from Epigenetics for Nutrition, Environmental and Public Health; JUNE 1, 2007; Vienna, AUSTRIA. 2007. [Oral Communication]

Zatloukal, K Biobanken als Wegbereiter für personalisierte Medizin
Wissenschaftliche Gesellschaft der Ärzte in der Steiermark, Neue Entwicklungen in der Pathologie; May 31, 2007; Graz, AUSTRIA. 2007. [Oral Communication]

Zatloukal K, Gottweis H, Eder J, Trauner M, Denk H, Samonigg H, Stöger U GATiB, Genome Austria Tissue Bank
GEN-AU Evaluierungskonferenz; APRIL, 16-17, 2007; Vienna, AUSTRIA. 2007. [Oral Communication]

Bernhardt, GA; Bacher, H; Cerwenka, H; Kornprat, P; El-Shabrawi, A; Zatloukal, K; Mischinger, HJ An in-vivo stress model and whole gene tissue array as modern research tool to identify stress proteins as diagnostic markers and therapeutic agents.
European Surgery. Eur Surg 2006; 38(S209):107--Congress of the Austrian Society of Surgery; JUN 16, 2006; Vienna. [Poster]

Bernhardt, GA; Zollner, G; Cerwenka, H; Bacher, H; Kornprat, P; Zatloukal, K; Trauner, M; Mischinger, HJ Influence of Pringle maneuver in liver resections on hepatobiliary transporter expression in hepatocytes and postoperative jaundice.
European Surgery. Eur Surg 2006; 38(S209):107--Congress of the Austrian Society of Surgery; JUN 6, 2006; Vienna. [Poster]

Froehlich, E; Gutmann, B; Hermetter, A; Wightman, L; Stumptner, C; Hecht, P; Denk, H; Zatloukal, K Mitochondria-targeted antioxidants prevent liver injury in animal models of steatohepatitis and CCl4 intoxication
J HEPATOL. 44: S267-S267.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80726-9 [Poster]
Web of Science FullText FullText_MUG

Richtig, E; Seidl, H; Stefan, M; Tilz, H; Asslaber, M; Schmidbauer, U; Wolf, P; Kerl, H; Zatloukal, K; Herlyn, M; Schaider, H. Expression profiles of chemokine receptors in melanoma metastases
keine. 2006; -EADV; Okt 4-8,2006; Rhodos. [Poster]

Richtig, E; Seidl, H; Stefan, M; Tilz, H; Asslaber, M; Schmidbauer, U; Wolf, P; Kerl, H; Zatloukal K; Herlyn, M; Schaider, H Expression profiles of chemokine receptors in melanoma metastases
ZMF day; October 24, 2006; Graz. 2006. [Poster]

Schmidt-Gann, G; Schuller, M; Zatloukal, K; van der Nest, DG; Furst, W; van Griensven, M; Redl, H Differential gene expression in different organs after gram+/- induction in primates.
SHOCK. 2006; 26: 6-6. Doi: 10.1097/00024382-200610001-00018 [Poster]
Web of Science FullText FullText_MUG

Stark, K; Eder, J; Zatloukal, K Achieving kanonymity in DataMarts used for gene expressions exploitation
Journal of Integrative Bioinformatics. Online Journal, http://journal.imbio.de/ ; 3(3) 2006: -Data Warehouse Technologies in Bioinformatics - DWTB 2006 ; December 4-6, 2006; Wittenberg, Germany. [Oral Communication]

Stoger, U; Fickert, P; Fuchsbichler, A; Moustafa, T; Gumhold, J; Silbert, D; Zatlouka, K; Denk, H; Trauner, M 3.5-diethoxycarbonyl-1.4-dihydrocollidine (DDC) feeding induces cholestasis, chronic inflammatory bile duct damage and biliary fibrosis in mice
J HEPATOL. 44: S123-S124.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80321-1 [Poster]
Web of Science FullText FullText_MUG

Stumptner, C; Fuchsbichler, A; Zatloukal, K; Denk, H In vitro production of mallory bodies and intracellular hyaline bodies: Clues to their pathogenesis and significance
J HEPATOL. ; 44: S264-S264.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80719-1 [Poster]
Web of Science FullText FullText_MUG

Wagner, M; Halilbasic, E; Marschall, HU; Zollner, G; Fickert, P; Langner, C; Zatloukal, K; Denk, H; Trauner, M CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Forum Forschung, Sanofi-Aventis Preisverleihung; NOV 8; Graz. 2006. [Oral Communication]

Zatloukal, K Challenges for tissue banks in the 21st century. Experiences from the Genome Austria Tissue Bank (GATiB).
Bio-Europe 2006: 12th Annual International Partnering Conference; NOV 6-8, 2006; Duesseldorf, GERMANY. 2006. [Oral Communication]

Zatloukal, K Aging leads to steatohepatitis in K18 null mice: Evidences for genetic and epigenetic influences on keratin-related disease phenotypes
Reflections from the Frontiers; -Gordon Research Conference 2006, Intermediate Filaments ; July 30 - Aug 4, 2006; Boston, USA. [Poster]

Zatloukal, K Biobanken - Reihe Bioethik
Podiumsdiskussion: Biobanken im Depot ; April 25, 2006 ; Vienna, AUSTRIA. 2006. [Oral Communication]

Zatloukal, K Neue Aspekte des Gentechnikgesetzes
52. Ausseer Symposium der Wissenschaftlichen Gesellschaft der Ärzte in der Steiermark ; May 11-13, 2006; Bad Aussee, AUSTRIA. 2006. [Oral Communication]

Zatloukal, K Tissue banks in personalised medicine: experiences from the Genome Austria Tissue Bank
ELSA I Conference on Biobanks; June 6, 2006; Vienna, AUSTRIA. 2006. [Oral Communication]

Zatloukal, K; Stumptner, C; Fuchsbichler, A; Nowak, S; Kolbe, T; Denk, H Aging leads to steatohepatitis in keratin 18 null mice
Hepatology. 44(4):665A-665A.-AASLD Liver Meeting; OCT 27-31, 2006 ; Boston, USA. [Oral Communication]
Web of Science

Zatloukal, K; Stumptner, C; Gülly, C; Wagner, K; Fuchsbichler, A; Froehlich, E; Hermetter, A; Stark, K; Denk, H Cellular stress is a major inducer of steatohepatitis.
Genomics for Health - GEN-AU Conference; OCT 15-18, 2006; Vienna, AUSTRIA. 2006. [Poster]

Bernhardt, GA; Bacher, H; Cerwenka, H; Zatloukal, K; Mischinger, HJ Hsp23 ein spezifischerer Marker als Hsp70 für den Ischämie-Reperfusionsschaden nach Leberoperationen?
Eur Surg 2005; 37(S203):103--Österreichischer Chirurgenkongress; May 27; Vienna. [Oral Communication]

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Krause, R; Zatloukal, K; Marschall, HU; Jaeschke, H; Denk, H; Trauner, M Lithocholic acid feeding induces biliary obstruction and destructive cholangitis in mice
J HEPATOL. 2005; 42: 113-113.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

Fickert, P; Wagner, M; Marshall, HU; Fuchsbichler, A; Zollner, G; Zatloukal, K; Liu, J; Waalkes, MP; Cover, C; Denk, H; Hofmann, AF; Jaeschke, H; Trauner, M 24-norursodeoxycholic acid as novel therapeutic approach to sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
HEPATOLOGY. 2005; 42: -56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science

Janig, E; Fuchsbichler, A; Fickert, P; Trauner, M; Denk, H; Zatloukal, K Clusterin: A novel stress marker in biliary disease models
HEPATOLOGY. 2005; 42 (4): 413-414.-56th Annual Meeting of the American Association for the Study of Liver Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science

Seidl, H; Richtig, E; Stefan, M; Strohmaier, H; Gülly, C; Bäck, B; Asslaber, M,; Schmidbauer, U; Wolf, P; Kerl, H; Zatloukal, K; Herlyn, M; Schaider, H Differential expression of chemokine receptors in melanocytic lesions.
Proceedings of the meeting2005; -10th Worls Congress on cancers of the skin; May 13-16, 2005; Wien. [Poster]

Seidl, H; Richtig, E; Stefan, M; Strohmaier, H; Gülly, C; Bäck, B; Asslaber, M,; Schmidbauer, U; Wolf, P; Kerl, H; Zatloukal, K; Herlyn, M; Schaider, H Differential expression of chemokine receptors in melanocytic lesions.
Proceedings of the meeting2005; -6th World Congress on melanoma; Sept 6-10, 2005; Vancouver. [Oral Communication]

Stumptner, C; Muller, T; Fuchsbichler, A; Zatloukal, K; Denk, H Pathogenesis and relationship of mallory bodies and intracellular hyaline bodies: In vitro studies
HEPATOLOGY 2005 42: -.
Web of Science

Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, J; Zatloukal, K; Jaeschke, H; Deck, H; Trauner, M Role of inflammation for hepatobiliary transporter expression in ICAM-/- and lpr mice after common bile duct ligation
GASTROENTEROLOGY. 2005; 128: A89-A89.
Web of Science

Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, JS; Zatloukal, K; Denk, H; Jaeschke, H; Trauner, M Alterations of hepatobiliary transporter expression in response to common bile duct ligation in mice are independent of ICAM-1 and FAS-receptor expression
J HEPATOL. 2005; 42: 115-115.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

Asslaber, M; Haedicke, W; Redl, H; Schnetz; Strohmaier, H; Pirklbauer, M; Wrighton, C; Buck, C; Zatloukal, K Automated production of tissue microarrays for high-throughput analysis of gene expression.
Abstractband #90, p47, 2004. Jahrestagung der ÖGBM, ÖGGGT, ÖGBT und ANGT; SEP 2004; Graz, AUSTRIA. [Poster]

Bacher, H; Cerwenka, H; El-Shabrawi, A; Bernhardt, GA; Zatloukal, K; Mischinger, HJ Heat shock protein 70 ein neuer Marker für das Reperfusionstrauma nach Leberresektionen?
Eur Surg 2004; 36(S198):4--Österreichischer Chirurgenkongress; June 10, 2004; Klagenfurt. [Poster]

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Biliary leakage of fluorescent bile acids in MDR2 knockout mice: Evidence for a critical role of bile duct leakage in the pathogenesis of sclerosing cholangitis
J HEPATOL. 2004; 40: 91-91.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90295-4
Web of Science FullText FullText_MUG

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Bile acids regurgitation from leaky bile ducts causes sclerosing cholangitis in Mdr2 knockout mice
GASTROENTEROLOGY. 2004; 126: A663-A663.
Web of Science

Janig, E; Stumptner, C; Denk, H; Zatloukal, K The unfolded protein response to keratin aggregates
2004; -The Gordon Conference on Intermediate Filaments; AUG 8-13; The Queen's College, Oxford, UK. [Poster]

Panzitt, K; Strohmaier, HM; Moustafa, T; Stradner, M; Gully, C; Buck, CR; Denk, H; Zatloukal, K A non-protein-coding RNA is a major deregulated gene in hepatocellular carcinoma and may act as a general modulator of gene expression
HEPATOLOGY 2004 40: 253A-253A.
Web of Science

Strohmaier, HM; Panzitt, K; Moustafa, T; Stradner, M; Gülly, C; Buck, CR; Zatloukal, K A novel non-coding RNA implicated in liver cancer.
Proceedings of the 95th Annual Meeting of the American Association for Cancer Research. 2004; -95th Annual Meeting of the American Association for Cancer Research; MAR 27-31, 2004; Orlando, FL, USA. [Poster]

Wagner, M; Fickert, P; Marschall, HU; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M Alternative exretory routes for accumulating bile acids via adaptive renal ABC transporter expression in common bile duct-ligated (CBDL) mice
GASTROENTEROLOGY. 2004; 126: A129-A130.
Web of Science

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Gu, GL; Marschall, HU; Denk, H; Trauner, M Role of adaptive hepatobiliary transporter expression and regulation of bile acid synthetic enzymes in MDR2-/- mice: A model for chronic cholestatic liver disease due to sclerosing cholangitis
J HEPATOL. 2004; 40: 163-163.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90557-0
Web of Science FullText FullText_MUG

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Adaptive renal ABC transporter expression in common bile duct-ligated mice
J HEPATOL. 2004; 40: 26-26.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90073-6
Web of Science FullText FullText_MUG

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Hepatic and renal ABC transporter expression in mice depends on gender and changes in pregnancy
GASTROENTEROLOGY. 2004; 126: A130-A130.
Web of Science

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Gender and pregnancy affect hepatic and renal ABC transporter expression in mice
J HEPATOL. 2004; 40: 94-94.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90307-8
Web of Science FullText FullText_MUG

Wagner, M; Halilbasic, E; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Denk, H; Trauner, M Nuclear receptor (PXR, CAR) agonists induce adaptive hepatic transporter and enzyme expression in mouse liver
J HEPATOL. 2004; 40: 25-25.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90069-4
Web of Science FullText FullText_MUG

Wagner, M; Halilbasic, E; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Xenobiotic nuclear receptor (PXR, CAR) agonists coordinately stimulate a spectrum of detoxification enzymes and transport systems involved in the adaptive response to cholestasis in vivo.
HEPATOLOGY. 2004; 40: 489A-489A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Cholic acid (CA) and ursodeoxycholic acid (UDCA) exert different effects on hepatic and renal expression of Mrp4 and Mrp6, two novel ABC transporters
GASTROENTEROLOGY. 2004; 126: A16-A16.
Web of Science

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Differential effects of ursodeoxycholic acid (UDCA) and cholic acid (CA) on hepatic and renal expression of MRP4 and MRP6, two novel abc transporters, in mice
J HEPATOL. 2004; 40: 25-25. Doi: 10.1016/S0168-8278(04)90070-0
Web of Science FullText FullText_MUG

Zollner, G; Wagner, M; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Guo, GL; Marschall, HU; Denk, H; Trauner, M Mdr2(-/-) mice with sclerosing cholangitis: A model of chronic cholestasis to study the role of the adaptive response of hepatobiliary transport systems and bile acid synthetic enzymes
GASTROENTEROLOGY. 2004; 126: A751-A751.
Web of Science

Asslaber, M; Haedicke, W; Redl, H; Schnetz; Strohmaier, H; Pirklbauer, M; Wrighton, C; Buck, C; Zatloukal, K Automated production Automated production of tissue microarrays for high-throughput analysis of gene expression
Virchows Archiv. 443(3):245-289.-19th European Congress of Pathology; SEP 6-11, 2003; Ljubljana, SLOVENIA. [Poster]

Panzitt, K; Moustafa, T; Stradner, M; Guelly, C; Strohmaier, H; Buck, CR; Zatloukal, K Non-coding RNA in disease.
Jahrestagung der ÖGBM, ÖGGGT und ANGT; SEP 21-24, 2003; Graz, AUSTRIA. 2003. [Poster]

Stumptner, C; Wagner, K; Denk, H; Zatloukal, K Molecular evidence for a toxic memory effect in steatohepatitis.
HEPATOLOGY 2003 38: 500A-500A.
Web of Science

Trauner, M; Fickert, P; Zollner, G; Zatloukal, K; Denk, H Acquired alterations of hepatobiliary transport systems in human cholestatic liver diseases: potential targets of pharmacotherapy
In: Paumgartner, G; Keppler, D; Leuschner, U; Stiehl, A editor(s).FALK SYMPOSIUM; BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY; MAY 30-JUN 01, 2002; FREIBURG, GERMANY. DORDRECHT: KLUWER ACADEMIC PUBL; 2003. p.163-177.

Wagner, M; Fickert, P; Fuchsbichler, A; Silbert, D; Gumhold, J; Zollner, G; Zatloukal, K; Marschall, HU; Schuetz, JD; Gonzalez, FJ; Denk, H; Trauner, M Hepatic and renal ABC transporter expression as critical determinants of ursodeoxycholic acid-induced bile infarcts in bile duct-ligated mice.
HEPATOLOGY 2003 38: 688A-689A.
Web of Science

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Marschall, HU; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M The role of the bile acid receptor FXR in determining ATP-binding cassette (ABC) transporter expression and liver injury in common bile duct ligated (CBDL) mice
J HEPATOL 2003 38: 190-190. Doi: 10.1016/S0168-8278(03)80031-4
Web of Science FullText FullText_MUG

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Tsybrovskyy, O; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Role of nuclear bile acid receptor, FXR, in determining ATP-binding cassette (ABC) transporter expression and cholestatic liver injury in common bile duct-ligated mice
GASTROENTEROLOGY 2003 124: A697-A698. Doi: 10.1016/S0016-5085(03)83527-8
Web of Science FullText FullText_MUG

Zatloukal, K; Stumptner, C; Fuchsbichler, A; Fickert, P; Trauner, M; Denk, H The role of keratin in steatohepatitis.
HEPATOLOGY 2003 38: 501A-501A.
Web of Science

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Guo, G; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M Role of nuclear bile salt receptors Fxr and Pxr in mediating adaptive hepatobiliary transporter response to cholic acid (CA) in mouse liver
GASTROENTEROLOGY 2003 124: A59-A59. Doi: 10.1016/S0016-5085(03)80292-5
Web of Science FullText FullText_MUG

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M Role of short heterodimer partner (SHP) -dependent and -independent pathways for regulation of Na+/taurocholate cotransporter (NTCP) expression in cholestatic mouse models.
J HEPATOL. 2003; 38(2):9-10.-38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; MAR 29-APR 01, 2003; ISTANBUL, TURKEY. Doi: 10.1016/S0168-8278(03)80442-7
Web of Science PubMed FullText FullText_MUG

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M Regulation of the Na+/taurocholate cotransporter Ntcp via short heterodimer partner (SHP)-dependent or SHP-independent mechanims depends on the type of cholestatic injury
GASTROENTEROLOGY 2003 124: A730-A730. Doi: 10.1016/S0016-5085(03)83688-0
Web of Science FullText FullText_MUG

Zollner, G; Fickert, P; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Zatloukal, K; Denk, H; Trauner, M Induction of intestinal multidrug resistance-associated proteins 2 and 3 (Mrp2, Mrp3) by cholic acid (CA) and ursodeoxycholic acid (UDCA) in mice.
HEPATOLOGY 2003 38: 689A-689A.
Web of Science

Fickert, P; Trauner, M; Fuchsbichler, A; Stumptner, C; Neuberger, J; Zatloukal, K; Denk, H Abnormal expression and phosphorylation of cytokeratins in primary biliary cirrhosis (PBC).
J HEPATOL. 2002; 36(S1):141-141. Doi: 10.1016/S0168-8278(02)80506-2
Web of Science PubMed FullText FullText_MUG

Zollner, G; Fickert, P; Arbeiter, S; Silbert, D; Fuchsbichler, A; Gonzalez, F; Zatloukal, K; Denk, H; Trauner, M Ursodeoxycholic acid (UDCA) feeding induces adaptive hepatic and renal ABC-transporter expression in mice.
HEPATOLOGY 2002 36: 454A-454A.
Web of Science

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Stumptner, C; Neuberger, J; Zatloukal, K; Denk, H; Trauner, M Alterations of hepatobiliary transporter expression in primary biliary cirrhosis (PBC)
J HEPATOL 2002 36: 28-29. Doi: 10.1016/S0168-8278(02)80086-1
Web of Science FullText FullText_MUG

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Messenger RNA expression of nuclear, orphan receptors and hepatocyte nuclear factor 1 alpha (HNF-1 alpha) in inflammation-associated cholestasis (IC) and primary biliary cirrhosis
HEPATOLOGY 2002 36: 454A-454A.
Web of Science

Denk, H; Stumptner, C; Zatloukal, K Alcoholic and non-alcoholic steatohepatitis: histological differences and pathogenesis of cytoskeleton alterations
In: Leuschner, U; James, OFW; Dancygier, H editor(s).FALK SYMPOSIUM; STEATOHEPATITIS (NASH AND ASH); OCT 14-15, 2000; THE HAGUE, NETHERLANDS. DORDRECHT: KLUWER ACADEMIC PUBL; 2001. p.227-237.

Fickert, P; Fuchsbichler, A; Zollner, G; Stumptner, C; Weiglein, A; Zatloukal, K; Denk, H; Trauner, M Mdr2-p-glycoprotein-deficient (Mdr2-/-) mouse - A new model for primary sclerosing cholangitis (PSC)?
HEPATOLOGY 2001 34: 509A-509A.
Web of Science

Fickert, P; Zollner, G; Fuchsbichler, A; Stumptner, C; Lammert, F; Zatloukal, K; Denk, H; Trauner, M Ursodeoxycholic acid feeding aggravates liver injury in bile duct-ligated mice
GASTROENTEROLOGY 2001 120: A1-A1.
Web of Science

Zollner, G; Fickert, P; Fuchsbichler, A; Stumptner, C; Denk, H; Zatloukal, K; Ferenci, P; Trauner, M Expression of multidrug resistance P-glycoproteins (MDRs) and multidrug resistance-associated proteins (MRPs) in Wilson disease (WD)
J HEPATOL 2001 34: 188-188.
Web of Science

Zollner, G; Fickert, P; Fuchsbichler, A; Stumptner, C; Denk, H; Zatloukal, K; Trauner, M Multidrug resistance P-glycoproteins (MDR) and multidrug resistance-associated proteins (MRP) are not overexpressed in human hepatocellular carcinomas (HCC).
J HEPATOL 2001 34: 189-189.
Web of Science

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Stumptner, C; Ott, P; Zatloukal, K; Denk, H; Trauner, M Expression of multidrug resistance p-glycoproteins (MDR), multidrug resistance-associated proteins (MRP) and bile acid transporters in human hepatocellular carcinomas (HCC).
HEPATOLOGY 2001 34: 665A-665A.
Web of Science

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M; Franzens, K Induction of the transcriptional repressor short heterodimer partner 1 precedes down-regulation of the Na+/taurocholate cotransporter in bile duct-ligated mice.
HEPATOLOGY 2001 34: 469A-469A.
Web of Science

Egger, G; Pfragner R; Siegl, V; Zatloukal, K; Steindorfer, P Die Affinität von MCF7 Brustkrebszellen zu Hyaluronsäure-Substraten und Konzentrationen in einem in vitro-Modell
Ersatz- und Ergänzungsmethoden zu Tierversuchen H. Schöffl, H. Spielmann, F. P. Gruber, H. Appl, F. Harrer, W. Pfaller, H. A. Tritthart (Herausgeber). 2000; 6: 405-413.-Forschung ohne Tierversuche 2000; 2000; Linz, Austria. (ISBN: 3-211-8304-4 ) [Oral Communication]

Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H Toxic bile acids induce cytokeratin 8/18 overexpression and hyperphosphorylation in mouse liver.
GASTROENTEROLOGY 2000 118: 3726-3726. Doi: 10.1016/S0016-5085(00)86223-X
Web of Science FullText FullText_MUG

Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H Cytokeratin 8/18 overexpression and hyperphosphorylation induced by toxic bile acids in mouse liver
J HEPATOL 2000 32: 76-76. Doi: 10.1016/S0168-8278(00)80623-6
Web of Science FullText FullText_MUG

Fickert, P; Zenz, R; Zoliner, G; Pojer, C; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Role of bile acid hydrophobicity in regulation of hepatocellular transporter expression in mice
J HEPATOL. 2000; 32(1 Su):39-39. Doi: 10.1016/S0168-8278(00)80479-1
Web of Science FullText FullText_MUG

Fickert, P; Zenz, R; Zollner, G; Pojer, C; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Regulation of hepatocellular transporter expression depends on bile acid hydrophobicity in mice.
GASTROENTEROLOGY 2000 118: 168-168. Doi: 10.1016/S0016-5085(00)85876-X
Web of Science FullText FullText_MUG

Mueller, T; Fuchsbichler, A; Müller, W; Bavdekar, AR; Pradhan, AM; Knisely, AS; Rodeck, B; Kobayashi, K; Nagasaka, H; Sternlieb, I; Zatloukal, K; Denk, H Characterization of Mallory bodies in non-Wilsonian hepatic copper toxicosis and alcoholic hepatitis.
HEPATOLOGY 2000 32: 1213-1213.
Web of Science

Stauber, RE; Hegenbarth, KS; Tiran, A; Höfler, G; Zatloukal, K; Stenzel, HC Phenotypic screening for hemochromatosis in 4000 Austrian military recruits.
HEPATOLOGY 2000 32: 1320-1320.
Web of Science

Fickert, P; Trauner, M; Fuchsbichler, A; Kenner, L; Zatloukal, K; Denk, H Role of Kupffer cells in hepatocellular cytokeratin 8/18 expression in lipopoly-saccharide or DDC-induced hepatic injury.
HEPATOLOGY 1999 30: 552A-552A.
Web of Science

Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H Cholestasis and bile acid feeding induce cytokeratin 8/18 expression and mallory body formation in mice.
HEPATOLOGY 1999 30: 464A-464A.
Web of Science

Lackner, C; Stadlbauer, V; Stindl, G; Mischinger, HJ; Denk, H; Zatloukal, K Overexpression of keratin 8- and 18 mRNA in hepatocellular carcinoma.
HEPATOLOGY 1999 30: 324A-324A.
Web of Science

Stumptner, C; Zatloukal, K; Fickert, P; Denk, H p62/A170 - A novel component of mallory bodies associated with alcoholic hepatitis.
HEPATOLOGY 1999 30: 412A-412A.
Web of Science

Stumptner, C; Zatloukal, K; Fickert, P; Denk, H P62/A170 - A novel component of Mallory Bodies associated with alcoholic hepatitis.
HEPATOLOGY 1999 30: 551A-551A.
Web of Science

Trauner, M; Fickert, F; Zenz, R; Pojer, C; Fuchsbichler, A; Zollner, G; Denk, H; Zatloukal, K Role of Kupffer cells in regulation of multidrug resistance (mdr) P-glycoprotein expression in intrahepatic and obstructive cholestasis.
HEPATOLOGY 1999 30: 463A-463A.
Web of Science

Trauner, M; Zenz, R; Fickert, P; Kenner, L; Stauber, RE; Denk, H; Zatloukal, K Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis.
HEPATOLOGY 1999 30: 467A-467A.
Web of Science

Guertl, B; Stumptner, C; Zatloukal, K; Denk, H Role of protein kinases and phosphatases in the pathogenesis of liver disease and related animal models.
HEPATOLOGY 1998 28: 638A-638A.
Web of Science

Kenner, L; Stumptner, C; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Tau overexpression in human alcoholic liver disease.
HEPATOLOGY 1998 28: 512A-512A.
Web of Science

Kenner, L; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Overexpression of keratin-8 and -18 RNA associated with mallory body formation in patients with alcoholic hepatitis.
HEPATOLOGY 1998 28: 303A-303A.
Web of Science

Magin, TM; Hesse, M; Zatloukal, K; Stumptner, C; Denk, H; Mayer, FJ Age-dependent formation of intermediate filament inclusion bodies in keratin 18-deficient mice.
MOL BIOL CELL 1998 9: 166A-166A.
Web of Science

Stumptner, C; Heid, H; Zatloukal, K; Fuchsbichler, A; Hauser, H; Denk, H Identification of p62, a phosphotyrosine-independent ligand of p56(lck), as a main component of intracytoplasmic hyaline bodies in hepatocellular carcinoma.
HEPATOLOGY 1998 28: 416A-416A.
Web of Science

Stumptner, C; Omary, MB; Denk, H; Zatloukal, K Changes in the phosphorylation of the hepatocytic keratins 8/18 in human alcoholic hepatitis and in experimentally intoxicated mouse liver.
HEPATOLOGY 1998 28: 512A-512A.
Web of Science

Stumptner, C; Omary, MB; Denk, H; Zatloukal, K Hepatocyte keratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a Mallory body mouse model.
MOL BIOL CELL 1998 9: 165A-165A.
Web of Science

Stumptner, C; Zatloukal, K; Magin, TM; Fuchsbichler, A; Franke, WW; Baribault, H; Denk, H Pronounced liver pathology in aged keratin 8 and keratin 18 knockout mice.
MOL BIOL CELL 1998 9: 165A-165A.
Web of Science

Stumptner, C; Zatloukal, K; Magin, TM; Fuchsbichler, A; Franke, WW; Baribault, H; Denk, H Different pathologic changes in livers of aged keratin 8 and keratin 18 knockout mice.
HEPATOLOGY 1998 28: 500A-500A.
Web of Science

Udvardi, A; Kapfer, I; Zatloukal, K; Grutsch, H; Volc-Platzer, B Horizontal transfer of exogenous DNA to the skin: Therapeutic applications and safety regulations.
J INVEST DERMATOL 1998 110: 609-609.
Web of Science

Eferl, R; Kenner, L; Fickert, P; Stauber, R; Denk, H; Zatloukal, K Validation of quantitative reverse transcription polymerase chain reaction for analysis of gene expression in liver biopsies.
HEPATOLOGY 1997 26: 1496-1496.
Web of Science

Egger, G; Pfragner, R; Siegl, V; Zatloukal, K; Steindorfer, P Die Affinität von MCF7 Brustkrebszellen zu Hyaluronsäure-Substraten unterschiedlicher Molekulargrüße und Konzentration in einem in vitro-Modell.
5. Österreichischer Internationaler Kongreß über Ersatz- und Ergänzungsmethoden zu Tierversuchen: Ersatzt- und Ergänzungsmethoden in der chirurgischen Forschung; FEB 23 - 24, 1997; 1997. [Oral Communication]

Stumptner, C; Zatloukal, K; Hauser, H; Mischinger, HJ; Fuchsbichler, A; Denk, H Common antigens in intracytoplasmatic hyaline bodies in hepatocellular carcinoma, mallory bodies and neurofibrillary tangles.
HEPATOLOGY 1997 26: 265-265.
Web of Science

Stumptner, C; Zatloukal, K; Magin, TM; Franke, WW; Denk, H Keratin 8 and keratin is knockout mice as models for alcoholic hepatitis - Evidence for different functions of keratin 8 and 18.
MOL BIOL CELL 1997 8: 360-360.
Web of Science

Stumptner, C; Zatloukal, K; Magin, TM; Fuchsbichler, A; Franke, WW; Denk, H Keratin 8 and keratin 18 knockout mice as models for alcoholic hepatitis - Evidence for a different role of keratin 8 and 18 in MB formation.
HEPATOLOGY 1997 26: 264-264.
Web of Science

Udvardi, A; Kapfer, I; Zatloukal, K; VolcPlatzer, B The skin-target or barrier to transfer of exogenous DNA.
J INVEST DERMATOL 1997 109: 422-422.
Web of Science

Zatloukal, K; Stumptner, C; Lehner, M; Fuchsbichler, A; Eshkind, LG; Baribault, H; Denk, H; Franke, WW Cytokeratin protects hepatocytes from intoxication: A possible new function of intermediate filaments revealed by cytokeratin 8 knock-out mice.
HEPATOLOGY 1997 26: 213-213.
Web of Science

Zatloukal, K; Stumptner, C; Lehner, M; Fuchsbichler, A; Eshkind, LG; Baribault, H; Denk, H; Franke, WW Keratin protects hepatocytes from intoxication: A possible new function of intermediate filaments as revealed by keratin 8 knock-out mice.
MOL BIOL CELL 1997 8: 361-361.
Web of Science

Eferl, R; Sibilia, M; Gurtl, B; Hilberg, F; Fuchsbichler, A; Kapfer, I; Stumptner, C; Denk, H; Wagner, EF; Zatloukal, K Role of c-jun in embryonic mouse liver development.
HEPATOLOGY 1996 24: 506-506.
Web of Science

Kenner, L; Zatloukal, K; Eferl, R; Stumptner, C; Denk, H Griseofulvin and DDC intoxication causes overexpression and changes in the alternative splicing of tau mRNA in murine liver.
HEPATOLOGY 1996 24: 911-911.
Web of Science

Lax, S; Hofler, G; Zatloukal, K; Langsteger, W; Semlitsch, G; Eber, O Mutations in the thyrotropin receptor gene in hyperfunctioning thyroid nodules do not correlate with morphology
LAB INVEST 1996 74: 274-274.
Web of Science

Pfragner, R; Siegl, V; Egger, G; Zatloukal, K; Steindorfer, P Adherence of MCF-7 breast cancer cells to hyaluronan.
13. Jahrestag der Österreichischen Gesellschaft für Senologie; OCT 17 - 19, 1996; Graz, AUSTRIA. 1996. [Poster]

Stumptner, C; Fuchsbichler, A; Denk, H; Zatloukal, K Overexpression of cytokeratin induces accumulation of the Mallory body-specific component M(M)120-1 in vitro.
HEPATOLOGY 1996 24: 10-10.
Web of Science

Stumptner, C; Fuchsbichler, A; Lehner, M; Denk, H; Zatloukal, K Overexpression of cytokeratin induces accumulation of the Mallory body-specific component M(M)120-1.
MOL BIOL CELL 1996 7: 300-300.
Web of Science

Zatloukal, K; Stumptner, C; Fuchsbichler, A; Lehner, M; Denk, H Induction of mallory bodies reflects a toxic memory response and is linked to overexpression of cytokeratin mRNA in hepatocytes.
HEPATOLOGY 1996 24: 1900-1900.
Web of Science

MAASS, G; SCHMIDT, W; SCHWEIGHOFFER, T; BERGER, M; SCHNEEBERGER, A; ZATLOUKAL, K; COTTEN, M; WAGNER, E; BIRNSTIEL, ML INTERLEUKIN-2 TRANSFECTED MELANOMA-CELLS FOR TUMOR VACCINATION - FROM ANIMAL-MODELS TO CLINICAL-TRIALS
EUR J CANCER. 1995; 31A: 24-24.
Web of Science

WAGNER, E; BUSCHLE, M; MECHTLER, K; KICHLER, A; PLANK, C; ZAUNER, W; BLAAS, D; KUCHLER, E; ZATLOUKAL, K; COTTEN, M; BIRNSTIEL, ML RECEPTOR-MEDIATED GENE-TRANSFER AND ENDOSOMAL RELEASE
J CELL BIOCHEM. 1995; 358-358.
Web of Science

COTTEN, M; WAGNER, E; ZATLOUKAL, K; BUSCHLE, M; CHIOCCA, S; PLANK, C; ZAUNER, W; SCHMIDT, W; BIRNSTIEL, ML RECEPTOR-MEDIATED GENE DELIVERY
J CELL BIOCHEM. 1994; 214-214.
Web of Science

KOSZIK, F; SCHNEEBERGER, A; ZATLOUKAL, K; PAYER, E; ELBE, A; WAGNER, E; BIRNSTIEL, ML; STINGL, G IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS PROTECTS MICE AGAINST SUBSEQUENT CHALLENGE WITH WILD-TYPE M-3 CELLS - CHARACTERIZATION OF THE EFFECTOR POPULATIONS
J INVEST DERMATOL. 1994; 102(4): 583-583.
Web of Science

MAASS, G; ZATLOUKAL, K; SCHNEEBERGER, A; SCHMIDT, W; BERGER, M; BUSCHLE, M; COTTEN, M; WAGNER, E; STINGL, G; BIRNSTIEL, ML MECHANISMS LEADING TO IL-2 MEDIATED TUMOR REJECTION IN MURINE MELANOMA
J CELL BIOCHEM. 1994; 239-239.
Web of Science

SCHNEEBERGER, A; KOSZIK, F; ZATLOUKAL, K; KUTIL, R; ELBE, A; WAGNER, E; BIRNSTIEL, ML; STINGL, G ANTITUMOR EFFECTOR MECHANISMS GENERATED BY VACCINATION WITH INTERLEUKIN-2 TRANSFECTED MURINE MELANOMA-CELLS
J INVEST DERMATOL. 1994; 103(3): 408-408.
Web of Science

SCHNEEBERGER, A; ZATLOUKAL, K; KOSZIK, F; PAYER, E; ELBE, A; WAGNER, E; BIRNSTIEL, ML; STINGL, G MECHANISMS LEADING TO INTERLEUKIN-2 MEDIATED IMMUNITY AGAINST M3 MURINE MELANOMA
J INVEST DERMATOL. 1994; 102(4): 583-583.
Web of Science

DUROVIC, S; KRASNAI, C; DIEPLINGER, H; FRANK, S; ZATLOUKAL, K; UTERMANN, G; ZECHNER, R; KOSTNER, GM THE INFLUENCE OF GLYCOSYLATION OF APO(A) ON ITS SECRETION AND LP(A) FORMATTING IN CULTURED-CELLS
CIRCULATION. 1993; 88(4): 132-132.
Web of Science

WAGNER, E; COTTEN, M; ZATLOUKAL, K; PLANK, C; CURIEL, DT; STINGL, G; BIRNSTIEL, ML RECEPTOR-MEDIATED GENE DELIVERY AND ITS AUGMENTATION BY ENDOSOME-DISRUPTIVE VIRUSES OR PEPTIDES
J CELL BIOCHEM. 1993; 210-210.
Web of Science

ZATLOUKAL, K; WAGNER, E; COTTEN, M; SCHMIDT, W; PLANK, C; BERGER, M; SALTIK, M; STINGL, G; BIRNSTIEL, ML RECEPTOR-MEDIATED CYTOKINE GENE DELIVERY TO TUMOR-CELLS FOR GENERATION OF CANCER VACCINES
J CELL BIOCHEM. 1993; 129-129.
Web of Science

HUTTER, H; SALMHOFER, H; ZATLOUKAL, K; WINTER, G; RAINER, I; DENK, H KERATIN EXPRESSION IN GRISEOFULVIN-INTOXICATED MOUSE-LIVER
MOL BIOL CELL. 1992; 3: A350-A350.
Web of Science

PREISEGGER, KH; KENNER, L; FORSTNER, M; HUTTER, H; HOEFLER, G; KURZBAUER, R; ZATLOUKAL, K; DENK, H FURTHER CHARACTERIZATION OF TAU-LIKE PROTEINS INVOLVED DURING HUMAN AND MURINE MALLORY BODY FORMATION
HEPATOLOGY. 1992; 16(4): A187-A187.
Web of Science

HUTTER, H; ZATLOUKAL, K; SPUREJ, G; DENK, H CHANGES OF KERATIN EXPRESSION IN GRISEOFULVIN-DAMAGED MOUSE LIVERS
J MUSCLE RES CELL MOTIL. 1991; 12(5): 499-499.
Web of Science

SALMHOFER, H; ZATLOUKAL, K; RAINER, I; DENK, H POSTTRANSLATIONAL MECHANISMS IN INTERMEDIATE FILAMENT PATHOLOGY OF GRISEOFULVIN LIVER-DAMAGE
J MUSCLE RES CELL MOTIL. 1991; 12(5): 500-500.
Web of Science

PREISEGGER, KH; ZATLOUKAL, K; RAINER, I; SPUREJ, G; DENK, H IMMUNOHISTOCHEMICAL AND BIOCHEMICAL ANALYSES CONCERNING THE ROLE OF UBIQUITIN DURING MALLORY BODY DEVELOPMENT
HEPATOLOGY. 1990; 12(4): 952-952.
Web of Science

PREISEGGER, KH; ZATLOUKAL, K; SPUREJ, G; RIEGELNEGG, D; DENK, H RELATIONSHIP BETWEEN MALLORY BODIES AND LEWY BODIES AS REVEALED BY A NEUROFILAMENT ANTIBODY
HEPATOLOGY. 1990; 12(4): 952-952.
Web of Science

ZATLOUKAL, K; LACKINGER, E; DENK, H REINDUCTION OF MALLORY BODIES IN GRISEOFULVIN-FED MICE AFTER DRUG-WITHDRAWAL
HEPATOLOGY. 1987; 7(5): 1161-1161.
Web of Science

ZATLOUKAL, K; SOHAR, R; LACKINGER, E; DENK, H MODULATION OF THE HEAT-SHOCK RESPONSE IN HEPATOCYTES OF CHRONICALLY GRISEOFULVIN INTOXICATED MICE
HEPATOLOGY. 1987; 7(5): 1087-1087.
Web of Science

ZATLOUKAL, K; SPUREJ, G; DENK, H DERANGEMENT OF THE HEPATOCYTES CYTOKERATIN FILAMENTS INDUCED BY GRISEOFULVIN AND THEIR REGENERATION AFTER DRUG-WITHDRAWAL
HEPATOLOGY. 1987; 7(5): 1161-1161.
Web of Science

↑ Top of page / Navigation